DOI,Species,Source Cell Type,Target Cell Type,"Duration, d","name of chemical 1,CID 1;name of chemical 2,CID 2",Medium,Growth Factors,Initial Culture (text),MoA chem 1; MoA chem 2,TFs/miRNA,Title,Assocoated Data,Yield (%),Comment on Yield,Type,Comment,"Authors;sorted=""Reverse"";sep=;",Stress factors
10.1371/journal.pone.0089678,Mus musculus,Fibroblasts,Induced Cardiomyocytes,14,"SB431542,4521392",doxycycline (2 µg mL−1) and the PGK-H2B-m Cherry lentivirus,_,"MEFs, isolated at E14.5",Inhibitor of the Activin/BMP/TGF-β pathway,_,Inhibition of TGFβ signaling increases direct conversion of fibroblasts to induced cardiomyocytes,GSE54022,16.95,,2,_,John D. Gearhart; Jonathan A. Epstein; Russell C. Addis;Jamie L. Ifkovits,_
10.1007/s12015-013-9477-9,Sus scrofa,Fibroblasts,Induced Pancreatic Beta Cells,36,"5-Aza-2'-deoxycytidine,9444","N2B27 with 0.1 mM β- mercaptoetanol (Sigma), 2 mM glutamine (Sigma), 1 mM MEM Non-Essential Amino Acids (Gibco) and 0.5 % (w/v) bovine serum albumin (Sigma)",basic fibroblast growth factor 20 ng/ml,Primary porcine skin fibroblast cultures were established from fresh biopsies,Inhibitor of DNA methylation,_,Reprogramming of pig dermal fibroblast into insulin secreting cells by a brief exposure to 5-aza-cytidine,_,38.1,Counting insulin labeled cells with a flow cytometer,1,_,F.; Gandolfi; T. A. L.; Brevini; M. M.; Rahman; M.; Campagnol; S.; Maffei; G.;Pennarossa,_
10.1038/ncomms3183,Homo sapiens,Fibroblasts,Induced Cholinergic Neurons,28,"Forskolin,47936;Dorsomorphin,11524144",_,FGF2 (10 ng ml−1),Human fibroblasts were obtained from commercial sources and maintained in fibroblast medium (DMEM supplemented with 10 or 15%  fetal bovine serum and penicillin/streptomycin) according to the  vendor’s instructions for cell culture.,"CAMP agonist;Inhibitor of ALK2, ALK3, ALK6",NGN2,Small Molecules Enable Neurogenin 2 to Efficiently Convert Human Fibroblasts Into Cholinergic Neurons,GSE45954,57.2,,2,_,Oliver Brüstle; Philipp Koch; Franz-Josef Müller; Gesine Kögler; Peter Wernet; Stefan Herms; Finnja Glaue; Daniel Poppe; Jonas Doerr; Jaideep Kesavan; Jerome Mertens;Julia Ladewig,_
10.1016/j.biocel.2013.04.022,Homo sapiens,Mesenchymal Stem Cells (Bone marrow derived),Induced Neurons,28,"SB431542,4521392;Dorsomorphin,11524144","NeuroCult supplemented with 1% penicillin/streptomycin, 2 mM Glutamine, 1% N2, 20 ng/ml recombinant human EGF10 ng/ml recombinant human bFGF, 4 g/ml heparin, 10 ng/ml recombinant human LIF",10 ng/ml recombinant human bFGF,8-week fetal forebrain,"Inhibitor of the Activin/BMP/TGF-β pathway;Inhibitor of ALK2, ALK3, ALK6",_,"Enhancing the efficiency of direct reprogramming of human mesenchymal stem cells into mature neuronal-like cells with the combination of small molecule modulators of chromatin modifying enzymes, SMAD signaling and cyclic adenosine monophosphate levels",_,1,"Sodium current, Electrophysiological recordings",1,_,Zhiying Zhang; Qing-song Liu;Alexanian Arshak R.,_
10.1371/journal.pone.0003531,Mus musculus,Primordial Germ Cells,Induced Pluripotent Epiblast Cells ,10,"Trichostatin A,444732","LIF (1200 IU/ml), FGF-2 (25 ng/ml) ",FGF-2 (25 ng/ml),"EG cell lines, 8.5 EGC-1 and 4-3 Rosa, were derived from E8.5 and −11.5 PGCs",Inhibitor of the histone deacetylases I and II,_,Reprogramming Primordial Germ Cells into Pluripotent Stem Cells,_,30,cells were stained for TNAP activity and the number of colonies was counted,2,_,M. Azim Surani; Reuben Tooze; Gina Doody; Fuchou Tang;Gabriela Durcova-Hills,_
10.2217/rme.10.67,Homo sapiens,Mesenchymal Stem Cells (Bone marrow derived),Induced Neurons,28,"Trichostatin A,444732;5-Aza-2'-deoxycytidine,126357;RG108,123134263;Forskolin,47936;IBMX,3758","epigenetic modifiers (e.g., inhibitors of DNA methylation and histone deacetylation) and to a neural environment (i.e., NSC condition medium and fixed NSCs), or neural induction factors, neurotrophins (NTs), mitogens, sonic hedgehog, Retinoic acid, 2-phospho-L-ascorbic acid and pharmacological agents that increase intracellular cAMP levels",NGF; NT-3; GDNF; BDNF,Human BM‑derived MSCs,Inhibitor of the histone deacetylases I and II;Inhibitor of DNA methylation;Inhibitor of the DNA methyltransferase;CAMP agonist;Inhibitor of the cyclic nucleotide phosphodiesterases,_,An efficient method for generation of neural-like cells from adult human bone marrow-derived mesenchymal stem cells,_,30,long axon- and dendrite-like extensions,1,TSA complimented by LIF and SCF,Alexanian A. R,_
10.1002/hep.23506,Homo sapiens,Embryonic stem cells,Induced Hepatocytes,20,"Retinoic acid,444795","CDM: 10 ng/mL activin, FGF2 12 ng/mL, CDM/PVA, 100 ng/mL activin, 20 ng/mL FGF2, 10 ng/mL BMP4, 10 μM, FGF10, 10−7 M Retinoic acid, 10 μM SB431542",FGF4; EGF;HGF;Activin;FGF2;BMP4,"hESCs (H9; WiCell, Madison, WI)",Agonist of a retinoic acid receptor,_,Generation of functional hepatocytes from human embryonic stem cells under chemically defined conditions that recapitulate liver development,_,60,"cuboidal shapes typical of hepatocytes. In addition, the cells generated expressed markers specific for mature liver cells, including α1‐antitrypsin (AAT), APOA‐II, tyrosine aminotransferase, tryptophan 2,3‐dioxygenase, factor IX, and the detoxifying enzymes Cyp3A7 and Cyp7A1",2,_,Ludovic Vallier; Anne Weber; James Di Santo; Roger Pedersen; Hélène Strick‐Marchand; Sylvie Mainot; Sophie Branchereau; ClémenceMartinet; Amélie Martinez; Sébastien Corbineau; Nicholas R. F. Hannan;Thomas Touboul,_
10.1089/scd.2013.0438,Mus musculus,Primordial germ cells,Induced Embryonic Germ Cells,10,"SB431542,4521392;PD0325901,9826528;CHIR99021,9956119","This medium contained knockout Dulbecco’s modified Eagle’s medium (KODMEM;Invitrogen), 2% fetal calf serum (FCS; HyClone)or knockout serum replacement (KSR; Gibco), 0.1% MEMnonessential amino acids (Invitrogen), 2mM L-glutamine(Invitrogen), 0.1mM b-mercaptoethanol (Sigma-Aldrich),100 U/mL penicillin and 100 mg/mL streptomycin (Invitrogen)supplemented with recombinant mouse LIF(1000 U/mL; ESGRO, Chemicon), homemade bFGF(25 ng/mL; Royan Institute), and SCF (100 ng/mL; R&D).The following day we replaced the medium with serumfreeN2B27-supplemented medium that consisted ofDMEM/F12 (Invitrogen) and neurobasal (Invitrogen) at a1:1 ratio, 1% N2 supplement (Invitrogen), 1% B27 supplement(Invitrogen), 2mM L-glutamine, 1% MEM nonessentialamino acids, 100 U/mL penicillin, 100 mg/mLstreptomycin, 0.1mM b-mercaptoethanol and 5 mg/mLBSA (Sigma-Aldrich), LIF (1000 U/mL)",LIF,"used outbred (NMRI) and inbred (DBA2; Pasteur Institute, Tehran, Iran) mice strains to derive EGCs.All  embryos were obtained by natural mating.",Inhibitor of the Activin/BMP/TGF-β pathway;Inhibitor of MEK/ERK pathway;Inhibitor of GSK3β,_,Efficient induction of pluripotency in primordial germ cells by dual inhibition of TGF-β and ERK signaling pathways,_,47,differentiation capacity,1,_,and Hossein Baharvand; Abdolhossein Shahverdi; Behrouz Asgari; Fereshteh Esfandiari; Seyedeh-Nafiseh Hassani; Hassan Ansari; Houri Sepehri;Farnoosh Attari,_
10.1089/scd.2013.0134,Homo sapiens,Fibroblasts,Induced Pancreatic Beta Cells,5,"Romidepsin,5352062;5-Aza-2'-deoxycytidine,9444","Islet cells were grown in Dulbeco modified Eagle medium (DMEM) supplemented with 2%fetal calf serum, 100U/mL of penicillin, 100 mg/mL of streptomycin, and 2mM glutamine",,Adult human primary dermal fibroblasts were obtained from ATCC. Human islets were obtained from cadaveric from ATCC. Human islets were obtained from cadaveric pancreases from the National Islet cell Resource Center Basic Science Islet Distribution Program,Inhibitor of the histone deacetylase;Inhibitor of DNA methylation,_,Reprogramming Adult Human Dermal Fibroblasts to Islet-Like Cells by Epigenetic Modification Coupled to Transcription Factor Modulation,_,84,"Over 80% of the cells stained positive for glucagon, while only around 2%–4% of the cells were positive for insulin",1,"TF Pdx1 can increase yield, but Romidepsin and 5-Azacytidine are able to induce islet-like cell from fibroblasts",Marvin C. Gershengorn; Elizabeth Geras-Raaka;Liora S. Katz,_
10.1089/cell.2011.0074,Sus scrofa,Fibroblasts,Induced Adipocytes,20,"SB431542,4521392;Thiazovivin,46209426","DMEM supplemented with 10% FBS, 0.1mM nonessential amino acids, 0.055mM 2-mercaptoethanol, and 2mM L-glutamine; chemical induction medium contained DMEM/F12, 15% Knockout Serum Replacement, 0.1mM nonessential amino acids, 0.055mM  2-mercaptoethanol, 2mM L-glutamine, 2 lM Thiazovivin, and 0.5 lM SB431542. The hormonal induction medium contained DMEM, 15% FBS, 0.1mM nonessential amino acids, 0.055mM 2-mercaptoethanol, 2mM L-glutamine, 5 lg/mL insulin, 1 lM dexamethasone, and 0.5mM isobutylmethylxanthine",,The PEFs were isolated from the 35-day-old fetuses of a 10-week-old Chinese miniature pig,Inhibitor of the Activin/BMP/TGF-β pathway;Inhibitor of the RHO/ROCK pathway,_,Direct Conversion of Porcine Embryonic Fibroblasts into Adipocytes by Chemical Molecules,_,27,Lipid accumulation was assessed by the quantification of A510 in destained Oil Red O with isopropanol,1,_,Hongsheng Ouyang; Mingjun Zhang; Liangxue Lai; Fei Gao; Wanhua Xie; Yongye Huang; Xiaochun Tang; Yang Zhou; Daxin Pang;Jianguo Zhu,_
10.1007/s12015-013-9482-z,Homo sapiens,Pluripotent Stem Cells,Induced Neural Precursors,12,"SB431542,4521392;LDN193189,25195294","KO-DMEM/SR medium (KO-DMEM, 20 % KO-SR, 1 % MEM-non essential amino acids, 1mML-Glutamine, 0.1mM β–Mercaptoethanol and 1 % Penicillin/Streptomycin) supplemented with ROCK inhibitor; mTeSR1 medium; DMEM/F12/N2 medium (DMEM-F12, supplemented with 1 % N2, 1.6 g/L Glucose, 1 % Penicillin/Streptomycin, and 20 μg/mL Insulin)",,"Model hPSC-Lines and Culture Conditions The hiPSC-line (iLB-C1-30 m-r12) and the iLB-C1-30 m-r12-derivedlong-term self-renewing neuroepithelial-like stem cell line(lt-NES®: iLB-C1-30 m-r12) were derived at Prof. OliverBrüstle laboratory (University of Bonn), and the hESC-line(BG01V/hOG - hOct4-GFP) was obtained from Invitrogen",Inhibitor of the Activin/BMP/TGF-β pathway;Inhibitor of TGF-beta/Smad signaling,_,Integrated Platform for Production and Purification of Human Pluripotent Stem Cell-Derived Neural Precursors,_,80.4,kinetic and phenotype analysis,1,_,Joaquim M. S. Cabral; Oliver Brüstle; Maria Margarida Diogo; Simone Haupt; Michael Peitz; Carlos A. V. Rodrigues; Tiago G. Fernandes; Andreia F. S. Matos;Gonçalo M. C. Rodrigues,_
10.1007/s12015-013-9493-9,Homo sapiens,Induced Neural Stem Cells,Induced Dopaminergic Neurons ,20,"IWP-4,2155264;SB431542,4521392;LDN193189,25195294","NP2 medium consisted of D-MEM/F-12/GlutaMAX, 1x Pen/Strep, FBS (1 %); ITS+3 or SITE+3, β-mercaptoethanol (10 μM), Heparin (2 μg/ml); EGF (20 ng/ml); rhFGF2 (10 ng/ml) and NT-3 (10 ng/ml); DMEM-F12-Glutamax medium that was supplemented with 1 % fetal bovine serum (FBS; where indicated), penicillin/streptomycin, SHH-C24II (500 ng/ml; 100 ng/ml), FGF8b (10 ng/ml), rhGDNF (5 ng/ml), rhBDNF (20 ng/ml), db c-AMP (1 mM) 2-phospho-L-ascorbic acid (200 μM), and CHIR99021 (0.5 μM; where indicated), B27 (minus vitamin A) supplement, brain derived neurotrophic factor (rhBDNF, 20 ng/ml), glial cell line derived factor (GDNF, 5 ng/ml), 2-phospho-L-ascorbic acid and dibutyryl cyclic AMP (db c-AMP; 100–500 μM). The WNT inhibitor, IWP-4 [ref 37] (100 nM days 4–6; 1 μM thereafter), SB431542 (10 μM) and LDN193189 (100 nM) were added as indicated. ","SHH-C24II (500 ng/ml, 100 ng/ml); FGF8b (10 ng/ml); rhGDNF (5 ng/ml); rhBDNF (20 ng/ml)",De-identified pubic hairy skin biopsies were obtained with ethical approval (REC REF: 08/H0907/1) from consenting individuals undergoing repeat elective Caesarean sections. ,Inhibitor of the WNT pathway;Inhibitor of the Activin/BMP/TGF-β pathway;Inhibitor of TGF-beta/Smad signaling,_,Differentiation of Human Epidermal Neural Crest Stem Cells (hEPI-NCSC) into Virtually Homogenous Populations of Dopaminergic Neurons,GSE42678,83.2,spontaneous Ca2+ activity in the form of brief spatially restricted elevations,1,_,Maya Sieber-Blum;Michael J. Taggart;Oliver Clewes;Michele Sweeney;Andrew Loughney;Bernard Verdon;Alla Narytnyk,_
10.1186/scrt423,Homo sapiens,Induced Pluripotent Stem Cells,Induced Neuronal Progenitor Cells,40,"SB431542,4521392;Dorsomorphin,11524144","knockout medium containing knockout DMEM, 20% knockout serum replacement, 0.1 mM MEM nonessential amino acids, 2 mM glutamax and 0.1 mM β-mercaptoethanol supplemented with 10 μM SB 431542 (SB, Biomol, Hamburg, Germany) and 1 μM DM (R&D Systems, Wiesbaden-Nordenstadt, Germany). On day four, the medium was changed to DMEM/F12 consisting of glutamax, N2 supplement, 10 μM SB, 1 μM DM, 0.6 μM purmorphamine (PMA, Biomol) and 100 ng/ml fibroblast growth factor 8 (FGF8). After six days, SB and DM were withdrawn. After six additional days in suspension, EBs were attached to poly-L-ornithine (20 μg/ml)/laminin (10 μg/ml)-coated cell culture plates and cultured in Neurobasal medium supplemented with glutamax, N2, B27 minus AO, 20 ng/ml BDNF, 20 ng/ml GDNF, 25 ng/ml TGFβ3, 200 μM 2-phospho-L-ascorbic acid (Sigma-Aldrich) and 1 mM cAMP (Sigma-Aldrich) for up to 30 days.",FGF8,hCBiPSC,"Inhibitor of the Activin/BMP/TGF-β pathway;Inhibitor of ALK2, ALK3, ALK6 and AMPK",Oct4; SOX2; NANOG; LIN28,Functional differentiation of midbrain neurons from human cord blood-derived induced pluripotent stem cells,_,44,sodium inward currents,1,_,Florian Wegner; Reinhard Dengler ; Andreas Leffler; Maximilian Naujock; Ulrich Martin; Alexandra Haase;Nancy Stanslowsky,_
10.1210/en.2012-1060,Homo sapiens,Embryonic Stem Cells,Induced Steroid-Producing Cells,21,"Retinoic acid,444795","Maintenance medium: 77% DMEM/F12 medium, 20% knockout serum replacement, 1% nonessential amino acids, 1% penicillin/streptomycin, 2 mML-glutamine, and 0.1 mM β-mercaptoethanol]","Activin,FGF2;BMP4;FGF10",Two human ES cell lines (H9 and KhES1) and one human iPS cell line (201B7),Agonist of a retinoic acid receptor,Oct3/4; Sox2; Klf4; c-Myc,Differentiation of Human Embryonic Stem Cells and Human Induced Pluripotent Stem Cells into Steroid-Producing Cells,_,_,"mRNA encoding adrenal cortical or gonad-specific steroidogenic enzymes, such as CYP17A1, CYP21A2, and CYP11B1 and produced steroid hormones such as progesterone, corticosterone, and cortisol.",2,_,Kazuwa Nakao; Naohisa Tamura; Naotetsu Kanamoto; Megumi Inuzuka; Katsutoshi Kojima; Daisuke Taura; Kyoko Honda; Masakatsu Sone;Takuhiro Sonoyama,_
10.1002/stem.1152,Homo sapiens,Embryonic Stem Cells;Induced Pluripotent Stem Cells,Induced Dopamine Neurons,12,"CHIR99021,9956119","Dulbecco's modified Eagle's medium/F12, N2 supplement, nonessential amino acids, and heparin in the presence of SB431542 (10 μM) and LDN193189 (200 nM, both from Stemgent). To pattern the differentiating cells to the midbrain FP progenitors, SHH (C25II, 500  ng/ml, R&D Systems, and CHIR99021 were added to the cultures from day 1 for 8 days.",FGF8 (100 ng/ml); transforming growth factor β3 (1 ng/ml),"Primate ESCs and iPSCs Human ESCs (WA09, passages 23‐45) and iPSCs (IMR90‐4, passages 45‐55)",Inhibitor of GSK3β,FoxG1,Specification of Midbrain Dopamine Neurons from Primate Pluripotent Stem Cells,_,96.7,TH‐positive neurons coexpressed FoxA2,2,_,Su‐Chun Zhang; Marina E. Emborg; Hong Chen; Huisheng Liu; Yan Liu;Jiajie Xi,_
10.1021/cn300029t,Homo sapiens,Induced Pluripotent Stem Cells,Induced Dopamine Neurons,21,"DMH1,50997747;SB431542,4521392","DMEM medium containing 10% FBS, penicillin/streptomycin, nonessential amino acids; hES medium (DMEM/F12, 20% Knockout serum replacement, 2 mM Glutamax, nonessential amino acids, penicillin/streptomycin, 55 μM β-mercaptoethanol, recombinant human FGF-2); mTeSR1 medium; neuralization medium (Knockout DMEM/F12, 15% KSR, glutamax, penicillin/streptomycin, nonessential amino acids, and 55 μM β-mercaptoethanol containing 10 μM of SB431542 Noggin or DMH1; N2-medium (DMEM/F12, N2 supplement, and high D-glucose 4.5 g/L) ",BDNF (20 ng/mL); recombinant human GDNF (20 ng/mL); recombinanthuman TGFβ-3 (1 ng/mL),Skin biopsies (3 mm) were obtained from four different subjects for the purpose of generating hiPSCs ,Inhibitor of the BMP;Inhibitor of the Activin/BMP/TGF-β pathway,Oct4; SOX2; KLF4; cMYC,"DMH1, a Highly Selective Small Molecule BMP Inhibitor Promotes Neurogenesis of hiPSCs: Comparison of PAX6 and SOX1 Expression during Neural Induction",_,100,PAX6 positive cells,2,_,Aaron B. Bowman; Kevin C. Ess; Charles C. Hong; Reed Chamberlin; Corey R. Hopkins; Asad A. Aboud; Gary G. Li; Andrew M. Tidball; Michael J. Litt;M. Diana Neely,_
10.1038/cr.2011.195,Homo sapiens;Mus musculus,Induced Pluripotent Stem Cells,Induced Cardiac Progenitor Cells,30,"Vitamin C,54670067","ESC medium containing 15% FBS, 1 μmol/l non-essential amino acids, 1 mmol/l Glutamine, 100 μmol/l β-mercaptoethanol, 50 U/ml penicillin, and 50 mg/ml streptomycin on mitomycin-C-treated mouse embryonic fibroblast (MEF) feeder layers in the presence of leukemia inhibitory factor (1 000 U/ml); medium containing 2.5% Knockout Serum Replacement; medium without bFGF; differentiation medium containing 20% FBS",,"MEFs, NPCs, Meningeal cells, AFDCs",_,_,2-phospho-L-ascorbic acid enhances the cardiac differentiation of induced pluripotent stem cells through promoting the proliferation of cardiac progenitor cells,_,86,expressed SSEA1,1,_,Huang-Tian Yang; Ying Jin; Liu Wang; Bin Wei; Jiuhong Kang; Lianju Qin; Yu Ma; Xiaoyang Zhao; Taotao Chen; Jia Wang; Zhongyan Chen; Zumei Liu;Nan Cao,_
10.1016/j.yjmcc.2011.04.012,Homo sapiens,Induced Pluripotent Stem Cells,Induced Cardiomyocytes,24,"IWR1,3137736",Undifferentiated ES culture medium. Differentiation medium.,BMP-4,human ES and iPS cells,Inhibitor of WNT pathway,BrachyuryT; mesoderm posterior 1 (MESP1),Small molecule Wnt inhibitors enhance the efficiency of BMP-4-directed cardiac differentiation of human pluripotent stem cells,_,39,beating EB,2,_,YibingQyanga; Barbara E.Ehrlich; Lawrence Lum; GrantSenyei; ShenjunZhu;MingyuYe; Xin Ge; Peter J.Amos; JerePaavola; SimonSchliffke; Min YoungLee;YongmingRen,_
10.1007/s00125-011-2246-x,Macaca mulatta,Induced Pluripotent Stem Cells,Induced Pancreatic Beta Cells,21,"SB431542,4521392","RPMI1640, DF12 and DMEM, were all supplemented with 2 mmol/l Glutamax, 0.1 mmol/l non-essential amino acids, 55 μmol/l beta-mercaptoethanol and penicillin/streptomycin. DF12 and DMEM were also supplemented with 1% B27",50 ng/ml keratinocyte growth factor KGF; 50 ng/ml EGF; 50 ng/ml hepatocyte growth factor HGF; 50 ng/ml IGF1,RM iPSC R14 and R19 cell lines,Inhibitor of the Activin/BMP/TGF-β pathway,octamer binding protein (OCT)3/4; SRY-box containing gene (SOX)2; Kruppel-like factor 4 (KLF4); c-MYC,Generation of pancreatic insulin-producing cells from rhesus monkey induced pluripotent stem cells,_,85,insulin-producing cells,2,_,H. Deng; M. X. Ding; Y. Shi; T. T. Xiang; M. Yin; X. Sui; D. H. Zhang; P. B. Zhang;F. F. Zhu,_
10.1038/nbt.1788,Homo sapiens,Induced Pluripotent Stem Cells,Induced Anterior Foregut Endoderm,19,"SU 5402,5289418;Cyclopamine,442972;AG-1478,2051;WP 1066,11210478","DMEM/F12, 20% knockout serum replacement, 0.1 mM β-mercaptoethanol, and 20 ng/ml FGF-2; DMEM/F12 supplemented with N2, B27, 2-phospho-L-ascorbic acid (50 μg/ml), Glutamax (2 mM), monothioglycerol (0.4 μM)",human BMP-4; 1 ng/ml and 10 ng/ml; human bFGF; 2.5 ng/ml; human activin A; 100 ng/ml; human Noggin; 200 ng/ml; Y-27632; 1 μM; SB431542; 10 μM; human FGF10; 10 ng/ml; human FGF7; 10 ng/ml; murine EGF 20 ng/ml; and human WNT3a; 100 ng/ml; BMP-4; 50 ng/ml; bFGF; 10 ng/ml; VEGF; 10 ng/ml; HGF; 10 ng/ml; TGFα; 20 ng/ml; dexamethasone; 40 ng/ml,"hESC (HES2, National Institutes of Health code ES02 from ES Cell International; passages 25–33); HDF2 and HDF9, hiPS cell lines","Inhibitor of VEGFR2, FGFR1 and PDGFRB;Inhibitor of the Smoothened (SMO);Inhibitor of the epidermal growth factor receptor;Inhibitor of the JAK2 and STAT3",SOX17; FOXA2,Generation of anterior foregut endoderm from human embryonic and induced pluripotent stem cells,_,95,"definitive endoderm markers CXCR4, c-KIT and EPCAM",2,_,Hans-Willem Snoeck; Gordon Keller; Valerie Gouon-Evans; Ihor R Lemischka; Christoph Schaniel; Sunita L d'Souza; Maria-Cristina Nostro; Antonia Chen;Michael D Green,_
10.1093/cvr/cvu023,Mus musculus,Fibroblast,Induced Cardiomyocytes,14,"GSK126,68210102;UNC0638,46224516",culture medium of fibroblasts,,fibroblasts from the heads of day 13.5 mouse embryos,Inhibitor of the EZH2 methyltransferase;Inhibitor of the G9a and GLP histone methyltransferase,Gata4; Hand2; Tbx5,Inhibitors of suppressive histone modification promote direct reprogramming of fibroblasts to cardiomyocyte-like cells,_,23,beat spontaneously (The prevalence of cells that showed beating or oscillation of fluorescence was calculated by dividing the  number of these cells by the number of nuclei detected by the Hoechst dye),2,_,Nobuaki Kikyo;Hiroyuki Hirai,_
10.1126/science.aaf1502,Homo sapiens,Fibroblast,Induced Cardiomyocytes,20,"CHIR99021,9956119;A83-01,16218924;Pluripotin,12003241;OAC2,2814138;Y-27632,448042;BIX01294,25150857;AS8351,135400486;SU16F,5329150;JNJ10198409,9797370",optimized cardiac induc-tion medium (CIM); human CM–conditioned medium,vascular endothelial growth factor,established human foreskin fibroblast (HFF) line that contains no cardiac cells,"Inhibitor of GSK3β;Inhibitor of ALK4, ALK5, ALK7 (activin receptor-like kinases);Inhibitor of the RasGAP and ERK1;_;Inhibitor of ROCK1 and ROCK2;Inhibitor of the G9a histone methyltransferase;Inhibit of the histone demethylase KDM5B;Platelet-derived growth factor receptor (PDGFR)-β inhibition;_",_,Conversion of human fibroblasts into functional cardiomyocytes by small molecules,_,97,spontaneously beat and uni-formly expressed multiple cardiac structural proteins,1,_,Sheng Ding; Deepak Srivastava; Guilai Shi; Tao Xu; Tianhua Ma; Haixia Wang; Mingliang Zhang; Min Xie; Baoming Nie; Ji-Dong Fu; Yu Zhang; C. Ian Spencer; Jiashun Zheng; Yu Huang;Nan Cao,_
10.1007/s12015-013-9477-9,Sus scrofa,Fibroblast,Induced Pancreatic Beta Cells,102,"5-Aza-2'-deoxycytidine,9444","DMEM with 20 % FBS, 2 mM glutamine and antibiotics; 0.1 % gelatin, 1 μM 5-aza-CR; ESC culture medium; N2B27 medium with 0.1 mM β- mercaptoetanol, 2 mM glutamine, 1 mM MEM Non-Essential Amino Acids, 0.5 % (w/v) bovine serum albumin, 30 ng/ml activinA, 10 μM Retinoic acid; 1 % B27, 20 ng/ml basic fibroblast growth factor, 1 % insulintransferrin-selenium",basic fibroblast growth factor 20 ng/ml,Primary porcine skin fibroblast cultures were established from fresh biopsies,Inhibitor of DNA methylation,_,Reprogramming of pig dermal fibroblast into insulin secreting cells by a brief exposure to 5-aza-cytidine,_,38.1,counting insulin labeled cells with a flow cytometer,1,_,F. Gandolfi; T. A. L. Brevini ; M. M. Rahman; M. Campagnol; S. Maffei;G. Pennarossa,_
10.1007/978-1-4939-0512-6_18,Mus musculus,Fibroblasts,Induced Cardiomyocytes,21,"JAK inhibitor I,5494425",Fibroblast culture medium—Dulbecco’s Modifi ed Eagle’s Medium supplemented with 15 % fetal bovine serum (not heat deactivated) and 1 % penicillin–streptomycin (100 U/mL penicillin and 100 μg/mL streptomycin fi nal concentration) ,,"From 1- to 2-day-old neonatal mouse pups, remove ventricles under sterile conditions and then wash briefl y in PBS. ",JAK inhibitor,_,Direct reprogramming of cardiac fibroblasts to cardiomyocytes using microRNAs,_,5.28,the expression of calcium signaling properties,2,_,Tilanthi JayawardenaMaria MirotsouVictor J. Dzau,_
10.1016/j.scr.2013.09.007,Mus musculus,Fibroblasts,Induced Dopaminergic Neuronal Progenitors,13,"JAK inhibitor I,5494425","Dulbecco's modified Eagle's medium (DMEM) containing 10% FBS, 1% nonessential amino acids (NEAA), and 1% penicillin/streptomycin; reprogramming initiation medium containing 10% knock-out serum replacer, 5% FBS, 1% NEAA, 2 mM Glutamax, and 0.055 mM  β-mercaptoethanol in knock-out DMEM RepM-DP containing 1x N2, 1x B27,0.05% BSA, 2 mM Glutamax, 0.11 mM β-mercaptoethanol, 200 ng/mL SHH, and 100 ng/mL FGF8b in advanced DMEM/F12 and neurobasal medium (1:1 mix); differentiation medium containing 1x N2, 1x B27, 1.0 mM Glutamax, 0.11 mM β-mercaptoethanol, 1.0 mM dibutyryl-cAMP , 0.2 mM 2-phospho-L-ascorbic acid, 10 ng/mL brain-derived neurotrophic factor (BDNF), 10 ng/mL glial cell line-derived neurotrophic factor (GDNF) in DMEM/F12",FGF2; EGF; FGF4; SHH; FGF8; BDNF; GDNF,mouse adult tail-tip fibroblasts (TTFs),JAK inhibitor,Oct4; Sox2; Klf4; c-Myc induction,Direct Lineage Reprogramming of Mouse Fibroblasts to Functional Midbrain Dopaminergic Neuronal Progenitors,_,42,"Under a currentclamp configuration, depolarizing current injections with 10-pA steps induced action potentials (APs) of recorded cells",2,_,Yee SookCho; DaejongJeon; YeonjuJo; JanghwanKimab;Han-SeopKima,_
10.1073/pnas.1200250109,Homo sapiens,Induced Pluripotent Stem Cells;Embryonic Stem Cells,Induced Cardiomyocytes,30,"CHIR99021,9956119;BIO,448949","hESC medium: DMEM/F12 culture medium 20%, KnockOut serum replacer, 0.1 mM nonessential amino acids, 1 mM l-glutamine, 0.1 mM β-mercaptoethanol, and 10 ng/mL human bFGF; mTeSR1 medium; RPMI/B27-insulin medium 5 ng/mL BMP4, 5 μM IWP2",,"Transgene-free human iPSCs (6-9-9 and 19-9-11), lentiviral integrated human iPSC (IMR90C4), and hESCs (H9, H13, H14)",Inhibitor of GSK3β;Inhibitor of GSK3,_,Robust cardiomyocyte differentiation from human pluripotent stem cells via temporal modulation of canonical Wnt signaling,_,98,contracted spontaneously as coordinated sheets,1,_,Cozzarelli Prize Winner; S. P.; Palecek; S. M.; Azarin; L. B.; Hazeltine; K.; Zhu; G.; Wilson; C.; Hsiao; X.;Lian,_
10.1038/nmeth.2999,Homo sapiens,Induced Pluripotent Stem Cells,Induced Cardiomyocytes,20,"CHIR99021,9956119;BIO,448949;Dexamethasone,5743","DMEM GlutaMAX 10% FBS, 1:200 dilution of growth factor–reduced Matrigel 9 μg/cm2; E8 medium (50:50 mixture of DMEM and Ham's F12 medium), 20 μg/ml Escherichia coli–derived recombinant human insulin, 64 μg/ml L-2-phospho-L-ascorbic acid 2-phosphate sesquimagnesium salt hydrate, 10.7 μg/ml O. sativa–derived recombinant human transferrin, 14 ng/ml sodium selenite, 100 ng/ml recombinant human FGF2, 2 ng/ml recombinant human TGFβ1, 100 nM hydrocortizone, 200 μM sodium butyrate; E7N (E8 minus TGFβ1; 200 μM sodium butyrate); blood medium: IMDM:F12, 2 mg/ml recombinant human albumin, 1% v/v chemically defined lipid concentrate, 10 μg/ml recombinant human insulin, 100 μg/ml recombinant human transferrin, 15 ng/ml sodium selenite, 64 μg/ml L-2-phospho-L-ascorbic acid 2-phosphate, 450 μM 1-thioglycerol, 50 ng/ml SCF, 10 ng/ml IL3, 2 U/ml EPO, 40 ng/ml IGF1 (Peprotech) and 1 μM dexamethasone; CDM3 medium: RPMI 1640 medium, 500 μg/ml O. sativa–derived recombinant human albumin, 75 mg/ml stock solution in water for injection (WFI) quality H2O, stored at −20 °C, 213 μg/ml L-2-phospho-L-ascorbic acid 2-phosphate, 2 μM Wnt-C59",FGF2; TGFβ1; IGF1,"two 2-mm skin punch biopsies were taken from each volunteer, diced with a scalpel",Inhibitor of GSK3β;Inhibitor of GSK3,_,Chemically Defined and Small Molecule-Based Generation of Human Cardiomyocytes,_,95,flow cytometry for TNNT2,1,_,Joseph C Wu; Joseph D Gold; Bianxiao Cui; Oscar J Abilez; Jordan R Plews; Nicholas M Mordwinkin; Bruno Huber; Sebastian Diecke; Feng Lan; Antje D Ebert; Jared M Churko; Ziliang C Lin; Praveen Shukla; Elena Matsa;Paul W Burridge,_
10.1016/j.stem.2010.11.015,Homo sapiens,Keratinocytes,Induced Pluripotent Stem Cells,28,"PS48,44141940",,,human epidermal keratinocytes (NHEKs),Activator of the PDK1,4-Oct,Reprogramming of Human Primary Somatic Cells by Oct4 and Chemical Compounds,_,-,_,2,_,Sheng Ding; Kang Zhang; Janghwan Kim; Tongxiang Lin; Rajesh Ambasudhan; Wanguo Wei; Hongyan Zhou; Wenlin Li;Saiyong Zhu,_
10.1111/j.1432-0436.2008.00284.x,Homo sapiens,Embryonic Stem Cells,Induced Cardiomyocytes,20,"SB203580,176155;Prostaglandin I2,5282411","KO-DMEM, 20% Knockoutt serum replacement (KO-SR), 1 NAA, 2mM L-glutamine, bFGF (10 ng/ml) on human fibroblasts (CCD-919Sk). Fibroblasts were cultured in DMEM, 20% FBS, 2mM L-glutamine, and 1 ITS (insulin-tranferrinselenium) to confluence, treated with mitomycin C (10 mg/ml)",IGF-1;IR-b,hESC lines HES2 and HES3-GFP from ES Cell International at passages 75–125 and NL-HES1 and 2 at passages 25–45,"Inhibitor of the MAP kinase;Activator of prostaglandin receptors EP1, EP3 and EP4",_,Chemically defined medium supporting cardiomyocyte differentiation of human embryonic stem cells.,_,9,Cytospin analysis and immunocytochemistry was conducted using cardiac a-MHC-specific staining,1,_,Bruce P.Davidson; Robert Zweigerdt; AlanColman; ChristineMummery; JenniferMoore; ChristianFreund; Su ChinTham; ShirlySieh; Siti NorfizaBte Rahmat; ThavamalarBalakrishnan; Set YenSoo; RalphGraichen;Xiu QinXu,_
10.1038/cr.2014.32,Mus musculus; Homo sapiens ,Fibroblasts,Induced Neural Progenitor Cells,20,"Valproic Acid,3121;CHIR99021,9956119;RepSox,449054","DMEM 10% FBS, 1 mM GlutaMAX, 0.1 mM non-essential amino acid; neural expansion medium 30 ng/ml heparin, 20 ng/ml EGF and 20 ng/ml bFGF; KSR medium including knockout DMEM, 15% knockout serum replacement, 1% NEAA, 1% GlutaMax, 1% sodium pyruvate, 0.1 mM β-mercaptoethanol, 1 000 U/ml leukemia inhibitory factor; mTeSR medium; N2B27 medium DMEM:F12, 1% N2, 2% B27, BMP4 50 ng/ml,1% FBS; neural differentiation medium neural basal medium, 2% B27, 1% N2, 10 ng/ml BDNF, 10 ng/ml GDNF, 10 ng/ml IGF-1, 1 μM cAMP, 200 μM 2-phospho-L-ascorbic acid",EGF; bFGF; BDNF; GDNF; IGF,MEFs were isolated from E13.5 mouse embryos; TTFs were isolated from C57BL/6 neonate on day 3,Inhibitor of histone deacetylase;Inhibitor of GSK3β;Inhibitor of the ALK5 (TGF-β type 1 receptor),_,Generation of neural progenitor cells by chemical cocktails and hypoxia.,_,25,morphological characteristics of oligodendrocytes ,1,_,Gang Pei; Wuzhou Yang; Min Wang; Wuqiang Guan; Yongchun Yu; Jian Zhao; Binlong Qiu; Wenxiang Hu;Lin Cheng,_
10.1155/2016/4304916,Mus musculus,Fibroblasts,Induced Neural Stem Cells,42,"Valproic Acid,3121;BIX01294,25150857;RG108,702558;PD0325901,9826528;CHIR99021,9956119;Vitamin C,54670067;A83-01,16218924","DMEM 10% FBS, 50 units/mL penicillin, 50 μg/mL streptomycin; Stem cell culture medium 15% FBS, 1% nonessential amino acids, 1% L-glutamine, 50 units/mL penicillin, 50 μg/mL streptomycin, 0.1 mM β-mercaptoethanol, 1,000 units mL−1 leukaemia inhibitory factor (LIF) small molecules (Valproic Acid, 1 μM; BIX01294, 1 μM; RG108, 0.04 μM; PD0325901, 1 μM; CHIR99021, 3 μM; Vitamin C, 25 μM; A83-01, 2.5 μM; neural stem cell medium DMEM/F12 with B-27, 50 units/mL penicillin, 50 μg/mL streptomycin, 8 mM HEPES buffer, 20 ng/mL EGF, and 10 ng/mL bFGF",20 ng/mL EGF; 10 ng/mL bFGF; 10 ng/mL PDGF-AA,Mouse embryonic fibroblasts (MEF) and tail-tip fibroblasts (TTF) were isolated from C57/BL6 mice,"Inhibitor of histone deacetylase;Inhibitor of the G9a histone methyltransferase;Inhibitor of the DNA methyltransferase;Inhibitor of MEK/ERK pathway;Inhibitor of GSK3β;_;Inhibitor of ALK4,  ALK7 (activin receptor-like kinases);Inhibitor of the RHO/ROCK pathway;Agonist of hedgehog;Inhibitor of histone deacetylase",_,Direct reprogramming of mouse fibroblasts to neural stem cells by small molecules.,_,2,the minimum cell number to form one colony,1,_,Xin-Fu Zhou; Damien J. Keating; Miao Yang; Nimshitha Pavathuparambil Abdul Manaph; Jia Liu; Hua Li;1 Michael D. Duffieldl; Yoon Lim;Yan-Chuang Han,_
10.1016/j.bbrc.2016.05.080,Mus musculus,Fibroblasts,Induced Neural Stem Cells,,"A83-01,16218924;Thiazovivin,46209426;Purmorphamine,5284329;Valproic Acid,3121",,bFGF; EGF;BDNF,mouse embryonic fibroblasts (MEFs),"Inhibitor of ALK4, ALK7 (activin receptor-like kinases);Inhibitor of the RHO/ROCK pathway;Agonist of hedgehog;Inhibitor of histone deacetylase",_,A combination of small molecules directly reprograms mouse fibroblasts into neural stem cells. ,_,60,_,1,_,SeungkwonYou; SungHoi Hong; Jang Bo Lee; Gyuman Park; Byung Sun Yoon; Yoon Sik Kim; Yang In Kim; Insik Hwang; Jai-Hee Moon; Suhyun Kwon; Solji Hyeon; Phil JunKang; Kyung-AhChoibc;JieZhenga,_
10.1016/j.stem.2016.03.020,Mus musculus,Fibroblasts,Induced Neural Stem Cells,25,"CHIR99021,9956119;LDN193189,25195294;A83-01,16218924;RG108,702558;Parnate,5530;SMER28,1560402;Retinoic acid,444795  ","MEF medium(DMEM supplemented with 10% fetal bovine serum, 0.1 mM nonessential amino acids, and 2 mM Glutamax); M9 medium (50% Neural basal, 50% DMEM/F12/Glutamax, 1 3 N2, 1 3 B27 without vitamin A, 0.075% BSA, 0.1 mM nonessential amino acids, with 3 mM CHIR99021, 100 nM LDN193189, 0.5 mM A83-01, 0.5 mM Hh-Ag1.5, 1 mM Retinoic acid, 10 mM SMER28, 10 mM RG108, 2 mM Parnate, and 10 ng/ml bFGF); neural stem cells medium (NSC medium: 50% Neural basal, 50% DMEM/F12/Glutamax, 1 3 N2, 1 3 B27 without vitamin A, 0.075% BSA, 0.1 mM nonessential amino acids, 20 ng/ml bFGF, and 20 ng/ml EGF)",bFGF; EGF,cells from MEFs derived from embryonic day 13.5 (E13.5) mouse embryos of Fsp1-Cre/ROSA26td,"Inhibitor of GSK3β;Inhibitor of TGF-beta/Smad signaling;Inhibitor of ALK4, ALK7 (activin receptor-like kinases);Inhibitor of the DNA methyltransferase;Inhibitor of lysine-specific demethylase 1 (LSD1);Enhancer of the mammalian autophagy;Agonist of a retinoic acid receptor",_,Pharmacological reprogramming of fibroblasts into neural stem cells by signaling-directed transcriptional activation.,_,31,Sox2+/Nestin+ ciNSLCs,1,_,ShengDing; Yadong Huang; Ke Li; Nan Cao; KaiLiu; Jiashun Zheng; Saiyong Zhu;Yujiao Jennifer Sun; Yuan-HungLin;Mingliang Zhang,_
10.1038/s41598-017-10394-y,Homo sapiens,Mesenchymal Stem Cells (Adipose-derived),Induced Neural Stem Cells,25,"SB431542,4521392;LDN193189,25195294 ","NSC induction medium Dulbecco’s modified Eagle’s medium F12 (DMEM/F12) supplement with 3% KOSR, 1% Glutamax, 1% non-essential amino acid  and 4 ng/mL basic fibroblast growth factor (bFGF) with or without three small molecules; 10 μM SB431542, 100 ng/ml noggin and 0.5 μM LDN193289",20 ng/mL epidermal growth factor (EGF); 20 ng/mL bFGF,Adipose tissue was obtained through liposuction from the healthy volunteers (23–26 years old),Inhibitor of the Activin/BMP/TGF-β pathway;Inhibitor of TGF-beta/Smad signaling,_,Small molecule-based lineage switch of human adipose-derived stem cells into neural stem cells and functional GABAergic neurons,_,85,Flow cytometry analyses the proportion of NCAM-positive,1,_,Mi-Sook Chang; Jun Soo Kwon; Ju Han Kim; C. Justin Lee; Seong Who Kim; Myong-Wuk Chon; Min Soo Byun; Jeonghoon Lee; Min Kyung Kim; Eun Kyung Choe; Jaekwang Lee; Nayeon Lee;Jihye Park,_
10.1016/j.celrep.2016.12.062,Mus musculus,Myoblasts,Induced Brown Adipocytes,8,"Bexarotene,82146 ","basal adipogenesis conditions (850 nM insulin, 1 nM T3, 0.5 mM isobuylmethylxanthine, 125 μM indomethacin, and 5 μM dexamethasone in 10% FBS DMEM); 10% FBS DMEM containing 850 nM insulin and 1 nM T3",bFGF,"C2C12, 3T3-L1, and C3H10T1/2 cells were purchased from the ATCC",Activator of the retinoid X receptors,PRDM16,Brown adipogenic reprogramming induced by a small molecule,_,70,the efficiency of Prdm16 knockdown in pre-brown adipocyte,2,_,ShengDing; Donghai Wu; Aimin Xu; Tao Xu; Yu Zhang; Shibing Tang; Ke Li; Haixia Wang; Jiashun Zheng; RanYuan; Kuai Li; Liufeng Mao; Ping Gu; Xiaoyan Hui; Tao Nie;Baoming Nie,_
10.1038/s41598-017-04665-x,Homo sapiens,Fibroblasts,Induced Brown Adipocytes,28,"SB431542,4521392;LDN193189,25195294;Forskolin,47936;Dorsomorphin,11524144;Rosiglitazone,77999  ","adipocyte medium including rosiglitazone; adipocyte medium in combination with GSK3β inhibitor, CHIR99021 (G), a MEK inhibitor, PD0325901 (M), a TGF-β signalling inhibitor, SB431542 (S), a BMP signalling inhibitor, LDN193189 (L), a P53 inhibitor, Pifithrin-α (P), and a cAMP inducer, Forskolin (F)",TGF-β,"The 3 lines of the human fibroblasts, HDF0, HDF38","Inhibitor of the Activin/BMP/TGF-β pathway;Inhibitor of TGF-beta/Smad signaling;CAMP agonist;Inhibitor of ALK2, ALK6	 and AMPK;Activator of the peroxisome proliferator-activated receptor gamma",_,"Takeda, Y., Harada, Y., Yoshikawa, T. and Dai, P. (2017) Direct conversion of human fibroblasts to brown adipocytes by small chemical compounds. Sci. Rep. 7, 4304, https://doi.org/10.1038/s41598-017-04665-x",_,100,Oil Red O staining,1,_,P.; T. and Dai; Yoshikawa; Y.; Harada; Y.;Takeda,_
10.1038/cr.2015.99,Mus musculus,Fibroblasts,Induced Cardiomyocytes,25,"CHIR99021,9956119;RepSox,9956119;Forskolin,47936;Valproic Acid,3121;Parnate,5530;TTNPB,5289501","CRM is composed of knockout DMEM, 15% FBS, 5% KSR, 0.5% N2, 2% B27, 1% Glutamax, 1% NEAA, 0.1 mM β-mercaptoethanol, 50 μg/ml 2-phospho-L-ascorbic acid (Vitamin C), 100 units/ml penicillin and 100 μg/ml streptomycin. CRFVPT cocktail consists of 10 μM CHIR99021 (C); 10 μM RepSox (R); 50 μM Forskolin (F); 0.5 mM Valproic Acid (V); 5 μM Parnate, (P); 1 μM TTNPB (T)",Tβ-4 (100 ng/ml); GDF-11 (100 ng/ml); G-CSF (20 ng/ml); NRG1-β1 (100 ng/ml).,MEFs were isolated from embryonic day 13.5 (E13.5) C57BL/6 mouse embryos,Inhibitor of GSK3β;Inhibitor of the ALK5 (TGF-β type 1 receptor);CAMP agonist;Inhibitor of histone deacetylase;Inhibitor of lysine-specific demethylase 1 (LSD1);Agonist of a retinoic acid receptor,_,"Fu, Y., Huang, C., Xu, X., Gu, H., Ye, Y., Jiang, C. et al. (2015) Direct reprogramming of mouse fibroblasts into cardiomyocytes with chemical cocktails. Cell Res. 25, 1013–1024, https://doi.org/10.1038/cr.2015.99",_,14.5,α-actinin positive,1,_,X.; Xu; C.; Huang; Y.;Fu,_
10.1038/srep13320,Rattus _,Mesenchymal Stem Cells (Hepatic Stellate Cells),Induced Hepatocytes,21,"Tauroursodeoxycholic acid,9848818","2 μM of different bile acids or by 50 ng/ml human FGF4, 40 ng/ml human HGF dissolved in Iscove’s Modified Dulbecco’s Medium supplemented with 1% insulin-transferrin-sodium selenite, 1% linolic acid-albumin from bovine serum, 1% antibiotic/antimycotic solution",,HSC were isolated from adult Wistar rats (>500 g) and Black 6 mice (>25 g),Bile acid,_,"Sawitza, I., Kordes, C., Götze, S., Herebian, D. and Häussinger, D. (2015) Bile acids induce hepatic differentiation of mesenchymal stem cells. Sci. Rep. 5, 13320, https://doi.org/10.1038/srep13320",_,23,albumin mRNA expression,1,_,Dieter Häussinger; Diran Herebian; Silke Götze; Claus Kordes;Iris Sawitza,_
10.1016/j.celrep.2016.03.071,Mus musculus,Fibroblasts,Induced Hepatocytes,21,"CHIR99021,9956119;A83-01,16218924","DMEM/F-12 10% fetal bovine serum (FBS), 0.1 mM dexamethasone, 10 mM nicotinamide, 1% ITS (insulin-transferrin-selenium) premix, penicillin/streptomycin/glutamine, 10 ng/ml fibroblast growth factor 4, hepatocyte growth factor, epidermal growth factor",fibroblast growth factor 4; hepatocyte growth factor; epidermal growth factor,mouse embryonic fibroblasts,"Inhibitor of GSK3β;Inhibitor of ALK4, ALK7 (activin receptor-like kinases)",Hnf1α,"Lim, K.T., Lee, S.C., Gao, Y., Kim, K.P., Song, G., An, S.Y. et al. (2016) Small molecules facilitate single factor-mediated hepatic reprogramming. Cell Rep. 15, 814–829, https://doi.org/10.1016/j.celrep.2016.03.071",_,14.5,_,2,_,Dong Wook Han; Lijian Hui; Jong-Hoon Kim; Amar Deep Sharma;Seung-Hoi Koo; Kinarm Ko; Jueng Soo You; Seon In Hwang; Tae Hwan Kwak; Kyoung-Jin Oh; Jonghun Kim; Yu Jin Jang; Kenjiro Adachi; Su Yeon An; Guangqi Song; Kee-Pyo Kim; Yimeng Gao; Seung Chan Lee;Kyung Tae Lim,_
10.1016/j.stemcr.2017.06.013,Mus musculus,Fibroblasts,Induced Hepatocytes,18,"Valproic Acid,3121;CHIR99021,9956119;RepSox,449054;Forskolin,47936;Parnate,5530;DZNep,73087;TTNPB,5289501","HRM (DMEM/F12, 10% FBS, 10% KSR [Gibco]). Insulin (1 μg/mL), 0.5× N2, 0.5× B27 (Gibco), 2 mM GlutaMAX, 0.1 mM NEAA, 100 units/mL penicillin, and 100 μg/mL streptomycin, containing the small-molecule cocktails CRFVPTD or CRVPTD (10 μM CHIR99021 [C], 10 μM RepSox [R], 0.5 mM Valproic Acid [V], 5 μM Parnate [P], 1 μM TTNPB [T], 50 μM Forskolin [F], and 50 nM DZNep [D]",epidermal growth factor (EGF); hepatocyte growth factor (HGF),MEFs were isolated from E12.5,Inhibitor of histone deacetylase;Inhibitor of GSK3β;Inhibitor of the ALK5 (TGF-β type 1 receptor);CAMP agonist;Inhibitor of lysine-specific demethylase 1 (LSD1);Inhibitot of histone EZH2 lysine methyltransferase;Agonist of a retinoic acid receptor,Foxa1;Foxa2;Foxa3,"Guo, R., Tang, W., Yuan, Q., Hui, L., Wang, X. and Xie, X. (2017) Chemical cocktails enable hepatic reprogramming of mouse fibroblasts with a single transcription factor. Stem Cell Rep. 9, 499–512, https://doi.org/10.1016/j.stemcr.2017.06.013 Lim, K.T., Lee, S.C., Gao, Y., Kim, K.P., Song, G., An, S.Y. et al. (2016) Small molecules facilitate single factor-mediated hepatic reprogramming. Cell Rep. 15, 814–829, https://doi.org/10.1016/j.celrep.2016.03.071",_,_,positive for albumin,2,_,Xin Xie; Xin Wang; Lijian Hui; Qianting Yuan; Wei Tang;Ren Guo,_
10.1016/j.stem.2016.06.006,Homo sapiens,Gastric Epithelial Cells,Induced Endoderm Progenitor Cells,55,"BIX01294,25150857;RG108,702558;Bay k 8644,2303;SB431542,4521392","Advanced DMEM/F12 supplemented with combinations of small molecules as indicated: Bay K 8644, 2 μM; BIX01294, 0.5 μM; SB431542, 2 μM; RG108, 0.04 μM ",FGF9,"The hGECs were isolated from macroscopically normal mucosa of surgical specimens from patients (ranging from 35 to 78 years old) who had undergone gastrectomies due to stomach cancer, or they were from endoscopic biopsies from patients who underwent physical reexamination after recovery from a gastric ulcer or gastritis with Helicobacter pylori (H. pylori) undetectable in the recovered tissue",Inhibitor of the G9a histone methyltransferase;Inhibitor of the DNA methyltransferase;Inhibitor of the L-type calcium channel;Inhibitor of the Activin/BMP/TGF-β pathway,_,"Wang, Y., Qin, J., Wang, S., Zhang, W., Duan, J., Zhang, J. et al. (2016) Conversion of human gastric epithelial cells to multipotent endodermal progenitors using defined small molecules. Cell Stem Cell 19, 449–461, https://doi.org/10.1016/j.stem.2016.06.006",_,90,the differentiating cells started to express ALB by day 14 of hepatic induction ,1,_,XuetaoPei; JiangLiu; BoFeng; XiaofangLiu; MingyangChang; FangYan; XinWang; JingZhang; JialeiDuan; WenchengZhang; ShuyongWang; JinhuaQin;Yunfang Wang,_
10.1074/jbc.M117.812537,Mus musculus,Fibroblasts,Induced Endoderm Progenitor Cells,24,"RepSox,449054;Forskolin,47936;Y-27632,448042;CHIR99021,9956119;TTNPB,5289501","N2B27 medium supplemented with bFGF(10ng/ml), BMP4(10ng/ml), RepSox(5μM), CHIR(3μM), FSK(10μM), TTNPB (1μM), Y-27632(10μM); modified medium, for which, the concentration of CHIR was adjust to 10μM, TTNPB was deleted from and ActivinA(100ng/ml) was added to the cocktails.",HGF; bFGF; FGF10; EGF; FGF2;BMP4;Activin A,MEFs were derived from 13.5 d.p.c mouse embryos from cross of male Oct4–GFP transgenic allele carrying mice (CBA/CaJ X C57BL/6J) to 129Sv/Jae female mice,Inhibitor of the ALK5 (TGF-β type 1 receptor);CAMP agonist;Inhibitor of ROCK1 and ROCK2;Inhibitor of GSK3β;Agonist of a retinoic acid receptor,_,"Cao, S., Yu, S., Chen, Y., Wang, X., Zhou, C., Liu, Y. et al. (2017) Chemical reprogramming of mouse embryonic and adult fibroblast into endoderm lineage. J. Biol. Chem. 292, 19122–19132, https://doi.org/10.1074/jbc.M117.812537",_,66.7,ALB positive,1,_,Duanqing Pei; Jing Liu; Jiekai Chen; Xiaodong Shu; Yinxiong Li; Lin Guo; Linlin Wu; Shilong Chu; Yue Qin; Jing Ye; Dongwei Li; He Liu; Junqi Kuang; Yuting Liu; Chunhua Zhou; Xiaoshan Wang; Yan Chen; Shengyong Yu;Shangtao Cao,_
10.1016/j.stem.2016.10.007,Rattus _;Mus musculus,Primary Hepatocytes,Induced Liver Progenitors (CliPs),14,"Y-27632,448042;A83-01,16218924;CHIR99021,9956119","MHs was SHM, namely, DMEM/F12 containing 2.4 g/L NaHCO3 and L-glutamine, which was supplemented with 5 mM HEPES, 30 mg/L L-proline, 0.05% BSA, 10 ng/ml epidermal growth factor, insulin-transferrin-serine (ITS)-X, 107 M dexamethasone (Dex), 10 mM nicotinamide, 1 mM 2-phospho-L-ascorbic acid-2 phosphate, an antibiotic/antimycotic solution with or without combinations of the following four small-molecule inhibitors, 10 mM Y-27632, 1 mM PD0325901, 0.5 mM A-83-01, 3 mM CHIR99021",EGF; TGF-β,Adult rat hepatocytes were isolated from 10–20-week-old female Wistar rats,"Inhibitor of ROCK1 and ROCK2;Inhibitor of ALK4, ALK7 (activin receptor-like kinases);Inhibitor of GSK3β",_,"Katsuda, T., Kawamata, M., Hagiwara, K., Takahashi, R., Yamamoto, Y., Camargo, F.D. et al. (2017) Conversion of terminally committed hepatocytes to culturable bipotent progenitor cells with regenerative capacity. Cell Stem Cell 20, 41–55, https://doi.org/10.1016/j.stem.2016.10.007",_,75,CLiPs repopulate chronically injured liver tissues,1,_,Takahiro Ochiya; Fernando D.Camargo; Yusuke Yamamoto; Ryou-u Takahashi; Keitaro Hagiwara; Masaki Kawamata;Takeshi Katsuda,_
10.1161/CIRCRESAHA.112.269035,Mus musculus,Fibroblasts,Induced Cardiomyocytes,28,"JAK inhibitor I,137226770;JAK inhibitor I,5494425",in vivo,_,_,JAK inhibitor;JAK inhibitor,miRNAs 1;miRNAs 33;miRNAs 208;miRNAs 499,MicroRNA-mediated in vitro and in vivo Direct Reprogramming of Cardiac Fibroblasts to Cardiomyocytes,_,27,αMHC-GFP reporter,2,_,Victor J. Dzau;Maria Mirotsou;Paul Rosenberg;Zhiping Zhang;Kumar Pandya;J. Alan Payne;Lunan Zhang;Elizabeth A. Finch;Bakytbek Egemnazarov;Tilanthi M. Jayawardena,_
10.1038/ncb2164,Mus musculus,Fibroblasts,Induced Cardiomyocytes,21,"JAK inhibitor I,137226770;JAK inhibitor I,5494425","Reprogramming media: knockout DMEM with 1–15% knockout serum replacement, 1–15% ES cell-qualified FBS, 1% Glutamax, 1% nonessential amino acids, 0.1 mM β-mercaptoethanol and 1% ESC-qualified nucleosides (all components from Invitrogen except nucleosides, which were from Millipore).
Chemically defined media (CDM): RPMI-1640 supplemented with 0.5 × N2, 1 × B27 (without vitamin A), 0.05% BSA (bovine serum albumin) fraction V, 0.5% Glutamax and 0.1 mM β-mercaptoethanol (all components from Invitrogen). BMP4 or JAK inhibitor 1 were added at the day 11.
Fresh media was added at least once every 48 h throughout all experiments. ",BMP,"All MEFs (129S2/SValproic AcidsCrlf) were derived according to WiCell protocols (https://www.wicell.org/index.php?option=com_docman&task=doc_download&gid=687). TTFs (tail-tip fibroblasts) were a gift from H. Schöler (Max Planck Institute for Biomolecular Medicine, Germany). 
MEFs were initially passaged on gelatin-coated (0.1%) tissue-culture dishes for 2 h at 37 °C in DMEM supplemented with 10% FBS, 2 mM Glutamax and 0.1 mM NEAA (non-essential amino acids; all components from Invitrogen). Before viral transduction, cells were seeded onto Matrigel (BD Biosciences) or Geltrex (Invitrogen)-coated plates (1:40, overnight at 4 °C) at 3.5 × 104 cells per well of a six-well plate (7 × 104 cells for TTFs) in the same media. After the addition of virus (12–24 h), cells were washed with PBS and switched to reprogramming media.",JAK inhibitor;JAK inhibitor,Oct4;Sox2;Klf4;c-Myc,Conversion of mouse fibroblasts into cardiomyocytes using a direct reprogramming strategy,_,39,"cTnT+ (Remarkably, nearly 40% (39 ± 2%, n = 5) of cells had become cTnT+ by day 18)",2,"After several rounds of experimentation employing many different combinations, we determined the following conditions to be by far the most effective: cells are first exposed to reprogramming media containing 15% FBS and 5% knockout serum replacer (KSR) for 6 days, followed by a switch to 1% FBS and 14% KSR for 3 days. During this initial 9-day period, the small-molecule JAK inhibitor JI1 is continuously kept in the media at a concentration of 0.5 μM. From day 9 onwards, the cells are cultured in CDM, with the cardioinductive growth factor BMP4 added at 20 ng ml−1 for the first 5 days.
Spontaneously contracting: https://static-content.springer.com/esm/art%3A10.1038%2Fncb2164/MediaObjects/41556_2011_BFncb2164_MOESM4_ESM.mov",Sheng Ding;Ju Chen;Gang Wang;Kunfu Ouyang;Hongyan Zhou;Hongyan Zhou;Janghwan Kim;Simon Hilcove;Jem A. Efe,_
10.1038/ncomms9243,Mus musculus,Fibroblasts,Induced Cardiomyocytes,30,"A83-01,16218924;Y-27632,448042;GW788388,10202642;LY-364947,447966;SD-208,10316032;Thiazovivin,46209426;SR-3677,25093235","Fibroblasts were plated on tissue culture dishes pre-coated with SureCoat (Cellutron) at a density of 40–50 cells mm  2 before transduction. Fibroblasts were infected twice with freshly made viral mixture containing polybrene (Sigma) 24 h, 48 h post plating, respectively. Twenty-four hours later, the viral medium was replaced with induction medium composed of DMEM/199 (4:1)
(Gibco), 10% FBS (Gemini), 5% horse serum (Gemini), antibiotics (Gibco), 1 non-essential amino acids (Gibco), 1  essential amino acids (Gibco), 1  B-27 (Gibco), 1  insulin–selenium–transferin (Gibco), 1  MEM vitamin solution (Gibco) and 1  sodium pyruvate (Gibco). The medium was changed every 2–3 days until cells were examined.",_,"MEFs: C57BL/6 pregnant mice at E13 were purchased from Charles River’s laboratory. Embryos at E14.5 were harvested and their internal organs and head were removed. The body below the liver was minced to fine pieces. Minced embryos were incubated with 2 ml of 0.25% trypsin/1 mM EDTA, Phenol Red (Gibco) for 40 min at 37 C with 5% CO2. Cells were suspended in 25 ml of
growth medium (DMEM/Hi glucose (Hyclone) 10% fetal bovine serum (FBS; Gemini), 1.1% Penicillin–Streptomycin (Gibco) and 1.1% GlutaMAX supplement (Gibco) and then plated on a 15-cm dish. In 24 h, the media were aspirated and new 25 ml of growth medium was added. In 72 h, MEFs were harvested and stored for future use.

Adult Cardiac Fibroblasts (ACFs): Hearts for mouse ACFs or skinned tails for ATTFs (adult tail-tip fibroblasts) from adult C57BL/6 mice were cut into small pieces with B1 mm diameter. The biopsies were seeded on a 10-cm culture dish and incubated with 10 ml of growth medium (DMEM/Hi glucose (Hyclone), 10% FBS (Gemini), 1.1% Penicillin–Streptomycin (Gibco) and 1.1% GlutaMAX supplement (Gibco) at 37 C with 5% CO2. Fibroblasts migrated out of the biopsies after 3 days. The media were changed every other day. Once the fibroblasts have reached a 70–80% confluence, the cells were harvested and stored for future useHearts for mouse ACFs or skinned tails for ATTFs from adult C57BL/6 mice were cut into small pieces with B1 mm diameter. The biopsies were seeded on a 10-cm culture dish and incubated with 10 ml of growth medium (DMEM/Hi glucose (Hyclone), 10% FBS (Gemini), 1.1% Penicillin–Streptomycin (Gibco) and 1.1% GlutaMAX supplement (Gibco) at 37 C with 5% CO2. Fibroblasts migrated out of the biopsies after 3 days. The media were changed every other day. Once the fibroblasts have reached a 70–80% confluence, the cells were harvested and stored for future use","Inhibitor of ALK4, ALK7 (activin receptor-like kinases);Inhibitor of ROCK1 and ROCK2;Inhibitor of Transforming Growth Factor Beta Signaling;TGF-b signalling inhibitor;Inhibitor of the TGF-b signalling;Inhibitor of the RHO/ROCK pathway;Inhibitor of the ROCK-II",Gata4;Hand2;Mef2c;Tbx5;miR-1;miR-133,High-efficiency reprogramming of fibroblasts into cardiomyocytes requires suppression of pro-fibrotic signalling,GSE71405;GSE71392,2.5,Percent of beating cardiomyocytes on day 11 (MEFs);GHMT2m plus A83-01 produced  2.5% spontaneously beating cells by 5 weeks,2,"Addition of A83-01 and Y-27632 together produced  69% spontaneously beating cells in GHMT2m cultures, which is not significantly different from the fraction of beating cells induced by A83-01 alone (GHMT2m -- miR-1 miR-133 (2m) + GHMT(GATA4, Hand2, Mef2C, Tbx5))",Kunhua Song;Timothy A. McKinsey;Peter M. Buttrick;Lori A. Walker;Mark Y. Jeong;Kenneth L. Jones;Rebecca O’Rourke;Catherine Proenza;Emily J. Sharpe;Yingqiong Cao;Pilar Londono;Yuanbiao Zhao,_
10.1016/j.celrep.2014.01.038,Mus musculus,Fibroblasts,Induced Cardiomyocytes,30,"SB431542,4521392;CHIR99021,9956119;Parnate,19493;Forskolin,47936","Cardiac reprogramming media (CRM): knockout DMEM with 5% knockout serum replacement, 15% ES cell-qualified FBS, 1% Glutamax, 1% nonessential amino acids, and 0.1 mM β-mercaptoethanol, with or without small molecules.",_,"MEFs (mouse embryonic fibroblasts) and TTFs (tail-tip fibroblasts) were prepared from C57B6 and OG2 mice (JAX) using established methods (doi:10.1038/ncb2164) . Isl1-Cre/ROSAmTmG embryos were obtained by crossing Isl-Cre mice with ROSAmTmG mice (JAX) (10.1002/dvg.20335;10.1186/1471-213X-1-4). Briefly, MEFs were isolated from E13.5 mouse embryos. The head, internal organs from the abdominal cavity, and heart regions were carefully removed from the embryos, and the tissues left were cut and trypsinized to produce single-cell suspensions. Those cells were expanded in MEF growth medium (MEF-GM) containing DMEM supplemented with 10% FBS, 2 mM Glutamax and 0.1 mM non-essential amino acids (NEAA). To generate TTFs, tail tips from neonatal mice were minced with a sterile razor blade and then evenly put into 10cm culture dish containing 2ml MEF-GM. Next day, additional medium was filled in. Five days later, fibroblasts migrated outof tissue samples were collected and expanded.",Inhibitor of the Activin/BMP/TGF-β pathway;Inhibitor of GSK3β;Inhibitor of lysine-specific demethylase 1 (LSD1);CAMP agonist,Oct4;Klf4;Sox2,"Small Molecules Enable Cardiac Reprogramming of Mouse Fibroblasts with a Single Factor, Oct4",_,40,"Number of beating clusters per 10^4 MEFs, not Percent",2,_,Sheng Ding;Deepak Srivastava;Xiaojing Wang;Yu Zhang;Tao Xu;Tianhua Ma;Baoming Nie;C. Ian Spencer;Nan Cao;Haixia Wang,_
10.1016/j.bbrc.2015.05.127,Mus musculus,Fibroblasts,Induced Cardiomyocytes,25,"Cardiogenol C,11345983;Vitamin C,54670067","Reprograming medium (RM): knockout DMEM (Invitrogen) with 5% knockout serum replace-ment (KSR, Invitrogen), 15% ES-FBS (Invitrogen), 1% Glutamax(Invitrogen), 1% nonessential amino acids (Invitrogen), 0.1 mMb-mercaptoethanol (Sigma), and 0.5mM JAK inhibitor (JI1, EMD). Forthose experiments carried out through the lentiviral induciblesystem, 5mg/ml doxycycline (SigmaeAldrich) was applied for thefirst 5 days.

Differentiation priming medium (DPM): knockout DMEM (Invitrogen) with 1% FBS, 14% KSR, 1% Glutamax, 1% nonessential amino acids, 0.1 mMb-mercaptoethanol and 0.5mM JI1.

Cardiomyocyte differentiation medium (CDM):RPMI-1640 supplemented with 0.5*N2, 1*B27(without vitamin A) (Invitrogen), 0.05% BSA-fraction V (Sigma),0.5% Glutamax, 0.1 mMb-mercaptoethanol, and 20 ng/ml BMP4(Stemgent).",BMP4,,Inducer of cardiac differentiation;_,Oct4;Sox2;Klf4;c-Myc,2-phospho-L-ascorbic acid promotes the direct conversion of mousefibroblasts intobeating cardiomyocytes,_,60,Percent of Beating Patches,2,_,Hossein Baharvand;Nasser Aghdami;Sara Pahlavan;Mahmood Talkhabi,_
10.1038/srep44534,Homo sapiens,Fibroblasts,Induced Mesenchymal Stem Cells,6,"SP600125,8515;SB202190,5169;GO6983,3499;Y-27632,448042;PD0325901,9826528;CHIR99021,9956119",DMEM-HG,TGF-β;bFGF;LIF,"Human primary neonatal foreskin fibroblasts (CRL2097) started from passage 4 after isolation were purchased from the ATCC (Manassas, VA, USA) and cultured in Dulbecco’s Modified Eagle Media-high glucose (DMEM-HG) medium with 10% fetal bovine serum (FBS) (HyClone, Logan, UT, USA). Primary adult abdominal skin fibroblasts derived from two adult females (DF440547 and DF443480) who are 42 and 56 years old, respectively (LONZA, Basel, Switzerland). These cells were cultured in DMEM-HG with 10% FBS and started in culture from passage 1.",Inhibitor of JNK;Inhibitor of the p38;Inhibitor of protein kinase C;Inhibitor of ROCK1 and ROCK2;Inhibitor of MEK/ERK pathway;Inhibitor of GSK3β,_,Efficient Generation of Chemically Induced Mesenchymal Stem Cells from Human Dermal Fibroblasts,GSE72693,38,"Percent of cells that fulfill three criteria, including (1) being plastic-adherent when maintained in standard culture conditions, (2) expressing CD105, CD73 and CD90 surface markers, and not expressing CD45, CD34, CD14/CD11b, CD79a/CD19 and HLA-DR surface molecules, and (3) able to differentiate into
osteoblasts, adipocytes, and chondrocytes in vitro5",1,_,Jean Lu;Hsiao-Chun Huang;Yu-Chuan Liu;Yi-Hsuan Lee;Frank Leigh Lu;Hsiang-Yi Chang;Ching-FangChang;Kuo-Hsuan Hung;Shang-ChihYang;Shang-FuChen;Hsuan Lin;Pei-Lun Lai,_
10.1016/j.stem.2015.06.003,Mus musculus,Fibroblasts,Induced Neurons,21,"Forskolin,47936;ISX9,19582717;CHIR99021,9956119;SB431542,4521392;I-BET151,52912189","Neuronal induction medium: Neurobasal Medium, N2
and B27 supplements, GlutaMAX, penicillin-streptomycin (all from Life technologies), and bFGF (100–250 ng/ml; Origene). 
Culture medium: neuronal induction medium + the small molecules. Refreshed every 3–4 days during the chemical induction period.
Maturation medium: the neuronal induction medium plus Forskolin, 10 mM; BDNF, 20 ng/ml; and GDNF, 20 ng/ml",BDNF;GDNF,"The passaged fibroblasts were seeded onto a Matrigel-coated plate (BD; 1:30 in pre-cold PBS) and were not chemically induced until confluent (preferentially seeded at a
density of 100,000 cells per well of a 6-well plate and induced after 4 days’culture). ",CAMP agonist;Neurogenic Modulator;Inhibitor of GSK3β;Inhibitor of the Activin/BMP/TGF-β pathway;Inhibitor of the BET family,_,Small-Molecule-Driven Direct Reprogramming of Mouse Fibroblasts into Functional Neurons,GSE68715,30,Percent of TUJ1-positive neuronal cells,1,_,Hongkui Deng;Yang Zhao;Zhen Chai;Jinlin Wang;Xiong Xiao;Jun Xu;Yuanyuan Du;Liang Xiong;Xiaomin Du;Jialiang Zhu;Defang Liu;Jiaming Wang;Yantao Ma;Junzhan Jing;Xiaohan Zuo;Xiang Li,_
10.1016/j.stem.2015.09.012,Homo sapiens,Astrocytes,Induced Neurons,10,"LDN193189,25195294;SB431542,4521392;TTNPB,5289501;Thiazovivin,46209426;CHIR99021,9956119;Valproic Acid,3121;DAPT,5311272;SAG,5284330;Purmorphamine,5284329","Neuronal Differentiation Medium (NDM): DMEM/F12 (GIBCO), 0.5% FBS (GIBCO), 3.5 mM glucose (Sigma), penicillin/streptomycin (GIBCO), and N2 supplement (GIBCO)",BDNF;IGF-1;NT3,"Human astrocytes were purchased from ScienCell (HA1800) or GIBCO (N7805-100). Human astrocytes were primary cultures obtained from human fetal brain tissue. They were isolated and maintained in the presence of 10% FBS, which will essentially cause any progenitor cells to differentiate. Human astrocytes were subcultured when they were over 90% confluent. For subculture, cells were trypsinized by TrypLE Select (Invitrogen), centrifuged for 5 min at 900 rpm, re-suspended, and plated in a culture medium consisting of DMEM/F12 (GIBCO), 10% FBS (GIBCO), penicillin/streptomycin (GIBCO), and
3.5 mM glucose (Sigma), supplemented with B27 (GIBCO), 10 ng/ml epidermal growth factor (EGF, Invitrogen), and 10 ng/ml fibroblast growth factor 2 (FGF2, Invitrogen). Cells were maintained at 37C in humidified air with 5% CO2",Inhibitor of TGF-beta/Smad signaling;Inhibitor of the Activin/BMP/TGF-β pathway;Agonist of a retinoic acid receptor;Inhibitor of the RHO/ROCK pathway;Inhibitor of GSK3β;Inhibitor of histone deacetylase;Inhibitor of γ-secretase;Agonist of the Smoothened;Agonist of hedgehog,_,Small Molecules Efficiently Reprogram Human Astroglial Cells into Functional Neurons,_,67,Percent of Tuj1+ cells,1,_,Gong Chen;Gang-Yi Wu;Peng Jin;Li Chen;Li Lin;Yanming Wang;Xiangyun Amy Chen;Grace Lee;Ning-Xin Ma;Hana Yeh;Jiu-Chao Yin;Lei Zhang,_
10.1016/j.stemcr.2017.01.014,Homo sapiens,Astrocytes,Induced Neurons,26,"Valproic Acid,3121;CHIR99021,9956119;RepSox,449054;Forskolin,47936;I-BET151,52912189;ISX9,19582717","Neurobasal medium (Gibco). 
Astrocyte growth medium (CellApplications, 821-500)",_,Human adult astrocytes were obtained with written consent from the patients or their guardians as approved by the ethics committees of the Third Military Medical University. The cells were maintained and expanded in human astrocyte growth medium,Inhibitor of histone deacetylase;Inhibitor of GSK3β;Inhibitor of the ALK5 (TGF-β type 1 receptor);CAMP agonist;Inhibitor of the BET family;Neurogenic Modulator,_,Direct Generation of Human Neuronal Cells From Adult Astrocytes by Small Molecules,GSE84826,8,"Percent, Conversion efficiency",1,_,Gang Pei;Li Shen;Xiuwu Bian;Yifang Ping;Yongchun Yu;Binlong Qiu;Qing Liu;Jiali Yu;Huihan Wang;Min Wang;Wuqiang Guan;Longfei Gao,_
10.1038/s41598-017-18324-8,Mus musculus,Fibroblasts,Induced Dopaminergic Neurons,19,"ISX9,19582717;SB203580,176155;Y-27632,448042;I-BET151,52912189","Neuronal induction medium: Neurobasal Medium, N2, and B27 supplements, GlutaMAX, 1% of penicillin-streptomycin (all from Life technologies), and bFGF (100 ng/mL) (refreshed every 3–4 days during the induction period).",bFGF;FGF8,Mouse Fibroblasts were trypsinized into single cells and cultured in six-well plates. ,Neurogenic Modulator;Inhibitor of the MAP kinase;Inhibitor of ROCK1 and ROCK2;Inhibitor of the BET family,Ascl1;Brn2;Myt1l,Generation of Functional Dopaminergic Neurons from Reprogramming Fibroblasts by Nonviral-based Mesoporous Silica Nanoparticles,_,81,Percent of Tuj1+ cells,2,This study utilized the mesoporous silica nanoparticles (MSNs) as a non-viral delivery system,Yuan Mou;Hwa Chiou;Ting Wei;Yi Wang;Hsing Tsai;Hsuan Chang,_
10.3164/jcbn.15-39,Homo sapiens,Fibroblasts,Induced Neurons,28,"SB431542,4521392;LDN193189,25195294;CHIR99021,9956119;PD0325901,9826528;Pifithrin-α,4587369;Forskolin,47936","Neuronal medium: DMEM/F12 [1% (vol/vol) N2 supplement, Gibco] and Neurobasal [2% (vol/vol) B27 supplement, Gibco] mixed at a 1:1 ratio",_,"Four human primary fibroblasts were purchased via DS Pharma Medical (Osaka, Japan. Lot: DFMF112410B,DFM062509,DFM1002511,DFM021610). Cells were seeded at 8 × 10 4 cells in a 35-mm dish in DMEM high-glucose medium (Gibco, Grand Island, NY) supplemented with 10% FBS, 100 U/ml penicillin, and 100 μg/ml streptomycin",Inhibitor of the Activin/BMP/TGF-β pathway;Inhibitor of TGF-beta/Smad signaling;Inhibitor of GSK3β;Inhibitor of MEK/ERK pathway;Inhibitor of the p53;CAMP agonist,_,Highly efficient direct conversion of human fibroblasts to neuronal cells by chemical compounds,_,89,Percent of Tuj1+ cells,1,_,Tetsuro Takamatsu;Yoshinori Harada;Ping Dai,_
10.1016/j.celrep.2016.06.042,Mus musculus,Fibroblasts,Induced Astrocytes,26,"Valproic Acid,3121;CHIR99021,9956119;RepSox,449054;Tranylcypromine,19493;OAC1,789882","Induced astrocyte medium (iAM): DMEM/F12 with 2 mM L-glutamine, 0.1 mM NEAA, 13N2, 13B27, and 100 ng/ml FGF",FGF;CNTF,"Mouse embryonic fibroblasts (MEFs) and mouse tail-tip fibro-blasts (TTFs) were derived from embryonic day 13.5 (E13.5) embryos of Oct4-GFP transgenic, WT, or GFAP-GFP transgenic mice. These cells were cultured in MEF medium containing DMEM, 10% fetal bovine serum (FBS), 0.1 mM nonessential amino acids, and 2 mM L-glutamine. Mouse pAs were isolated from postnatal day 1 (P1)–2 pups following published protocol and cultured in DMEM containing 10% FBS.",Inhibitor of histone deacetylase;Inhibitor of GSK3β;Inhibitor of the ALK5 (TGF-β type 1 receptor);Inhibitor of lysine-specific demethylase 1 (LSD1);Epigenetic modulator,_,Small-Molecule-Based Lineage Reprogramming Creates Functional Astrocytes,GSE81927,12,Percent of GFAP+S100b+ cells,1,Replacement of RepSox with SB431542 increased % of GFAP+ cells to 38,Yanhong Shi;Arthur D;Charles Warden;Peng Ye;Jianfei Chao;Guihua Sun;Guoqiang Sun;E Tian,_
10.1016/j.stem.2014.01.006,Mus musculus,Fibroblasts,Induced Pancreatic beta cells,27,"Retinoic acid,444795;A83-01,16218924;LDE225,24775005;BIX01294,25150857;Vitamin C,91899426","Med I: (Knock-out DMEM with 10% knock-out serum replacer, 5% FBS, 2 mM Glutamax, 0.1 mM NEAA, and 0.055 mM β-mercaptoethanol) supplemented with 4 μg/ml Dox, 50 ng/ml Activin A and 1 mM LiCl.
Med II: (75% Iscove’s modified Dulbecco’s medium, 25% Ham’s F12 medium, supplemented with 1 x N2 supplements, 0.05% bovine serum albumin, 2 mM Glutamax, and 0.45 mM MTG) supplemented with 50 ng/ml Activin A and 1 mM LiCl.
Med III: (DMEM supplemented with 1xB27, 2mM Glutamax), and treated with 2 μM RA, 1 μM A83-01, 2 μM LDE225 and 280μM pVc for 1day, and then with 1 μM A83-01, 2 μM LDE225 and 280μM pVc for another 3 days.
Med IV: contains laminin, nicotinamide, and B27 etc., as described (DOI: 10.1055/s-0035-1554720)",FGF10;EGF,Dox-inducible secondary MEFs (cells at passage 3–4 were regularly used) were plated on Matrigel-coated culture dishes at a cell density of 1 x 10^4 cells/cm2. Cells were cultured in MEF medium (Dullbecco’s modified Eagle’s medium with 10% fetal bovine serum and 2 mM Glutamax) for an additional day.,"Agonist of a retinoic acid receptor;Inhibitor of ALK4, ALK7 (activin receptor-like kinases);_;Inhibitor of the G9a histone methyltransferase;_",Oct4;Sox2;Klf4;c-Myc,Small Molecules Facilitate the Reprogramming of Mouse Fibroblasts into Pancreatic Lineages,_,2,Percent of insulin+/Pdx1+ cells,2,"Complex multistage protocol (MEF > definitive endoderm-like cells (DELCs) > pancreatic progenitor-like cells (PPLCs) > Mature Pancreatic-like Cells, Figure 1A represents protocol stages)",Sheng Ding;Matthias Hebrok;Tianhua Ma;Yu Zhang;Tao Xu;Shaohua Xu;Holger A;Saiyong Zhu,_
10.1016/j.chembiol.2013.10.013,Homo sapiens,PANC-1 Ductal Adenocarcinoma Cells,Induced Pancreatic Beta Cells,,"BRD7552,23891512 ",_,_,PANC-1 cells were plated and allowed to attach overnight before the compound pin-transferred from concentrated DMSO stocks at a final concentration of 20 mM. Cells were treated with the compound for 3 days before the qPCR assay.,Increase PDX1 promoter methylation at H3K4me3 (mark of active chromatin) and decrease H3K9me3 methylation (repressive mark),_,A Small-Molecule Inducer of PDX1 Expression Identified by High-Throughput Screening,_,4,Fold change of PDX1 expression level (PDX1 is the master regulatory gene involved in beta-cell development),1,High-Throughput Screening,Bridget Wagner;Stuart Schreiber;Etienne Sokal;Nicola Tolliday;Young-kwon Kim;Damian Young;Cheng Zhong;Philippe Lysy;Deepika Walpita;Yikai Wang;Zarko Boskovic;Kate Hartland;Yuan Yuan,_
10.1038/ncomms10080,Homo sapiens,Fibroblasts,Induced Pancreatic Beta Cells,32,"Sodium butyrate,5222465;Parnate,19493;RG108,702558;NECA,4400;CHIR99021,9956119;A83-01,16218924;Compound E,222786;GDC-0449,24776445;LDN193189,25195294;Nicotinamide,936;NECA,448222","Reprogramming initiation medium: DMEM/F12, 10% Knockout serum replacement, 5% ES-FBS, 1% Glutamax, 1% Non-essential amino acids, 1% penicillin/streptomycin, 0.1 mM
b-mercaptoethanol, 10 ng ml  1 bFGF, 10 ng ml  1 EGF, 2 mM Par, 0.5 mM RG, 0.1 mM NaB, 0.5 mM NECA and 3 mM CHIR99021.
Endodermal induction medium: Advanced RPMI, 2% ES-FBS, 1% Glutamax, 1% Non-essential amino acids, 1% penicillin/streptomycin, 0.1 mM b-mercaptoethanol, 2 mM Par, 0.5 mM RG, 0.1 mM NaB, 0.5 mM NECA, 3 mM CHIR99021 and 100 ng ml  1 Activin A.
Expansion medium: DMEM, 1% Glutamax, 0.5  N2, 0.5  B27, 5 mg ml  1 BSA, 1% penicillin/streptomycin, 10 ng ml  1 bFGF, 10 ng ml  1 EGF, 0.5 mM A83-01 and 3 mM CHIR99021.",EGF;bFGF;FGF7;FGF10,"Human foreskin fibroblasts (CRL-2097, ATCC) and adult human dermal fibroblasts (Cell Applications) were cultured in a 10-cm tissue-culture dish in regular fibroblast culture medium.","Inhibitor of histone deacetylase;Inhibitor of lysine-specific demethylase 1 (LSD1);Inhibitor of the DNA methyltransferase;Agonist of the cAMP;Inhibitor of GSK3β;Inhibitor of ALK4, ALK7 (activin receptor-like kinases);Inhibitor of the Notch signaling;Inhibitor of the sonic hedgehog;Inhibitor of TGF-beta/Smad signaling;_;Agonist of the cAMP",Oct4;SOX2;KLF4;short hairpin RNA against p53,Human pancreatic beta-like cells converted from fibroblasts,_,17.3,"Percent of PDX1 and NKX6.1 double-positive cells. Glucose-stimulated insulin secretion (GSIS) assays demonstrated that in vitro-generated cPB cells released insulin in response to physiological levels of glucose (n=7, fold increase 2.0 ± 0.4) The stimulation index, as calculated by the ratio of insulin secreted in high glucose to low glucose, was similar among the cPB cells, hESC-derived beta-like cells and primary human islets.",2,Fibroblasts -> Converted definitive endodermal progenitor (cDE) cells -> PDX1 and NKX6.1 double-positive pancreatic progenitors > Pancreatic beta-like cells,Sheng Ding;Matthias Hebrok;Shibing Tang;Tao Xu;Tianhua Ma;Mingliang Zhang;Xiaojing Wang;Holger A;Saiyong Zhu,_
10.1016/j.bbrc.2009.11.054,Homo sapiens,PANC-1 Ductal Cells,Induced Pancreatic Beta Cells,7,"5-Aza-2'-deoxycytidine,451668",PANC-1 cells were cultured for 3 days in the presence of 10 nmol/l of TSA or 1 l mol/l of AZA then 2 days in normal media.,_,"PANC-1 human ductal cell line was purchased from ATCC and cultured in Dulbecco’s modified Eagle’s medium Glutamax-1, high glucose (Invitrogen) supplemented with 10% fetal calfserum (PAA laboratories Gmbh) plus 100 U of penicillin and 100 ug of streptomycin per ml (Invitrogen).",Inhibitor of DNA methylation,_,5'-AZA induces Ngn3 expression and endocrine differentiation in the PANC-1 human ductal cell line,_,2.5,Relative PDX1 expression,1,_,Julie Kerr; François Pattou;Valery Gmyr;Jose Oberholzer;Brigitte Vandewalle;Justine Longue;Sandrine Belaich;Bruno Lefebvre,_
10.1016/j.cell.2015.11.017,Mus musculus,Fibroblasts,Induced Pluripotent Stem Cells,40,"Valproic Acid,3121;CHIR99021,9956119;RepSox,449054;Tranylcypromine,19493;Forskolin,47936;DZNep,73087;EPZ004777,56962336;5-Aza-2'-deoxycytidine,451668;AM580,2126;SGC0946,56962337","Stage 1 medium: 100 ng/ml bFGF, 0.5 mM Valproic Acid, 20 mM CHIR99021, 10 mM 616452, 5 mM Tranylcypromine, 50 mM Forskolin, 0.05 mM AM580 and 5 mM EPZ004777.
Stage 2 medium: 25 ng/ml bFGF, 0.5 mM Valproic Acid, 10 mM CHIR99021, 10 mM 616452, 5 mM Tranylcypromine, 10 mM Forskolin, 0.05 mM AM580, 0.05 mM DZNep,
0.5 mM 5-Aza-2'-deoxycytidine, and 5 mM SGC0946). On day 28, the culture was transferred into stage 3 medium (N2B27-2iL medium with 3 mM CHIR99021, 1 mM
PD0325901, and 1,000 U/ml LIF). After another 8–12 days, 2i-competent, ESC-like, and GFP-positive (if using pOct4-GFP reporter).",,,Inhibitor of histone deacetylase;Inhibitor of GSK3β;Inhibitor of the ALK5 (TGF-β type 1 receptor);Inhibitor of lysine-specific demethylase 1 (LSD1);CAMP agonist;Inhibitot of histone EZH2 lysine methyltransferase;Inhibitor of H3K79 histone methyltransferase DOT1L;Inhibitor of DNA methylation;Agonist of the retinoic acid receptor;Inhibitor of the DOT1L methyltransferase,_,A XEN-like State Bridges Somatic Cells to Pluripotency during Chemical Reprogramming,GSE73631,_,"Using this new protocol, a well of 50,000 initial fibroblasts was induced, and the cells were expanded to >1,000,000 or more re-plated cells (re-plated into 10–15 wells). A total of 1,000–9,000 CiPSC colonies were obtained at the en",1,_,Hongkui Deng;Weifeng Yang;Linlin Su;Ting Wang;Chaoran Zhao;Yaqin Du;Lin Cheng;Susu Yang;Jian Ge;Gaofan Meng;Jialiang Zhu;Junqing Ye;Yao Fu;Xu Zhang;Jingyang Guan;Ting Zhao;Yang Zhao,_
10.1073/pnas.1010018107,Mus musculus,Alpha Cell,Induced Pancreatic Beta Cells,5,"BRD7389,1080352",_,_,"Mouse pancreatic cell lines αTC1 and βTC3 were grown in low-glucose DMEM supplemented with 10% FBS, 50 U/mL penicillin, and 50 μg/mL streptomycin.","Inhibitor of the RSK1, and RSK3",_,Small-molecule inducers of insulin expression in pancreatic α-cells,_,_,"5-d treatment with BRD7389 resulted in greater induction of insulin gene expression, about 50-fold at 0.85 μM",1,High-Content Screening,Stuart Schreiber;Bridget Wagner;Paul Clemons;Alykhan Shamji;Tanaz Sharifnia;Joshua A;Jacob Hecksher;Vlado Dancik;Deepika Walpita;Stefan Kubicek;Dina Fomina,_
10.1021/acschemneuro.8b00365,Homo sapiens,U87MG Glioblastom Cells,Induced Neurons,13,"Forskolin,47936;ISX9,19582717;CHIR99021,9956119;I-BET151,52912189;DAPT,5311272","Neuronal induction medium: Brainphys, 1% N-2, and 1% B-27 and the following small molecules: 10 μM Forskolin, 10 μM ISX9, 3 μM CHIR99021, 2 μM I-BET151, and 5 μM DAPT.",_,"U87MG glioblastoma cells were obtained from the American Type Culture Collection (U.S.A). Cells were maintained in Astrocyte Media (ScienCell) with media being was changed every 3-4 days. Upon reaching >90% confluence, cells were passaged onto an experimental plate at a rate of approximately 3.3 x 10 4 cells/cm 2 .",CAMP agonist;Neurogenic Modulator;Inhibitor of GSK3β;Inhibitor of the BET family;Inhibitor of γ-secretase,_,Direct Reprogramming of Glioblastoma Cells into Neurons Using Small Molecules,_,71.4,Percent of TUJ1 positive cells,1,_,Stephanie M;Meghan Robinson;Christopher Lee,_
10.1161/CIRCULATIONAHA.116.024692,Mus musculus,Fibroblasts,Induced Cardiomyocytes,28,"SB431542,4521392;XAV939,135418940",Explant medium: IMDM/20% FBS.,_,"Mouse cardiac fibroblasts were isolated from P0-P4 α-myosin heavy chain–green fluorescent protein (α-MHC–GFP) transgenic neonates with the migration method. Heart tissue was isolated, minced, and cultured on gelatin-coated plates in fibroblast explant media (20% FBS in Iscove modified Dulbecco medium) for 1 week at 37°C.",Inhibitor of the Activin/BMP/TGF-β pathway;Inhibitor of the WNT/β-catenin signaling,Gata4;Mef2c;Tbx5;ZFPM2,Chemical Enhancement of In Vitro and In Vivo Direct Cardiac Reprogramming,_,50,Percent of cells exhibited spontaneous calcium transients,2,_,Deepak Srivastava;Kathryn Ivey;Sheng Ding;Sergey Magnitsky;Shibing Tang;Haixia Wang;Pengzhi Yu;Yen-Sin Ang;Karishma Pratt;Yu Huang;Ethan Radzinsky;Emily Berry;Nicole Stone;Tamer Mohamed,_
10.1016/j.stemcr.2017.01.025,Mus musculus,Fibroblasts,Induced Cardiomyocytes,9,"DAPT,5311272","Cardiomyocyte induction medium: DMEM/ 199 (4:1), 10% FBS, 5% horse serum, 1% penicillin/streptomycin, 1% non-essential amino acids, 1% essential amino acids, 1%
B-27, 1% insulin-selenium-transferrin, 1% vitamin mixture, and 1% sodium pyruvate (Invitrogen).",_,"Wild-type, aMHC-GFP transgenic, or p27 knockout MEFs and wild-type TTFs were isolated as described by Nam et al. (doi: 10.1242/dev.114025), and cultured in DMEM containing 10% fetal bovine serum (FBS) and 1% penicillin/streptomycin",Inhibitor of γ-secretase,GATA4;HAND2;MEF2C;TBX5,Notch Inhibition Enhances Cardiac Reprogramming by Increasing MEF2C Transcriptional Activity,_,45,Percent of cells displaying spontaneous beating,2,_,Eric Olson;Rhonda Bassel;Beibei Chen;Maria Gabriela;Huanyu Zhou;Hisayuki Hashimoto;Maria Abad,_
10.1038/s41586-020-2201-4,Mus musculus,Fibroblasts,Induced Photoreceptor-like cells,15,"Valproic Acid,3121;CHIR99021,9956119;RepSox,449054;Forskolin,47936;IWR1,3137736;Taurine,1123;Retinoic acid,444795","IMR-90: MEM : 99 ml, NEAA: 1125 µlm, FBS: 11.25 ml, Pen/Strep: 1125 µl.
Photoreceptor induction medium (PIM): KO Serum: 5ml, B27:1ml, Noggin: 12.5µl, IGF1: 1.25 µl, Make volume upto 50 ml with DMEM/F12.
Photoreceptor differentiation medium (PDM): B27: 1ml, N2: 0.5ml, Noggin: 25 µl, IWR1: 50 µl, IGF1: 2.5 µl, bFGF 40 µl, Make volume upto 50 ml with DMEM F12. ",IGF1;bFGF,"Approximately 50,000–80,000 MEFs (passage 2) were seeded into each well of a 12-well plate (0.1% gelatin-coated overnight) and cultured overnight.",Inhibitor of histone deacetylase;Inhibitor of GSK3β;Inhibitor of the ALK5 (TGF-β type 1 receptor);CAMP agonist;Inhibitor of WNT pathway;_;Agonist of a retinoic acid receptor,_,,_,_,_,1,_,,
10.1038/cr.2010.142,Mus musculus,Fibroblasts,Induced Pluripotent Stem Cells,20,"Valproic Acid,3121;CHIR99021,9956119;RepSox,449054;Parnate,19493","mESC culture medium: 80% DMEM/F12 (Invitrogen), 10% knockout serum replacement (Invitrogen), 10% fetal bovine serum, 1 mM l -glutamine, 1% nones-sential amino acids, 0.1 mM β-mercaptoethanol (all from Invitro-gen) and 1 000 U/ml Lif (Millipore). iPS cells and mESCs were passaged by trypsin (Invitrogen). The medium was changed every day.",FGF,"Primary MEFs were derived from transgenic mice including ICR×OG, 129×OG and C57×OG. Adult skin fibroblasts were isolated from the lips and backs of 7-week-old transgenic mice
including ICR×OG, 129×OG and C57×OG. Fibroblasts and 293T cells were cultured in Dulbecco’s modified Eagle’s medium (DMEM; Hyclone) containing 10% fetal bovine serum (Invitro-
gen). mESC line R1 and iPS cells were maintained on Mitomycin C-treated MEFs in mESC culture medium consisting of 80% DMEM/F12 (Invitrogen), 10% knockout serum replacement (In-
vitrogen), 10% fetal bovine serum, 1 mM l -glutamine, 1% nones-sential amino acids, 0.1 mM β-mercaptoethanol (all from Invitro-gen) and 1 000 U/ml Lif (Millipore). iPS cells and mESCs were
passaged by trypsin (Invitrogen). The medium was changed every day.",Inhibitor of histone deacetylase;Inhibitor of GSK3β;Inhibitor of the ALK5 (TGF-β type 1 receptor);Inhibitor of lysine-specific demethylase 1 (LSD1),Oct4,"Generation of iPSCs from mouse fibroblasts with a single gene, Oct4, and small molecules",_,_,1-15 GFP+/iPS-like colonies (in 10 independent experiments) were generated from 5 × 10^4 OG-MEFs,2,_,Hongkui Deng;Yan Shi;Zhihua Song;Chen Wu;Kang Liu;Honggang Li;Yetao Wu;Xu Zhang;Weiqi Zhang;Chun Liu;Jian Ge;Pingping Hou;Yuanyuan Du;Weifeng Yang;Xiaolei Yin;Qiang Zhang;Yanqin Li,_
10.1038/srep01185,Rattus _,WB-F344 cells,Induced Pancreatic Beta Cells,17,"5-Aza-2'-deoxycytidine,451668;Trichostatin A,444732;Retinoic acid,444795","Basal medium: knockout-serum DMEM and the main components: 1 mM b-mercaptoethanol, 1% non-essential amino acids, 1% B27 supplement, 2 mM L-glutamine, 2% N 2 supplement (all from Invitrogen, California , USA), 20 ng/ml fibroblast growth factor (Peprotech, New Jersey, USA), 20 ng/ml epidermal growth factor (Peprotech, New Jersey, USA), 100 U/ml penicillin, and 100 mg/ml STZ (Sigma, Missouri, USA).

Induction medium: DMEM with low glucose (1 g/L; Sigma, Missouri, USA), 13ITS (Invitrogen, California, USA), 2 mM RA (Sigma, Missouri, USA), and the main components for 7 days. In the last step (maturation), the medium was modified from differentiation medium by adding 10 mM nicotinamide (Sigma, Missouri, USA) without fibroblast growth factor and epidermal growth factor.",FGB;EGF,"WB cells were maintained in Dulbecco’s modified Eagle’s medium (DMEM) supplemented with 10% fetal bovine serum (PAA, Dresden, Germany), 11.1 mmol/L (mM) D-glucose, 100 U/ml penicillin, and 100 mg/ml STZ (Sigma, Missouri, USA).",Inhibitor of DNA methylation;Inhibitor of the histone deacetylases I and II;Agonist of a retinoic acid receptor,_,Direct differentiation of hepatic stem-like WB cells into insulin-producing cells using small molecules,_,5,Pdx1-expressing cells,1,_,Weidong Han;Yiming Mu;Chunlin Li;Jun Shi;Jing Shen;Qingwang Han;Haojie Hao;Honggang Wang;Yanmei Liu;Jianping Liu,"Cells were maintained at 37uC in a
humidified atmosphere containing 5% CO 2 ."
10.1016/j.jhep.2018.09.007,Homo sapiens,Hepatocytes,Induced Hepatic Progenitors,15,"CHIR99021,9956119;A83-01,16218924;Dexamethasone,5743","Hepatocyte induction medium: basal medium supplemented with 20 ng/ml Oncostatin M (R&D Systems, MN, USA), 10 -7 M dexamethasone (Sigma) and 20 ng/ml HGF.
Cholangiocyte differentiation medium (CDM): DMEM/F12 medium containing 10% FBS and 20 ng/mL HGF.",EGF;HGF,"Human liver tissues were obtained from six donors operated on in Hanyang University Medical Center. Hepatocytes were isolated using a modified two-step collagenase perfusion technique. Hepatocytes were seeded on collagen-coated dishes (STEMCELL Technologies, BC, Canada) at 5000 cells/cm 2 in basic High Glucose DMEM/F-12 media (Gibco, CA, USA) containing 1% FBS (Gibco), 10 mM nicotinamide, 0.1 μM dexamethasone (Sigma-Aldrich), 1% insulin-transferrin-selenium (ITS) (Gibco), 1% penicillin/streptomycin (Gibco), and 20 ng/ml epidermal growth factor (EGF).","Inhibitor of GSK3β;Inhibitor of ALK4, ALK7 (activin receptor-like kinases);Activator of glucocorticoid pathway",_,Small molecule-mediated reprogramming of human hepatocytes into bipotent progenitor cells,_,_,_,1,_,Dongho Choi;Jaemin Jeong;Valentina Factor;Kyeong Geun;Yun Kyung;Kiseok Jang;Sung Joo;Heung Mo;Sangtae Yoon;Daekwan Seo;Seung Bum;Kyojin Kang;Yohan Kim,_
10.1016/j.stem.2015.07.006,Homo sapiens,Fibroblasts,Induced Neurons,28,"Valproic Acid,3121;CHIR99021,9956119;RepSox,449054;Forskolin,47936;SP600125,8515;GO6983,3499;Y-27632,448042;Dorsomorphin,11524144","Fibroblast medium: DMEM (Life Technologies, C11965) supplemented with 10% fetal bovine serum (Ausbian, VS500T), 1mM GlutaMAX (Life Technologies, 35050-061), 0.1 mM non-essential amino acid (NEAA, Millipore, TMS-001-C) and penicillin/streptomycin.
Neuronal induction medium: (DMEM/F12, Life Technologies, 11330-032): (Neurobasal, Life Technologies, 21103-049) (1:1), 0.5% N-2 (Invitrogen, 17502048), 1% B-27 (Invitrogen, 17504044), 100 μM cAMP and 20 ng/ml bFGF and penicillin/streptomycin.
Neuronal maturation medium: DMEM/F12: Neurobasal (1:1), 0.5% N-2, 1% B-27, 100 μM cAMP, 20 ng/ml bFGF, 20 ng/ml BDNF, 20 ng/ml GDNF, 20 ng/ml NT3 and penicillin/streptomycin. Neuron medium: DMEM/F12: Neurobasal (1:1), 0.5% N-2, 1% B-27, 20 ng/ml BDNF, 20 ng/ml GDNF, 20 ng/ml NT3 and penicillin/streptomycin.",BDNF;GDNF;bFGF,"Initial fibroblasts were seeded onto gelatin-coated culture plates (10,000-15,000 cells/well in 24-well plates) and cultured in fibroblast medium for1 day. ","Inhibitor of histone deacetylase;Inhibitor of GSK3β;Inhibitor of the ALK5 (TGF-β type 1 receptor);CAMP agonist;Inhibitor of JNK;Inhibitor of protein kinase C;Inhibitor of ROCK1 and ROCK2;Inhibitor of ALK2, ALK6	 and AMPK",_,Direct Conversion of Normal and Alzheimer's Disease Human Fibroblasts Into Neuronal Cells by Small Molecules,_,5,Percent of Tuj1-positive cells,1,_,Gang Pei;Jian Zhao;Yongchun Yu;Beisha Tang;Ying Jin;Hanzhi Zhao;Gangcai Xie;Yin Huang;Lu Shen;Longfei Gao;Wei Li;Min Wang;Qinying Wang;Wuqiang Guan;Binlong Qiu;Wenxiang Hu,_
10.1038/nbt1418,Mus musculus,Fibroblasts,Induced Pluripotent Stem Cells,21,"Valproic Acid,3121;Dexamethasone,5743","Mouse ES cell media: Knockout DMEM supplemented with 15% Hyclone FBS, Lglutamine, penicillin/streptomycin, nonessential amino acids, β-mercaptoethanol,
and with 1000 U/ml LIF.",_,"MEFs were derived from e13.5 embryos hemizygous for the Oct4-GFP transgenic allele. Embryos were sexed by inspecting gonads for the pattern of Oct4-GFP expression. Gonads and internal organs were removed before processing the embryos for MEF isolation. To generate iPS cells that can be identified in mouse chimeras after blastocyst injection, we derived MEFs from e13.5 embryos that are hemizygous for Oct4-GFP and heterozygous for the Rosa26-lacZ reporter allele. MEFs were grown in DMEM supplemented with 10% FBS, L-glutamine, penicillin/streptomycin, nonessential amino acids, and sodium pyruvate. MEFs in early passages (up to passage 5) were used for generation of iPS cells. Oct4-GFP and Rosa26-lacZ mice were both obtained from the Jackson Laboratory.",Inhibitor of histone deacetylase;Activator of glucocorticoid pathway,Oct4;Sox2;Klf4;c-Myc,Induction of pluripotent stem cells by defined factors is greatly improved by small-molecule compounds,_,11.8,Percent of cells with ES cell morphology and expressed Oct4-GFP,2,_,Douglas Melton;Alice Chen;Melinda Snitow;Astrid Eijkelenboom;Wenjun Guo;Rene Maehr;Danwei Huangfu,_
10.1038/cr.2015.142,Mus musculus,Fibroblasts;Neural stem cells;Intestinal Epithelial Cells,Induced Pluripotent Stem Cells,52,"Valproic Acid,3121;CHIR99021,9956119;RepSox,449054;Parnate,19493;Forskolin,47936;EPZ004777,56962336;Ch 55,6184667;AM580,2126",,bFGF;EGF,"MEFs were cultured in high glucose Dulbecco’s modified Eagle medium (DMEM, Hyclone). 

Fetal NSCs were isolated from mouse forebrain at embryonic day 13.5 as previously described, and postnatal NSCs were isolated from the subventricular zone of the postnatal mouse brain. NSCs were cultured in NSC culture medium (DMEM/F-12 (1:1), DF12) containing N2 and B27 supplements, 1% non-essential amino acids (NEAA), 2 mM GlutaMAX, 10 U PS, 55 μM β-mercaptoethanol (β-me) (all from Invitrogen), 25 ng/ml basic fibroblast growth factor (bFGF, Origene), and 20 ng/ml epidermal growth factor (EGF, R&D), and passaged by accutase (Millipore) every 4-5 days. Single-cell suspension of NSCs were allowed to form neurospheres for 2-3 days. 

Fetal small intestinal epithelial cells were isolated from mouse embryonic small intestine at embryonic 13.5 day as previously described, and cultured in DMEM/F-12 (1:1) (Invitrogen) containing N2 and B27 supplements, 10% knockout serum re-placement (KSR, Invitrogene), 1% NEAA, 2 mM GlutaMAX-I (GlutaMAX), 10 U penicillin-streptomycin (PS), 55 μM β-me, 25 ng/ml Wnt3a (R&D), 20 ng/ml EGF, and 20 ng/ml Noggin (AC-ROBiosystems).",Inhibitor of histone deacetylase;Inhibitor of GSK3β;Inhibitor of the ALK5 (TGF-β type 1 receptor);Inhibitor of lysine-specific demethylase 1 (LSD1);CAMP agonist;Inhibitor of H3K79 histone methyltransferase DOT1L;Agonist of retinoid acid receptor (RAR);Agonist of the retinoic acid receptor,_,Pluripotent stem cells induced from mouse neural stem cells and small intestinal epithelial cells by small molecule compounds,GSE75522,_,"Sox17,Gata6,Sall4Dppa2 expression + morphology",2,_,Hongkui Deng;Yang Zhao;Junfang Liu;Weifeng Yang;Hua Lin;Yuping Wang;Shan He;Zhengyuan Zhang;Lin Cheng;Xu Zhang;Jian Ge;Junqing Ye,_
10.1126/science.1239278,Mus musculus,Fibroblasts;Adipose-derived stem cells,Induced Pluripotent Stem Cells,36,"Valproic Acid,3121;CHIR99021,9956119;RepSox,449054;Parnate,19493;Forskolin,47936;DZNep,73087","ESC culture medium: 10% knockout serum replacement, 10% fetal bovine serum, 2 mM GlutaMAXTM-I, 1% nonessential amino acids, 0.1 mM 2-mercaptoethanol, 1% penicillin-streptomycin and 1,000 U/ml leukemia inhibitory factor.
2i-medium: ESC culture medium supplemented with 2i (3 μM CHIR99021 and 1 μM PD0325901))",_,"MEFs, MNFs, MAFs and ADSCs were cultured in DMEM/High Glucose (Hyclone) containing 10% fetal bovine serum (Hyclone). The cells used in reprogramming were from passage 1 to 5. ",Inhibitor of histone deacetylase;Inhibitor of GSK3β;Inhibitor of the ALK5 (TGF-β type 1 receptor);Inhibitor of lysine-specific demethylase 1 (LSD1);CAMP agonist;Inhibitot of histone EZH2 lysine methyltransferase,_,Pluripotent Stem Cells Induced from Mouse Somatic Cells by Small-Molecule Compounds,GSE48243,0.2,_,1,_,Hongkui Deng;Yang Zhao;Qiang Zhang;Jun Xu;Jian Ge;Kang Liu;Weifeng Yang;Junqing Ye;Ting Zhao;Honggang Li;Jingyang Guan;Chun Liu;Xu Zhang;Yanqin Li,_
10.1016/j.stem.2009.09.012,Mus musculus,Induced Pluripotent Stem Cells,Induced Pluripotent Stem Cells,22,"SB431542,4521392;Valproic Acid,3121;RepSox,449054;EI 275,1400","Mouse ESC media: Knockout DMEM,15% Hyclone FBS, L-glutamine, penicillin/strepto-mycin, nonessential amino acids,b-mercaptoethanol, and 1000 U/ml LIF.",_,"MEFs were infected with two to three poolsof viral supernatant during a 72 hr period. On day 4 postinfection, infected MEFs were trypsinized and reseeded on irra-diated feeders in 96-well plates at 2000 cells/well",Inhibitor of the Activin/BMP/TGF-β pathway;Inhibitor of histone deacetylase;Inhibitor of the ALK5 (TGF-β type 1 receptor);Inhibitor of Src-family kinase,_,A Small-Molecule Inhibitor of Tgf-β Signaling Replaces Sox2 in Reprogramming by Inducing Nanog,_,2,Percent of Oct4::GFP+ colonies,2,_,Kevin Eggan;Lee Rubin;David Liu;Hidenori Akutsu;Danwei Huangfu;Kathryn Koszka;Francesco Giorgio;Ava Carter;Kyle Loh;Dieter Egli;Julia Chung;Esther Son;Kelvin Lam;Joel Blanchard;Justin Ichida,_
10.1016/j.stemcr.2013.12.014,Homo sapiens,Induced Pluripotent Stem Cells,Induced Corneal Epithelial Progenitor Cells,44,"SB-505124,9858940;IWP-2,_","Commercial CnT-30 corneal epithelium medium.
RegES- medium (10.1371/journal.pone.0010246).",FGF2;bFGF,"To initiate corneal epithelial differentiation of hiPSCs, undifferentiated colonies were manually dissected and transferred to suspension culture in 6-well plates (Corning Ultra-Low Attachment; Corning Life Sciences). Cells were cultured as three-dimensional cell aggregates for 4 days, changing the culture medium daily",Inhibitor of TGF-b;Inhibitor of Wnt,_,Small-Molecule Induction Promotes Corneal Epithelial Cell Differentiation from Human Induced Pluripotent Stem Cells,_,60,Percent of p63 positive cells,1,_,Heli Skottman;Hannu Uusitalo;Tanja Ilmarinen;Alexandra Mikhailova,_
10.1016/j.stemcr.2020.01.013,Mus musculus,Fibroblasts,Induced Fibrocartilaginous cells,33,"Valproic Acid,3121;CHIR98014,53396311;RepSox,449054;TTNPB,5289501;Celecoxib,2662","The chemical conditional medium: composed of KnockOut Serum Replacer (KSR) medium (Life Technologies), 15% knockout serum replacement, 1% nonessential amino acid (Invitrogen), 1% GlutaMax
(Gibico), 1% sodium pyruvate (Gibico), 0.1 mM b-mercaptoethanol (Millipore), and 1,000 U/mL leukemia inhibitory factor (PeproTech).

Chondrogenic differentiation medium: H-DMEM supplemented with 107 M dexamethasone [Sigma], 50 mg/mL 2-phospho-L-ascorbic acid [Sigma], 1 mM sodium pyruvate [Gibico], 1% ITS + premix
[Gibico], and 10 ng/mL TGF-b3 [PeproTech].",_,"Expanded MEFs that had been cultured in H-DMEM for 48 h
(confluency 90%).",Inhibitor of histone deacetylase;Inhibitor of GSK-3 kinases;Inhibitor of the ALK5 (TGF-β type 1 receptor);Agonist of a retinoic acid receptor;Inhibitor of cyclooxygenase [COX] 2,_,High-Resolution Dissection of Chemical Reprogramming from Mouse Embryonic Fibroblasts into Fibrocartilaginous Cells,GSE118236,_,_,1,_,Hongwei Ouyang;Junfeng Ji;Ahmed El-Hashash;Varitsara Bunpetch;Jing Zhou;Shufang Zhang;Xianzhu Zhang;Heng Sun;Shouan Zhu;Qikai Li;Xiaoan Zhang;Chengrui An;Yeke Yu;Zixuan Sheng;Xiaotian Du;Dongsheng Yu;Junxin Lin;Bingbing Wu;Yishan Chen,_
10.1038/s41598-020-63992-8,Mus musculus,Fibroblasts,Induced Cardiomyocytes,29,"PTC-209,1117196;CHIR99021,9956119;RepSox,449054;Forskolin,47936;Valproic Acid,3121;Tranylcypromine,19493;TTNPB,5289501;PD0325901,9826528","Cardiac Reprogramming Medium (CRM): composed of knockout DMEM (Gibco), 15% FBS, and 5% KSR (Gibco), 0.5% N2 (Gibco), 2% B27 (Gibco), 1% Glutamax, 1% NEAA, 0.1 mM β-mercaptoethanol (Gibco), 50 μg/ml 2-phospho-L-ascorbic acid (Vitamin C, Sigma), 100 units/ml penicillin and 100 μg/ml streptomycin.

Cardiomyocyte Maintaining Medium (CMM): DMEM medium with 15% FBS, 2i (3 μM CHIR99021 and 1 μM PD0325901, Sigma), 1 000 units/ml LIF, 50 μg/ml Vitamin C, and 1 μg/ml insulin.",_,"MEFs were isolated from embryonic day 13.5 (E13.5) C57BL/6 mouse embryos. The head, limbs, and internal organs were carefully removed from embryos, and then the rest tissues were washed in PBS, minced
and digested with 0.05% Trypsin-EDTA into single-cell suspensions. Cells were resuspended in fibroblasts medium, consisting of DMEM (Gibco), 15% FBS (Hyclone), 2 mM Glutamax (Gibco), 0.1 mM non-essential amino acids (NEAA; Gibco), 100 units/ml penicillin and 100 μg/ml streptomycin (Gibco), and plated onto one 10 cm dish per embryo. Cells were passaged at the ratio of 1:3 (passage 1). Passage 3 MEFs were used for reprogramming.",Inhibitor of Bmi1;Inhibitor of GSK3β;Inhibitor of the ALK5 (TGF-β type 1 receptor);CAMP agonist;Inhibitor of histone deacetylase;Inhibitor of lysine-specific demethylase 1 (LSD1);Agonist of a retinoic acid receptor;Inhibitor of MEK/ERK pathway,_,"CRM, composed of knockout DMEM (Gibco), 15% FBS, and 5% KSR (Gibco), 0.5% N2 (Gibco), 2% B27 (Gibco), 1% Glutamax, 1% NEAA, 0.1 mM β-mercaptoethanol (Gibco), 50 μg/ml 2-phospho-L-ascorbic acid (Vitamin C, Sigma), 100 units/ml penicillin and 100 μg/ml streptomycin, plus CRFVPT cocktails (10 μM CHIR99021 (C, Sigma); 10 μM RepSox (R, Selleckchem); 50 μM Forskolin (F, Selleckchem); 0.5 mM Valproic Acid (V, Sigma); 5 μM Parnate, (P, Selleckchem); 1 μM TTNPB (T, Selleckchem).",_,43,Percent of muscle α- myosin heavy chain (α -MHC) positive cells (α-MHC+).,1,_,Fabiana Passaro;Tommaso Russo;Domenico Bonaduce;Pasquale Abete;Carlo Tocchetti;Flora Pirozzi;Silvia Parisi;Matteo Barbato;Giorgia Benedetto;Michele Russo;Gianluca Testa,_
10.1007/978-1-0716-0301-7_16,Mus musculus,Fibroblasts,Induced Neural Stem Cells,12,"Valproic Acid,3121;CHIR99021,9956119;RepSox,449054","Dulbecco’s Modified Eagle’s Medium (DMEM), high glucose (Gibco).",bFGF;EGF; FGF-5,"Female Nestin-GFP transgenic mice at day 13.5 postcoitum are sacrificed by cervical dislocation then rinsed in 70% EtOH outside of the tissue culture hood.
Mouse is placed on its back and cut in the abdomen skin with scissors. Uterus is cut out by new scissors and transferred by forceps into petri dish with DPBS on ice.
Embryos are released from uterus and the head, limbs, visceral tissues, gonads, and vertebral column are carefully torn out. The remaining tissues are placed in a new Petri dish with PBS on ice and chopped into small pieces with ~1 mm by scissors. Minced tissues are digested in 15 mL conical centrifuge tube with trypsin then placed in 37 C incubator for 15 min. Pipet
up and down every 5 min. Digested cell suspension is transferred into 50 mL conical centrifuge tube. 1:1 DMEM medium with 10% FBS is added to inactivate the trypsin.",Inhibitor of histone deacetylase;Inhibitor of GSK3β;Inhibitor of the ALK5 (TGF-β type 1 receptor),_,Reprogramming of Fibroblasts to Neural Stem Cells by a Chemical Cocktail,_,_,_,1,_,Lin Cheng;Chuijin Wei;Shumin Xiong,_
10.1161/JAHA.119.015686,Homo sapiens;Rattus _,Fibroblasts,Induced Cardiomyocytes,10,"Sodium butyrate,5222465;ICG-001,11238147;Retinoic acid,444795","Initial transfer medium: DMEM/199[4:1], 10% FBS, and 1% penicillin/streptomycin.

Induction medium (iCM media): DMEM/199 (4:1), 10% FBS, 5% horse serum, 1% penicillin/streptomycin, 1% nonessential amino acids, 1% essential amino acids, 1% B-27, 1% insulin-selenium-transferrin, 1% vitamin mixture, and 1% sodium pyruvate,19 with or without addition of candidate small molecules.",,"Standard explantation protocols were likewise used to harvest adult human cardiac fibroblasts from ventricular myocardial tissue obtained from explants of heart failure patients undergoing mechanical assist device placement or cardiac transplantation at Baylor St. Luke’s Medical Center.19 After mincing of these tissues, explants were cultured in DMEM, 10% fetal bovine serum (FBS), and 1% penicillin/streptomycin, as previously described (10.1073/pnas.1301019110).",Inhibitor of histone deacetylase;Inhibitor of Wnt;Agonist of a retinoic acid receptor,Gata4;Mef2C;Tbx5,Enhanced Generation of Induced Cardiomyocytes Using a Small‐Molecule Cocktail to Overcome Barriers to Cardiac Cellular Reprogramming,_,23,Percent of cTnT+ cells,2,_,Megumi Mathison;Deepthi Sanagasetti;Aarthi Pugazenthi;Jaya Pratap;Vivek Singh,_
10.1038/s41598-019-53007-6,Homo sapiens,Urine Cells,Induced Neurons,30,"CHIR99021,9956119;A83-01,10202642;Y-27632,448042;TTNPB,5289501;Forskolin,47936;Valproic Acid,3121;Sodium butyrate,5222465","Induction medium: NM3 basic neuronal induction medium supplemented with 10 μM Y-27632, 5 μM A83-01, 3 μM CHIR99021, 1 μM TTNPB, 5 μM Forskolin, 0.5 mM Valproic Acid,
and 0.1 mM NaB.
Maturation medium.
Neuronal medium.",BDNF;GDNF;NT3,"Initial hUCs were seeded onto Matrigel (Corning, USA)-coated culture plates (20000–30000 cells/well in 24-well plates, Corning) and cultured in urine cell medium.","Inhibitor of GSK3β;Inhibitor of ALK4, ALK7 (activin receptor-like kinases);Inhibitor of ROCK1 and ROCK2;Agonist of a retinoic acid receptor;CAMP agonist;Inhibitor of histone deacetylase;Inhibitor of histone deacetylase",_,Direct Conversion of Human Urine Cells to Neurons by Small Molecules,_,38.36,Percent of Tuj1+/MAP2+,1,_,Yin-xiong Li;Hongcheng Wei;Tingcai Pan;Fan Yang;Dongsheng Guo;Zuoxian Lin;Xiaofen Zhong;Yuanqi Zhuang;Anteneh Getachew;Yan Chen;Kai You;Jiaye Zhang;Xiaotong Gu;Feima Wu;Guosheng Xu,_
10.1016/j.stemcr.2019.09.007,Homo sapiens,Fibroblasts,Induced Glutamatergic Neurons,21,"A83-01,16218924;CHIR99021,9956119;DAPT,5311272;Dorsomorphin,11524144;Forskolin,47936;ISX9,19582717;LDN193189,25195294;P7C3-A20,46853447;PD0325901,9826528;Purmorphamine,5284329;RG108,702558;Y-27632,448042","Neuronal induction medium (NIM): DMEM/F12:neurobasal medium (1:1) supplemented with 1% N-2, 2% B-27, 40 ng/mL brain-derived neurotrophic factor, 20 ng/mL glial cell-derived neurotrophic factor, 20 ng/mL insulin-like growth factor 1, and 1 mM GlutaMAX.",PDGF-AA;bFGF,"Fibroblasts were first cultured on poly-D-lysine-coated coverslips in 24-well plates with 10,000–15,000 cells/well. Cells were maintained in fibroblast medium for 24 h","Inhibitor of ALK4, ALK7 (activin receptor-like kinases);Inhibitor of GSK3β;Inhibitor of γ-secretase;Inhibitor of ALK2, ALK3	 ALK6 and AMPK;CAMP agonist;Neurogenic Modulator;Inhibitor of TGF-beta/Smad signaling;Neurogenic Modulator;Inhibitor of MEK/ERK pathway;Agonist of hedgehog;Inhibitor of the DNA methyltransferase;Inhibitor of ROCK1 and ROCK2",_,Rapid and Efficient Conversion of Human Fibroblasts into Functional Neurons by Small Molecules,SRP150612,61,Percent of TUJ1+ cells,1,_,"Yaming Yang,Ruiguo Chen,Xianming Wu,Yannan Zhao,Yongheng Fan,Zhifeng Xiao,Jin Han,Le Sun,Xiaoqun Wang,Jianwu Da",_
10.7554/eLife.41356,Homo sapiens,Fibroblasts,Induced Neurons,24,"CHIR99021,9956119;SB431542,4521392;LDN193189,25195294;A83-01,10202642;Forskolin,47936;db-cAMP,9934146;Pyrintegrin,46223724;AZ 960,25099184;ZM33637,5730;KC7f2,16047442","Neuron conversion (NC):  DMEM:F12/Neurobasal (1:1) for
three weeks. NC contains the following supplements: N2 supplement, B27 supplement (both 1x;
Thermo Fisher Scientific), doxycycline (2 mg/ml, Sigma Aldrich), Laminin (1 mg/ml, Thermo Fisher Scientific Scientific), dibutyryl cyclic-AMP (500 mg/ml, Sigma Aldrich), human recombinant Noggin (150
ng/ml; Preprotech), LDN193189 (5 mM; Fisher Scientific Co) and A83-1 (5 mM; Santa Cruz Biotechnology Inc), CHIR99021 (3 mM, LC Laboratories), Forskolin (5 mM, LC Laboratories) and SB431542
(10 mM; Cayman Chemicals). ZPAK contains the following supplements: Pyrintegrin (1 mM; Tocris),
ZM336372 (0.175 mM; Cayman), AZ960 (0.1 mM; Cayman), and KC7F2 (7.5 mM; Fischer Scientific)",,"Primary human dermal fibroblasts from donors between 0 and 88 years of age were obtained from the Coriell Institute Cell Repository, the University Hospital in Erlangen and Shiley-Marcos Alzhiemer’s Disease Research Center (Figure 2—source data 2). Protocols were previously approved by the Salk Institute Institutional Review Board and informed consent was obtained from all subjects.
Fibroblasts were cultured in DMEM containing 15% tetracycline-free fetal bovine serum and 0.1% NEAA (Thermo Fisher Scientific), transduced with lentiviral particles for EtO and XTP-Ngn2:2A:Ascl1
(E + N2A), or the combined tetOn system cassette consisting of the rtTAAdv. [Clonech] driven by the UbC promoter, Ngn2:2A:Ascl1 under control of the TREtight promoter [Clontech], and a puromycin-resistance gene driven by the PGK promoter (UNA, Figure 1A) and expanded in the presence of G418 (200 mg/ml; Thermo Fisher Scientific) and puromycin (1 mg/ml; Sigma Aldrich), or puromycin
only, respectively, as ‘iN-ready’ fibroblast cell lines. Following at least three passages after viral transduction, ‘iN-ready’ fibroblasts were trypsinized and pooled into high densities (30.000–50.000
cells per cm2; appx. a 2:1 – 3:1 split from a confluent culture) and, after 24 hr, the medium was changed to neuron conversion (NC) or NC+ZPAK medium based on DMEM:F12/Neurobasal (1:1) for
three weeks. NC contains the following supplements: N2 supplement, B27 supplement (both 1x; Thermo Fisher Scientific), doxycycline (2 mg/ml, Sigma Aldrich), Laminin (1 mg/ml, Thermo Fisher Scientific Scientific), dibutyryl cyclic-AMP (500 mg/ml, Sigma Aldrich), human recombinant Noggin (150 ng/ml; Preprotech), LDN193189 (5 mM; Fisher Scientific Co) and A83-1 (5 mM; Santa Cruz Biotechnology Inc), CHIR99021 (3 mM, LC Laboratories), Forskolin (5 mM, LC Laboratories) and SB431542 (10 mM; Cayman Chemicals). ZPAK contains the following supplements: Pyrintegrin (1 mM; Tocris),
ZM336372 (0.175 mM; Cayman), AZ960 (0.1 mM; Cayman), and KC7F2 (7.5 mM; Fischer Scientific). Medium was changed every third day","Inhibitor of GSK3β;Inhibitor of the Activin/BMP/TGF-β pathway;Inhibitor of TGF-beta/Smad signaling;Inhibitor of ALK4, ALK7 (activin receptor-like kinases);CAMP agonist;CAMP agonist;Integrin activator;Inhibitor of JAK2;Activator of Raf-1;Inhibitor of HIF 1-alpha",Ngn2;Ascl1,Chemical modulation of transcriptionally enriched signaling pathways to optimize the conversion of fibroblasts into neurons,_,90,Percent of NeuN+/βIII-tub+ cells,2,_,Hyungjun Lee;Apua Paquola;Manching Ku;Dina Zangwill;Zoya Ansari;Yongsung Kim;Simon Schafer;Joseph Herdy;,_
10.1155/2019/2945435,Homo sapiens,Nasal Olfactory Stem Cells,Induced Dopamine Neurons,46,"Purmorphamine,5284329;Bucladesine,9687;CHIR99021,9956119;LDN193189,25195294;SB431542,4521392","Complete medium (CM): Dulbecco’s modified Eagle’s medium/nutrient mixture F-12 (DMEM/F-12) supplemented with 10% fetal bovine serum (FBS), 1% penicillin/streptomycin (P/S), 1% GlutaMAX (200 mM; Thermo Fisher Scientific, Waltham, MA, USA), and 1/1000 Plasmocin™ prophylactic (InvivoGen, San Diego, CA, USA),

N2B27 medium: DMEM/F12-neurobasal medium (1 : 1), 1/100 50X B27 (without vitamin A), 1/200 100X N2, 1/1000 2-mercaptoethanol, 1/100 L-glutamine, and P/S. This medium (N2B27) was supplemented with 10 μg/mL fibroblast growth
factor 2 (FGF2) and 25 μg/mL activin A and was changed every other day. ",FGF2;Activin A;FGF8;BDNF;GDNF;Sonic hedgehog,"Olfactory ectomesenchymal stem cells (OE-MSCs) used in this study were obtained from human biopsies from healthy donors, in accordance with the local ethical committee (Comité de Protection des Personnes) of Marseille. Isolated OEMSCs were cultured in Dulbecco’s modified Eagle’s medium/nutrient mixture F-12 (DMEM/F-12) supplemented with 10% fetal bovine serum (FBS), 1% penicillin/streptomycin (P/S), 1% GlutaMAX (200 mM; Thermo Fisher Scientific, Waltham, MA, USA), and 1/1000 Plasmocin™ prophylactic (InvivoGen, San Diego, CA, USA), hereafter referred to as complete medium (CM).",Agonist of hedgehog;CAMP pathway activator;Inhibitor of GSK3β;Inhibitor of TGF-beta/Smad signaling;Inhibitor of the Activin/BMP/TGF-β pathway,_,Pharmacological Transdifferentiation of Human Nasal Olfactory Stem Cells into Dopaminergic Neurons,_,20,Percent of cells with neurites,1,_,Francois Feron;Emmanuel Nivet;David Piwnica;Esther Schenker;Crancis Coge;Alain Dupront;Helene Darville;Amelie Pontisso;Sophie Landron;Rodolphe Billiras;Emmanuelle Lacassagne;Audrey Chabrat,_
10.1007/s12031-019-01388-8,Homo sapiens,Adipose-Derived Stem Cells,Induced Retinal Precursor Cells,,"LDN193189,25195294;SB431542,4521392;CKI 7,129236","Adipogenic induction medium: DMEM supplemented with 10% FBS, 10 μM insulin, 200 μM indomethacin, 0.5 mM 3-isobutyl-1-methylxan-thine, and 1 μM dexamethasone.

Anterior neuroectodermal induction medium containing DMEM-F12 (Bioidia, Bl1027) supplemented with 1% B27 (Gibco, 17504–044), 5% FBS (Gibco, 16000–044), 1% L -glutamine ( L -Glu, PAA, M11–004), 1% non-essential amino acid (NEAA, PAA, M11–003), 1% penicillin/streptomycin, 0.5 μM LDN193189 (Abcam, ab142186), 5 μM SB431542 (Abcam, ab120163), 5 μM CKI-7 (Santa Cruz, SC-252621), and 5 ng/ml IGF-1 (R&D, 291-GI-200).

Precursor medium: Neurobasal medium supplemented with 1% B27, 2% N 2, 1% L -glutamine, 1% non-essential amino acid, 1% penicillin/streptomycin, 0.5 μM LDN193189 (Abcam, ab142186), 5 μM SB431542, 5 μM CKI-7, 5 ng/ml IGF-1 (R&D, 291-GI-200), and 5 ng/ml bFGF.",IGF-1;bFGF,"All samples were obtained from subcutaneous adipose tissue of healthy donors (N, 3; mean age 31.51 ± 4.2 years). Stem cells from each donor were considered as an independent cell line in all experiment. The adipose tissues were washed and chopped into small pieces mechanically then digested with 0.075% collagenase type I (Sigma, C9891). After neutralization, cell suspension was centrifuged at 1600 rpm. Then cells were seeded in 75-cm culture flask with culture medium containing Dulbecco’s Modified Eagle’s Medium (DMEM), 10% fetal bovine serum (FBS), and 1% penicillin/streptomycin (all from Bioidea, Iran), at 37 °C and 5% Co 2 . Medium refreshment was performed every 2 to 3 days. When cells reached 70–80% confluence, they were subcultured.",Inhibitor of TGF-beta/Smad signaling;Inhibitor of the Activin/BMP/TGF-β pathway;Inhibitor of Wnt,_,Application of Hanging Drop Culture for Retinal Precursor-Like Cells Differentiation of Human Adipose-Derived Stem Cells Using Small Molecules,_,75,"Retinal precursor gene expression profile (PAX6, RAX, CHX10, and CRX)",1,Hanging drop (HDC) culture significantly increased efficiency,Noushin Amirpour;Shahram Amini;Mohammad Kazemi;Ebrahim Esfandiari;Shahnaz Razavi;Hossein Salehi,_
10.1038/s41401-018-0170-z,Homo sapiens,Urine Cells,Induced Hepatocytes,24,"CHIR99021,9956119;RepSox,449054;Valproic Acid,3121;Parnate,19493;TTNPB,5289501;DZNep,73087","Human urine cell medium (hUCM): renal epithelial cell growth medium (Lonza, Basel, Switzerland), 10% fetal bovine serum (FBS; Gibco, Grand Island, NY, USA), 100 units/mL penicillin and 100 µg/mL streptomycin. Cells were then transferred into 12-well plates coated with 1% gelatin solution (Gibco).
Hepatic reprogramming medium HRM: DMEM/F12, 10% FBS, 10% KSR (Gibco), 1 µg/mL insulin, 0.5 × N2 (Gibco), 0.5 × B27 (Gibco), 2 mM Glutamax, 0.1 mM non-essential amino acids, 100 nM dexamethasone, 10 mM nicotinamide, 20 ng/mL epidermal growth factor (EGF), 20 ng/mL hepatocyte growth factor (HGF), 100 units/mL penicillin and 100 µg/mL streptomycin) containing the small-molecule cocktail CRVPTD (10 µM CHIR99021 (C), 10 µM RepSox (R), 0.5 mM Valproic Acid (V), 5 µM Parnate (P), 1 µM TTNPB (T), 50 nM DZNep (D).",,"Urine samples were collected from two healthy volunteers (hUC1, a 21-year-old male, and hUC2, a 23-year-old male). Urine was collected with a sterile bottle of proper volume and kept on ice before isolation. The urine sample was centrifuged at 400 × g for 10 min at room temperature to collect the cells. After careful aspiration of the supernatant, the cell pellet was washed in sterile phosphate-buffered saline (PBS) with 100 units/mL penicillin and 100 µg/mL streptomycin and then centrifuged at 400 × g for 10 min. To generate hiHep cells, urinary epithelial cells were seeded at a density of 400,000 cells per well in a six-well plate and cultured overnight in hUCM. ",Inhibitor of GSK3β;Inhibitor of the ALK5 (TGF-β type 1 receptor);Inhibitor of histone deacetylase;Inhibitor of lysine-specific demethylase 1 (LSD1);Agonist of a retinoic acid receptor;Inhibitot of histone EZH2 lysine methyltransferase,Foxa3;Hnf1α;Hnf4α,Chemical cocktails enable hepatic reprogramming of human urine-derived cells with a single transcription factor,_,20,Percent of albumine positive cell (20-27 %),2,"Human urine-derived epithelial-like cells (hUCs) can also be transdifferentiated into human hepatocyte-like cells (hiHeps) using one TF (Foxa3, Hnf1α, or Hnf4α) plus the same chemical cocktail CRVPTD (C, CHIR99021; R, RepSox; V, Valproic Acid; P, Parnate; T, TTNPB; and D, DZNep)",Xue Cui;Meng-meng Jiang;Yu-ting Lu;Yang Zheng;Shi-jun Shen;Ren Guo;Wei Tang,_
10.1016/j.biomaterials.2018.11.037,Mus musculus,Fibroblasts,Induced Skeletal Muscle-like Cells,,"Valproic Acid,3121;CHIR99021,9956119;RepSox,449054;Forskolin,47936;Parnate,19493;TTNPB,5289501","Differentiation medium composed of high glucose DMEM supplemented with 2% (v/v) horse serum (HyClone, IL, USA) and 1% (v/v) penicillin/streptomycin and incubated for 48 to 72 hours. P19 cells were maintained in α-modified Eagle’s MEM (GIBCO , MA, USA) supplemented with 10% heat-inactivated FBS and 1% penicillin and streptomycin at 37°C in a humidified atmosphere of 5% CO 2 and were passaged every 2 days.

Muscle Reprogramming Medium: composed of knockout DMEM (GIBCO, MA, USA), 15% knockout serum replacement, 5% FBS, 1% Glutamax, 1% non-essential amino acid, 0.1 mM β-mercaptoethanol, and 1X penicillin/streptomycin, containing chemical compound combinations, such as VCRFPT or VCRF. VCRFPT cocktail consists of 0.5 mM Valproic Acid (V), 20 μM CHIR99021 (C), 10 μM RepSox (R), 50 μM Forskolin (F), 5 μM Parnate (P), and 1 μM TTNPB (T).

Expansion medium: DMEM/F12 (Welgene, Korea), 1% penicillin and streptomycin, 0.5% BSA (Gibco, MA, USA), 1% Glutamax, 1% non-essential amino acid, 300 μg/ml phospho 2-phospho-L-ascorbic acid, 10 ng/ml BMP4, 0.15 mM monothioglycerol, 1X B27 supplements without Vitamin A (Gibco, MA, USA), 20 μM CHIR99021, and 20 ng/ml FGF2 (Preprotech, NJ, USA).",Activin A;BMP4;VEGF,"Mouse embryonic fibroblasts (MEF) were isolated from an embryonic day (13.5) C57BL.6 mouse embryo (Orientbio, Korea). The head, spinal cord, and the internal organs were carefully
removed to eliminate any chance of contamination of neural crest cells. The rest of the tissues were cut and trypsinized with 0.25% trypsin-EDTA (GIBCO, MA, USA) to produce a single cell
suspension. MEFs were subsequently cultured in high glucose DMEM supplemented with 10% (v/v) FBS (Gibco, MA, USA) and 1% (v/v) penicillin and streptomycin (Welgene, Korea). For lineage tracing experiments, FSP-Cre mice were mated with R26R tdTomato mice (Jackson Laboratories, ME, USA) to generate mice with fibroblast specific expression of tdTomato in MEF. MEF were isolated in a similar procedure as described above.",Inhibitor of histone deacetylase;Inhibitor of GSK3β;Inhibitor of the ALK5 (TGF-β type 1 receptor);CAMP agonist;Inhibitor of lysine-specific demethylase 1 (LSD1);Agonist of a retinoic acid receptor,_,Chemical Induced Conversion of Mouse Fibroblasts and Human Adipose-Derived Stem Cells Into Skeletal Muscle-Like Cells,_,1.5,Percent of α-actinin immuno-positive skeletal muscle cells,1,_,Kyeong Kyu;Jong-Sun Kang;Hyeon-Ju Jeong;Tong Mook;Jieun An;Debojyoti De;Varun Bansal,_
10.1016/j.stemcr.2018.04.009,Mus musculus,Fibroblasts,Induced Myogenic Progenitor Cells,14,"CHIR99021,9956119;RepSox,449054;Forskolin,47936","iMPC medium: containing KnockOut-DMEM (ThermoFisher Scientific, catalog number 10829-018) supplemented with 10% FBS (HyClone catalog number SH30396.03), 10% KnockOut Serum Replacement (ThermoFisher Scientific, Catalog number 10828028), 1% GlutaMAX (Catalog number 35050061), 1% non-essential amino acids (ThermoFisher Scientific, Catalog number 11140050), 1% penicillin-streptomycin (ThermoFisher
Scientific, catalog number 15140122), 0.1% β-mercaptoethanol (ThermoFisher Scientific, catalog number 21985-023) and 10ng/ml basic FGF (R&D 233-FB). Forskolin (SigmaAldrich F6886) and RepSox (Sigma-Aldrich, R0158) were added at a concentration of 5μM each. For most experiments, 3μM of the GSK3β inhibitor CHIR99021 (Tocris) was used. Doxycycline (Sigma-Aldrich, D9891) was added at a final concentration of 2μg/ml.",_,"Mouse embryonic fibroblasts (MEFs), tail-tip fibroblasts (TTFs) and the commercial myoblast cell line C2C12 (ATCC®CRL-1772TM) were cultured in “MEF medium”.containing DMEM (ThermoFisher Scientific, catalog number 10313-021), supplemented with 10% Fetal Bovine Serum (FBS) (HyClone catalog number SH30396.03), 1% GlutaMAX (ThermoFisher Scientific, catalog number 35050061), 1% non-essential amino
acids (ThermoFisher Scientific, catalog number 11140050), 1% penicillin-streptomycin (ThermoFisher Scientific, catalog number 15140122), 0.05% β-mercaptoethanol (ThermoFisher Scientific, catalog number 21985-023). Freshly isolated satellite cells and derivative myoblasts were cultured using a 1:1 ratio of DMEM and F-10 (1X) Nutrient mix (ThermoFisher Scientific, catalog number 11550-043) supplemented with 10% horse serum (ThermoFisher Scientific, catalog number 16050-122), 20% FBS (HyClone catalog number SH30396.03) and 10ng/ml basic-FGF (R&D Systems 233-FB). Satellite cells and
myoblasts were cultured on plates coated with Matrigel Basement Membrane Matrix (Catalog number 356237, Corning) or laminin (Catalog number 23017015, Thermo Fisher Scientific).",Inhibitor of GSK3β;Inhibitor of the ALK5 (TGF-β type 1 receptor);CAMP agonist,MyoD,Direct Reprogramming of Mouse Fibroblasts into Functional Skeletal Muscle Progenitors,GSE108543;GSE92336,50,Percent of Pax7+ cells,2,_,Konrad Hochedlinger;Amy Wagers;Michael Rudnicki;Shahragim Tajbakhsh;Harald Ott;Ruslan Sadreyev;Anthony Anselmo;Sylvain Paisant;Duygu Payzin;Priscilla Cheung;Cassandra Verheul;Peter Feige;Aaron Huebner;Amy Coffey;Amy Galvin;Albert Almada;Bruno Stefano;Mattia Gerli;Ori Bar,_
10.1073/pnas.1720273115,Homo sapiens,Peripheral Blood T Cells,Induced Neurons,21,"Forskolin,47936;Dorsomorphin,11524144;SB431542,4521392;IWP-2,_;DAPT,5311272;Retinoic acid,444795;SU 5402,5289418;Y-27632,448042;SP600125,8515",N3 media,Activin A,"Peripheral blood mononuclear cells(PBMCs) were isolated using gradient centrifugation and electroporated these cells with episomal vectors encoding the four transcription factors Brn2, Ascl1, Myt1l, and Ngn2, collectively termed the BAMN pool, which was previously found to generate iN cells from human fibroblasts (9), and enhanced green fluorescent protein (EGFP) into 3 million PBMCs. Transfected cells were then cultured in IL-2 and CD3/CD28 antibodies containing media supporting T cell growth.","CAMP agonist;Inhibitor of ALK2, ALK3, ALK6         and AMPK;Inhibitor of the Activin/BMP/TGF-β pathway;Inhibitor of Wnt;Inhibitor of γ-secretase;Agonist of a retinoic acid receptor;Inhibitor of VEGFR2, FGFR1         and PDGFRB;Inhibitor of ROCK1 and ROCK2;Inhibitor of JNK
",Brn2;Ascl1;Myt1l;Ngn2,Transdifferentiation of human adult peripheral blood T cells into neurons,GSE113804,6.2,Percent of cells with neuronal morphologies and expressed multiple pan-neuronal markers,2,_,Marius Wernig;Thomas Sudhof;Douglas Levinson;Daniel Haag;Victor Olmos;Soham Chanda;Cheen Ang;Koji Tanabe,_
10.1016/j.celrep.2018.06.116,Mus musculus,Fibroblasts,Induced Neural Stem Cells,12,"Valproic Acid,3121;CHIR99021,9956119;RepSox,449054","Conditional medium: DMEM supplemented with 10% fetal bovine serum (FBS), KnockOut DMEM with 10% KnockOut serum replacement (KSR), Dulbecco’s Modified Eagle Medium/Nutrient Mixture F-12 with 10% KSR, neural basal medium (STEMCELL Technologies) with N2 and B27, Roswell Park Memorial Institute RPMI 1640 medium  with 10% FBS, and MyeloCult M5300 medium containing FBS and horse serum.

M5300 medium.",FGF5;EGF;bFGF;LIF;IL-6,"MEFs were isolated from E13.5 mouse embryos and mouse TTFs were isolated from 8-week-old mice as our previous report (https://www.nature.com/articles/cr201432). Briefly, embryonic tissues without head, limbs, visceral tissues, gonads, or vertebral column were scissored into pieces and trypsinized. The front 1/5 part of tail from adult mice were scissored into 1 mm pieces and cultured till cells migrated out from the tail-tip pieces. Both MEFs and TTFs were cultured in Dulbecco’s Modified Eagle’s Medium (DMEM) supplemented with 10% fetal bovine serum (FBS), 1 mM GlutaMAX, 0.1 mM non-essential amino acid, 100 units/mL penicillin and 100 mg/mL streptomycin at 37C with 5% CO 2 . All cells at early passages (less than 3 passages) were used further experiment.",Inhibitor of histone deacetylase;Inhibitor of GSK3β;Inhibitor of the ALK5 (TGF-β type 1 receptor),_,Direct Conversion of Mouse Fibroblasts into Neural Stem Cells by Chemical Cocktail Requires Stepwise Activation of Growth Factors and Nup210,GSE108300,20,Percent of Nestin+ cells,1,_,Lin Cheng;Feng Liu;Pei Yu;Shumin Xiong;Yuewen Tang,_
10.22074/cellj.2020.6582,Homo sapiens,Mesenchymal Stem Cells (Adipose-derived),Induced Cardiomyocytes,21,"Valproic Acid,3121;5-Aza-2'-deoxycytidine,451668","For cardiac differentiation, third to fifth-passaged ADSC were seeded into 0.1% gelatin-coated 6-well tissue culture plates with a density of 105 cell/ml (2 ml per each well). After 24 hours, the cells were induced for cardiac differentiation with 10 ng/ml bFGF and 20 ng/ml BMP4 for four days. After the induction stage, growth factors were omitted completely and differentiation of the cells was continued in 10% FBS-containing medium up to three weeks. ",BMP4;bFGF,"Adipose tissue was minced and digested by 2 mg/ml collagenase I (Thermo Fisher Scientific, USA) in PBS containing 2% bovine serum albumin. The stromal vascular fraction (SVF) was plated at 5×104
cells/ml in tissue culture flasks. Growth medium contained Dulbecco’s Modified Eagle’s Medium (DMEM), 20% fetal bovine serum (FBS), 100 U/ml penicillin and 100 µg/ml streptomycin. Medium was changed every other day, and the cells were subcultured after reaching 80-90% confluency. ",Inhibitor of histone deacetylase;Inhibitor of DNA methylation,_,Cardiac Differentiation of Adipose Tissue-Derived Stem Cells Is Driven by BMP4 and bFGF but Counteracted by 5-Azacytidine and Valproic Acid,_,39,Cardiac troponin positive cells,1,_,Masoumeh Taha;Asadollah Asadi;Arash Javeri;Sanaz Hasani,_
10.1007/s11033-020-05370-1,Homo sapiens,Urine Cells,Induced Neurons,12,"Valproic Acid,3121;CHIR99021,9956119;RepSox,449054;Forskolin,47936;SP600625,_;GO6983,3499;Y-27632,448042;ISX9,19582717;I-BET151,52912189;QVD-OPH,24794416","HUC-1 medium [DMEM-F12 medium with 1% p/s, 0.1% each supplement from Renal Epithelial Cell Growth (REGM) BulletKit (Lonza, US) and 10% Fetal Bovine Serum (FBS, Gibco)] and transferred into two wells of gelatin-coated four-well plate. Medium was half-changed every other day.

HUC-2 medium (Renal Epithelial Basal Medium (REBM) with 1% p/s, 0.1% each supplement from REGM BulletKit and 1% FBS (Gibco)) at day 3 after first seeding.

NIM1; Neurobasal medium (Gibco, AUS) supplemented with 1% p/s (Gibco), 1% L-glutamine (Gibco), 2% B27 (Gibco), 1% N2 (Gibco) supplemented with 100 μM cAMP-Na (Sigma), 4 μM Valproic Acid (Valproic Acid, Calbiochem), 3 μM CHIR99021(selleck chemicals), 1 μM RepSox (Sigma), 10 μM Forskolin (Sigma), 10 μM SP600125 (Sigma), 5 μM GO6983 (Sigma), 10 μM Y-27632 (Sigma), 2 μM IBET151 (Sigma), 20 μM Isoxazole9 (ISX9, R&D Systems), 10 μM Retinoic acid (RA, Sigma), 5 μM QVD-OPh (MedChemExpress) and 0.2 mM Vitamin C (VitC, Sigma)).

Urine Stem Cell Medium (USCM) (keratinocyte serum-free media (KSFM): DMEM-F12 (1:1) with 10% FBS (Gibco), 1% p/s, 50 µg/ml bovine pituitary extract (BPE), 10 ng/ml epidermal growth factor (EGF) and 1.8 × 10–4 M adenine.

Neurobasal medium: 1% p/s, 1% L-glutamine, 2% B27, 1% N2 supplemented with 20 ng/ml BDNF, 20 ng/ml GDNF, 20 ng/ml IGF and 20 ng/ml NT3",,"Urine samples were collected from three donors (all male, 35–50 years old; cell record number (CRN): 201, 205, 234). After collection, samples were collected into 50 ml centrifuge tubes and centrifuged for 10 min at 400×g. Supernatants were then discarded, leaving about 1 ml of sample in each tube. About 10 ml of sterile phosphate buffered saline (PBS) with 1% penicillin/streptomycin (p/s) was added into the tube to prevent any possible contamination. Then the cells were transferred into new 15 ml sterile tubes and centrifuged again at 400 g for 10 min. '",Inhibitor of histone deacetylase;Inhibitor of GSK3β;Inhibitor of the ALK5 (TGF-β type 1 receptor);CAMP agonist;Inhibitor of the JNK;Inhibitor of protein kinase C;Inhibitor of ROCK1 and ROCK2;Neurogenic Modulator;Inhibitor of the BET family;Inhibitor of the broad-spectrum caspase,_,Conversion of human urine-derived cells into neuron-like cells by small molecules,_,_,"Induction efficiency were not measured. Cells were stained positive for neuronal markers Tuj1, MAP2, Tau, PSA-Ncam, but not NeuN or SYNJ1. The electrophysiology analysis showed that about 30% of the induced cells have acquired voltage gated Na+ and K+ currents.",1,_,Xin-Fu Zhou;Hong Liao;Larisa Bobrovskaya;Fiona Zhou;Nimshitha Pavathuparambil;Mohammed Al;Grigori Rychkov;Donghui Liu,_
10.5713/ajas.19.0796,Sus scrofa,Mesenchymal Stem Cells (Bone marrow derived),Induced Pancreatic Beta Cells,30,"Valproic Acid,3121;5-Aza-2'-deoxycytidine,451668","BM-MSCs were seeded at a density of 1×105 134 135 cells/35 mm dish in ADMEM (Advanced Dulbecco's modified Eagle's medium (ADMEM) supplemented with 10% FBS for 24 hours (Day 0), followed
by treatment with 1 µM 5-Aza and/or 50 g/ml Valproic Acid (Valproic Acid) and were cultured at 37 °C and 5% CO2 in a humidified incubator for next 24 hours.

N2B27-based medium: DMEM/F12 medium supplemented with 156 N2, B27, 0.1 mM ß-mercaptoethanol, 2 mM glutamine, 1 mM MEM nonessential amino acids, 0.5% bovine serum albumin (BSA) and 100 ng/mL of basic fibroblast growth factor.",,"BM-MSCs were cultured in Advanced Dulbecco's modified Eagle's media (ADMEM) supplemented with 10% fetal bovine serum (FBS), 1X GlutaMAX (Gibco), and 1% penicillin-streptomycin (10,000 IU and 10,000 g/mL) at 37 °C and 5% CO2 in a humidified incubator.",Inhibitor of histone deacetylase;Inhibitor of DNA methylation,,"Transdifferentiation of α-1,3-galactosyltransferase knockout pig bone marrow derived mesenchymal stem cells into pancreatic β-like cells by microenvironment modulation",_,_,Induction efficiency were not measured. NEUROD1 and NKX6 expression were measured by Real-Time qPCR ,1,_,Sun Ock;Tai-Young Hur;Youngim Kim;Seongsoo Hwang;Keon Bong;Ran Lee;Imran Ullah,_
10.1242/dev.172569,Zebrafish,_,Induced Pancreatic Beta Cells,21,"XL147,1893730;Chaulmoogric Acid Ethyl Ester,2700;SKF-86055,453216;HC-Toxin,107864;SB-736290,11680113;PD168393,4708;DTXSID80301486,286003;Scriptaid,5186",_,_,Whole genome zebrafish with TgBAC(pdx1:luciferase2) reporter,Inhibitor of PI3 kinase;Agonist of the GPR40;Inhibirot of the ALK5;Inhibitor of the HDAC;Inhibitor of the MSK1;Inhibitor of the EGFR;Agonist of the Adenosine Receptor;Inhibitor of the HDAC,_,A whole organism small molecule screen identifies novel regulators of pancreatic endocrine development,_,_,"In this study, we used a newly generated zebrafish reporter to screen over 8000 small molecules for modulators of pdx1 expression. We found four hit compounds and validated their efficacy at different stages of pancreas development. ",1,_,Didier Stainier;Francesca Spagnoli;Ole Korsgren;Stefan Offermanns;Mario Looso;Duc Dong;Remy Bonnavion;Joseph Lancman;Florian Kreuder;Hyouk-Bum Kwon;Oskar Skog;Sorin Tunaru;Jens Preussner;Laura Mueller;Sri-Teja Mullapudi;Christian Helker,_
10.1038/s41467-019-08626-y,Mus musculus,Fibroblasts,Induced Cardiomyocytes,28,"Diclofenac,3033;STK081095,135456876;STK833231,3823504;STK825882,2978770","Medium: 6 mL of Dulbecco’s modified Eagle medium, DMEM, containing 10% fetal bovine serum, FBS, per embryo.

Explant medium: IMDM with L-glutamate and 25 mM HEPES, Gibco, 12440-053, 20% FBS",_,"For TTF isolation, postnatal day 1–3 or 8–week-old adult mouse tails were minced into pieces smaller than 1 mm3. The explants were plated on gelatin-coated dishes and cultured for 10–14 days in explant medium.",Inhibitor of the Cyclooxygenase-2;Putative Inhibitor of the Cyclooxygenase;Putative Inhibitor of the Cyclooxygenase;Putative Inhibitor of the Cyclooxygenase,Gata4;Mef2c;Tbx5;Hand2,Role of cyclooxygenase-2-mediated prostaglandin E2-prostaglandin E receptor 4 signaling in cardiac reprogramming,GSE116227,6,Percent of cTnT+ positive cells (FACS analyses),2,_,Naoto Muraoka;Kaori Nara;Fumiya Tamura;Hidenori Kojima;Hiroyuki Yamakawa;Taketaro Sadahiro;Kazutaka Miyamoto;Mari Isomi;Sho Haginiwa;Hidenori Tani;Shota Kurotsu;Rina Osakabe;Satoru Torii;Shigeomi Shimizu;Hideyuki Okano;Yukihiko Sugimoto;Keiichi Fukuda;Masaki Ieda,_
10.1155/2019/7627148,Homo sapiens,Mesenchymal Stem Cells (Bone marrow derived),Induced Neurons,10,"I-BET151,52912189;CHIR99021,9956119;Forskolin,47936;RepSox,449054;Y-27632,448042;Bucladesine,9687","Neurobasal medium, α-MEM, RPMI medium, DMEM low glucose (DMEM-lg), DMEM/F-12, fetal bovine serum (FBS), L-glutamine, dispase II, Glutamax, antibiotics, trypsin/EDTA, human neurotrophic factors, N2, and B27 were all purchased from GibcoTM Thermo Fisher Scientific Inc. (MA, USA).

Neuronal induction medium: 50% neurobasal medium, 50% DMEM/F12 with 1 × N2 and 1 × B27 with vitamin A, 1 × Glutamax, 1 × nonessential amino acids, and 20 ng/mL FGF2 plus 5 μg/mL heparin) plus the defined chemical cocktails for 8
or 4 days (as appropriate) at 37 ° C and 5% CO 2.",FGF2;hBDNF;hGDNF,"The bone marrow samples were obtained according to the Local Ethics Committee of the Villa Coapa Hospital, Mexican Institute for Social Security (IMSS, Mexico). Adult and neonatal MSCs were seeded onto fibronectin (2 μg/cm 2 )/0.1% gelatin-coated plates at a density of 2 × 10 4 cells/cm 2 and cultured in MSC growth medium for one day.",Inhibitor of the BET family;Inhibitor of GSK3β;CAMP agonist;Inhibitor of the ALK5 (TGF-β type 1 receptor);Inhibitor of ROCK1 and ROCK2;CAMP pathway activator,_,Neuronal Transdifferentiation Potential of Human Mesenchymal Stem Cells from Neonatal and Adult Sources by a Small Molecule Cocktail,GSE120681,50,Percent of the TUJ1+cells,1,_,Marco Alvarez;Laura Bonifaz;Erika Hernandez;Rosa Ruiz;Victor Cortes;Juan Montesinos;Enoch Luis;Cesar Lara;Arturo Picones;Alejandro Aguilera;Herminia Pasantes;Lorena Cortes,_
10.1038/s41598-019-39544-0,Homo sapiens,Myofibroblasts,Fibroblasts,1,"Y-27632,448042","Minimum Essential Medium (MEM), foetal bovine serum, 4‐(2‐hydroxyethyl)‐1‐piperazineethanesulfonic acid (HEPES), trypsin EDTA, and penicillin (100 U/mL)/streptomycin (100 μg/mL) were supplied by Gibco‐Invitrogen (Carlsbad, California). Phosphate‐buffered saline (PBS), radioimmunoprecipitation assay buffer, and phosphatase inhibitor solution were from Wako Pure Chemical Industries, Ltd (Osaka, Japan).",_,The Tenon tissue from each patient was excised and digested as previously described. Cells from patients were then cultured in MEM supplemented with 10% foetal bovine serum and penicillin (100 U/mL)/streptomycin (100 μg/mL) and maintained in the exponential growth phase of culture.,Inhibitor of ROCK1 and ROCK2,_,Forskolin and IBMX Induce Neural Transdifferentiation of MSCs Through Downregulation of the NRSF,_,_,"Expression of α‐SMA, Tubulin, Vimentin",1,_,Christina Chan;Christina Casali;Ryan Thompson,_
10.1016/j.yexcr.2019.04.011,Mus musculus,Mesenchymal Stem Cells (Bone marrow derived),Induced Neurons,8,"Forskolin,47936;IBMX,3758",Cells were cultured in low glucose DMEM (Invitrogen) supplemented with 10% fetal bovine serum (Invitrogen) and free from antibiotics.,_,The two ends of the bone were cut open and the marrow was flushed with 10 mL of DMEM using a 25 g needle and syringe. The cell suspension was filtered through a 70-um nylon mesh to remove bone debris and blood aggregates. Cells were cultured in low glucose DMEM (Invitrogen) supplemented with 10% fetal bovine serum (Invitrogen) and free from antibiotics. Cells were incubated in a humidified atmosphere containing 5% CO2 at 37 C. Non-adherent cells from the flushed marrow were removed after 48 h after isolation. Media was replaced every 3 days until the cells reached 80–90% confluence.,CAMP agonist;Inhibitor of the cyclic nucleotide phosphodiesterases,_,Programming of ES cells and reprogramming of fibroblasts into renal lineage-like cells,_,_,Expression of the Tuj1,1,_,Reza Moghadasali;Hossein Baharvand;Nasser Aghdamia;Mahdi Hesarakia;Mehdi Totonchi;Zohreh Mansoori,_
10.1038/s41421-019-0096-8,Mus musculus,Fibroblasts,Uterine Epithelial Cells,12,"CHIR99021,9956119;AC1LA18U,459803;A83-01,10202642","Expanding medium: DMEM/F12 and Neurabasal (3:1), 2% KOSR 100 ng/mL EGF (R&D, 2028-EG-200), 10 ng/mL FGF2, 1000 U/mLif, 5 μM A 83-01, 3 μM CHIR99021, 1 μg/mL Heparin (Sigma, H4784), 55 μM β-mercaptoethanol (Gibco, 21985), 0.002% BSA (Sigma, A7906-100G), NEAA (Gibco, 11140-050, 100 ×), N2 and B27]. Trypsin (0.25%) (Gibco, 25200072) digestion was done to passage the cells, the passage ratio was 1: 4 to 1: 6. 

Inducing medium: FBLDAC cocktail and other supplements including DMEM/F12 (Gibco, 12400-024) and Neurabasal (Gibco, 21103-049) (1:1 mixture), N2 (Gibco, 17502-048), B27 (Gibco, 17504-044), 10% FBS and 10% KOSR (Gibco, 10828028). ",FGF2;BMP4;mLif,"Mouse embryonic fibroblasts (MEFs) were isolated from embryos at embryonic day 13.5 (E13.5) and then cultured with a chemical cocktail consisting of FGF2, BMP4, mLif, 1,4-DPCA (a competitive inhibitor of HIF prolyl 4-hydroxylase), A8-301 (an inhibitor of TGF-β type I receptor ALK5 kinase), and CHIR99021 (a GSK-3α/β inhibitor)-inducing medium (FBLDAC).","Inhibitor of GSK3β;Inhibitor of the HIF prolyl 4-hydroxylase;Inhibitor of ALK4, ALK5, ALK7 (activin receptor-like kinases)",_,Reprogramming of fibroblasts to uterine glandular epithelium by a chemical cocktail induction,_,_,"Hierarchical clustering analysis revealed that the gene expression patterns of ciGEs were closely related to priUterus, while differed significantly from MEFs. Furthermore, ciGEs have high expression levels of Sprr2f and Ltf, similar to GE.",1,_,Qi Zhou;Wei Li;Ying Zhang;Zhonghua Liu;Jia Guo;Xin Liu;Yanping Hu;Junjie Mao;Zhengquan He;Xuewei Yuan,_
10.1016/j.jcyt.2019.01.004,Mus musculus,Mesenchymal Stem Cells (Wharton’s jelly),Endothelial Cells,14,"Celecoxib,2662","Endothelial basal medium: (EBM-2; Lonza)supplemented with various growth factors includingvascular endothelial growth factor (VEGF-A; Endo-thelial Growth Medium-2 (EGM-2), CC-3162;Lonza)",VEGF-A;EGM-2,Well-characterized commercially available human WJ-MSCs were cultured in MSC expansion media (AL512; HiMedia) containing 10% fetal bovine serum (FBS) and 1% penicillin-streptomycin (Invitrogen) at 37°C. All experiments were performed between passages 5 and 7.,Inhibitor of cyclooxygenase [COX] 2,_,Cycloxygenase-2 inhibition potentiates trans-differentiation of Wharton's jelly–mesenchymal stromal cells into endothelial cells: Transplantation enhances neovascularization-mediated wound repair,_,_,"Expression of VE-cadherin,ANGPT2,VEGFR-2,CD31 and CD144",1,_,Amitava Das;Komal Kaushik,_
10.1002/cpsc.44,Homo sapiens,Induced Pluripotent Stem Cells,Induced Osteoblasts,21,"Adenosine,60961","hPSC maintenance medium: Knockout DMEM, 10% (v/v) knockout serum replacement, 10% (v/v) human plasmanate, 1% (v/v) nonessential amino acids, 1% (v/v) GlutaMAX, 1% (v/v) penicillin/streptomycin 55 μM 2-mercaptoethanol 30 ng/ml recombinant human bFGF.

hPSC differentiation medium: High-glucose DMEM, 10% (v/v) fetal bovine serum, 4 mM L-glutamine 1% (v/v) penicillin/streptomycin 30 μg/ml adenosine.

hPSC intermediate medium: Knockout DMEM, 10% (v/v) knockout serum replacement, 10% (v/v) human plasmanate, 1% (v/v) nonessential amino acids, 1% (v/v) GlutaMAX, 1% (v/v) penicillin/streptomycin 55 μM 2-mercaptoethanol",_,,Osteogenic inducer,,Direct Conversion of Human Pluripotent Stem Cells to Osteoblasts With a Small Molecule,_,_,Expression of the osteocalcin,1,_,Shih  Shyni Varghese;Heemin Kang  Yu‐Ru,_
10.1038/s41422-018-0036-4,Mus musculus,Fibroblasts,Induced Cardiomyocytes,7,"CHIR99021,9956119;RepSox,449054;Forskolin,47936;Valproic Acid,3121;Parnate,19493;TTNPB,5289501;Rolipram,5092",_,_,_,Inhibitor of GSK3β;Inhibitor of the ALK5 (TGF-β type 1 receptor);CAMP agonist;Inhibitor of histone deacetylase;Inhibitor of lysine-specific demethylase 1 (LSD1);Agonist of a retinoic acid receptor;Inhibitor of the type 4 cyclic nucleotide phosphodiesterases (PDE4),_,Chemical-induced cardiac reprogramming in vivo,_,_,Expression of the α-actinin and Mef2C,1,in vivo model,Xin Xie;Jinxi Wang;Yanbin Fu;Wanzhi Tu;Chenwen Huang,_
10.1007/s11427-018-9359-8,Homo sapiens;Mus musculus,Fibroblasts,Induced Motor Neurons,5,"Valproic Acid,3121;SB431542,4521392;RepSox,449054;CHIR99021,9956119;Kenpaullone,3820;Purmorphamine,5284329;SAG,5284330;Retinoic acid,444795;Y-27632,448042","Medium: Neurobasal medium, 2% B27, 2 mmol L−1 GlutaMAX, 1% penicillin/streptomycin.

Fibroblast medium consisting of Dulbecco’s modified eagle medium (DMEM) supplemented with 10% FBS, 2 mmol L−1 GlutaMAX, 1% penicillin/streptomycin at 37°C with 5% CO.

Neuronal induction medium consisting of Neurobasal medium, 2% B27, 2 mmol L−1 GlutaMAX, 1% penicillin/streptomycin",_,Human fetal lung IMR-90 fibroblasts were maintained in the DMEM containing 10% fetal bovine serum (FBS),Inhibitor of histone deacetylase;Inhibitor of the Activin/BMP/TGF-β pathway;Inhibitor of the ALK5 (TGF-β type 1 receptor);Inhibitor of GSK3β;Inhibitor of the GSK3β;Agonist of hedgehog;Agonist of the Smoothened;Agonist of a retinoic acid receptor;Inhibitor of ROCK1 and ROCK2,_,Chemical conversion of human and mouse fibroblasts into motor neurons,_,95,Percent of TUJ1-positive cells,1,1,Xiaobing Fu;Kui Ma;Andong Zhao;Hua Qin,_
10.1016/j.stemcr.2018.09.004,Mus musculus,Striatal Neurons,Induced Dopamine Neurons,56,"Valproic Acid,312",in vivo,_,_,Inhibitor of histone deacetylase,SOX2;URR1;LMX1A;FOXA2,Phenotypic Reprogramming of Striatal Neurons into Dopaminergic Neuron-like Cells in the Adult Mouse Brain,_,_,iDALs (induced dopaminergic neuron-like cells) Exhibit Electrophysiological Properties Similar to DA Neurons,2,in vivo model,Chun-Li Zhang;Yuhua Zou;Lei-Lei Wang;Tong Zang;Wenze Niu,_
10.2217/rme-2017-0155,Homo sapiens,Astrocytes,Induced Oligodendrocytes,14,"Trichostatin A,444732;5-Aza-2'-deoxycytidine,451668",in vivo,_,_,Inhibitor of the histone deacetylases I and II;Inhibitor of DNA methylation,_,In vivo conversion of astrocytes to oligodendrocyte lineage cells using chemicals: targeting gliosis for myelin repair,_,_,,1,in vivo model,Mohammad Javan;Hossein Baharvand;Leila Zare,_
10.1089/cell.2017.0028,Homo sapiens,Mesenchymal Stem Cells (Wharton’s jelly);Mesenchymal Stem Cells (Bone marrow derived),Induced Dental Pulp Pluripotent-like Stem Cells,3,"Vitamin C,54670067;Retinoic acid,444795;KAAD Cyclopamine,16760383;LDN193189,25195294;Phorbol dibutyrate,37783","MCDB131 media: 8 mM D-(+)-Glucose, 14.6 mM NaHCO3, 1% fatty acid free-BSA, 2 mM Glutamax, 1% Pen/Strep, 1:200 ITS-X in PBS, 250 lM ascorbic acid, and 50 ng/mL KGF/FGF-7 (R&D 
Systems), 2 lM retinoic acid, 0.5 lM cyclopamine-KAAD (Calbiochem), 2 lM LDN193189 hydrochloride (Sigma), and 0.25 lM Phorbol 12,13-dibutyrate (Sigma).",KGF;FGF-7,"Human umbilical cord matrix, Wharton’s Jelly, WJ-MSCs and human BM-MSCs were purchased from ATCC. ",_;Agonist of a retinoic acid receptor;Inhibitor of Smoothened (Smo) and Sonic hedgehog;Inhibitor of TGF-beta/Smad signaling;Activator of the protein kinase C,_,Chemically Defined Conditions Mediate an Efficient Induction of Mesodermal Lineage from Human Umbilical Cord- and Bone Marrow- Mesenchymal Stem Cells and Dental Pulp Pluripotent-Like Stem Cells,_,_,"Fold Change of the Mesoderm markers including the transcription factors Brachyury T (BraT), Mix Paired-Like Homeobox (MixL1) and Heart and Neural Crest Derivatives expressed 1 (Hand1) (10)",1,_,Fahd Al;Milad Bitar;Maher Atari;Neus Carrio;Hamad Ali;Sarah Alkandari;Ashraf Madhoun,_
10.1007/978-1-4939-7649-2_8,Homo sapiens,Fibroblasts,Schwann Cells,,"Valproic Acid,312","Fibroblast medium. FibroGRO™-LS Complete Media Kit (Millipore) is used as fibroblast medium. Complete medium consists of FibroGRO™ Basal Medium supplemented with 5 ng/ml basic fibroblast growth factor (bFGF), 50 μg/ml
ascorbic acid (Sigma), 7.5 mM l-glutamine, 1 μg/ml hydrocortisone hemisuccinate, 5 μg/ml insulin, and 2% fetal bovine serum (FBS). Complete medium is light sensitive; prolonged exposure to light has to be avoided.

Neural induction medium. NeuroCult NS-A proliferation medium (Stemcell Technologies) supplemented with 1% penicillin/streptomycin (Gibco), 20 ng/ml bFGF, 20 ng/ml epidermal growth factor (EGF), 20 ng/ml brain-derived
neurotrophic factor (BDNF), 2 μg/ml heparin (Stemcell Technologies), 500 ng/ml delta-like 4 (Dll4), 500 ng/ml Jagged1, 500 ng/ml sonic hedgehog (SHH) (PeproTech), 0.2 mM ascorbic acid, 100 ng/ml FGF8a, 10% NSC-CM (see
item 4), and 2 μM Compound B (Roche).

Neural induction medium supplemented with inhibitor mix. Neural induction medium supplemented with 500 ng/ml Noggin (Peprotech), 10 μM SB431452 (Tocris), and 1 μM CP21 (Roche, GSK3 inhibitor).

Neural differentiation medium (N2B27). DMEM/F12 and Neurobasal (1:1) supplemented with 50 μM β-mercaptoethanol, 2% B27 supplement without vitamin A (Invitrogen), 1% N2 supplement (Invitrogen), 1% penicillin/streptomycin, 20 ng/
ml BDNF, 20 ng/ml GDNF, 1 μg/ml laminin (Roche), 0.2 mM ascorbic acid, and 0.5 mM dibutyryl-cAMP (Sigma).

Neural differentiation medium supplemented with inhibitor mix. Neural differentiation medium supplemented with 500 ng/ml Noggin (Peprotech), 10 μM SB431452 (Tocris), and 1 μM CP21 (Roche, GSK3 inhibitor)
",,,Inhibitor of histone deacetylase,_,Chemical Conversion of Human Fibroblasts into Functional Schwann Cells,_,_,_,1,_,Eva C. Thoma,_
10.1371/journal.pgen.1007846,Mus musculus,Fibroblasts,Induced Neurons,14,"ISX9,19582717;Forskolin,47936;CHIR99021,9956119;I-BET151,52912189","Neuron induction medium (Neurobasal Medium) contains the following supplements: N2 (1X) and B27 (2X) supplements, GlutaMAX (1X), penicillin-streptomycin (100 μg/ml), bFGF (20 ng/ml), 100 μM cAMP, Non-essential Amino Acid (1X) and Trace element B (1X). MEFs were seeded to Matrigel-coated plate (1:30 dilution in pre-cold PBS and coat overnight at 4 oC, at a density of 200,000 cells per well in 6-well plate and 10,000 cells/well in 96 well plate. ",bFGF,"The mouse embryonic fibroblasts (MEFs) WTM, HETM and KOM (from the lab of Dr. Christophe Ampe, University of Gent, Belgium) were maintained and cultured with Dulbecco’s modified Eagle medium (DMEM) with high glucose, 10% fetal bovine serum (FBS) and 100 units/mL penicillin and 100 μg/mL streptomycin, in a humidified incubator with 5% CO2 at 37 oC.",Neurogenic Modulator;CAMP agonist;Inhibitor of GSK3β;Inhibitor of the BET family,_,β-actin regulates a heterochromatin landscape essential for optimal induction of neuronal programs during direct reprograming,GSE95830;GSE113733,_,_,1,_,Piergiorgio Percipalle;Nizar Drou;Aslam Mazari;Robertas Jankauskas;Xin Xie,_
10.1038/s41598-018-26745-2,Homo sapiens,Fibroblasts,Induced Osteoblasts,28,"RepSox,449054;Vitamin D3,5280795;D4476,6419753;SB431542,4521392","Dulbecco’s modified Eagle’s medium (DMEM) was supplemented with 100 mM non-essential amino acids, 100 U/mL penicillin, 100 μg/mL streptomycin and 10% fetal bovine serum (FBS) and used as the complete medium. Osteogenic medium consisted of the complete medium supplemented with 50 μg/mL ascorbic acid, 10 mM β-glycerol phosphate, and 100 nM dexamethasone.",BMP-2;IGF-1,"Normal human dermal fibroblasts derived from breast of 18-years-old male (aHDFs), Normal primary osteoblasts (pOBs) derived from a human femur and normal mesenchymal stem cells (MSCs) derived from a human adipose tissue were purchased from Lonza (Basel, Switzerland) and Kurabo (Kurashiki, Japan), respectively. Fibroblasts were cultured in the complete medium, which was replaced by fresh one every 3 to 4 days. To convert fibroblasts into osteoblasts, fibroblasts were resuspended in the complete medium and seeded onto 60-mm dishes at a density of 1 × 105 cells/dish (for DNA microarray analyses and transplantation experiments), 60-mm dishes at a density of 2 × 105 cells/dish (for ELISA and western blotting), or 24-well plates at 1 × 104 cells/well (for ALP staining,",Inhibitor of the ALK5 (TGF-β type 1 receptor);_;Inhibitor of the CK1;Inhibitor of the Activin/BMP/TGF-β pathway,_,Direct phenotypic conversion of human fibroblasts into functional osteoblasts triggered by a blockade of the transforming growth factor-β signal,GSE101140,90,Efficiency of conversion of fibroblasts into osteoblasts was ~90% (immunostaining to osteocalcin),1,_,Osam Mazda;Narisato Kanamura;Toshiro Yamamoto;Yuta Nishizawa;Shin-ichiro Kotani;Yoshiki Sato;Kei Nakai;Tsunao Kishida;Kenta Yamamoto,_
10.1038/nbt.3835,Homo sapiens,Astrocytes,Induced Dopamine Neurons,18,"Vitamin C,54670067;SB431542,4521392;LDN193189,25195294;CHIR99021,9956119;5-Aza-2'-deoxycytidine,451668;Purmorphamine,5284329","Eagle's Minimum Essential Medium.

RTMP medium.",TGFβ1,"Astrocytes were purchased from ATCC (SVGp12, cat. n CRL86-21) and hPA were purchased from Lonza (Normal Human Astrocytes, cat. n CC-2565). The cells were initially grown and amplified according to the manufacturer's instructions, and were used for experiments at low passages (maximum number of passages, four). Cells were chosen based on their inability to generate neurons in our control experimental conditions, indicating that they do not behave as stem/progenitor cells.",_;Inhibitor of the Activin/BMP/TGF-β pathway;Inhibitor of TGF-beta/Smad signaling;Inhibitor of GSK3β;Inhibitor of DNA methylation;Agonist of hedgehog,NEUROD;ASCL1;LMX1A;miR218,Induction of functional dopamine neurons from human astrocytes in vitro and mouse astrocytes in a Parkinson's disease model,GSE93528,16,Percent of tyrosine hydroxylase-positive cells,2,_,Ernest Arenas;Gilberto Fisone;Tibor Harkany;Marius Wernig;Sten Linnarsson;Sara Padrell;Yi-Han Ng;Christian Pifl;Michael Feyder;Gioele La;Enrique M;Elisa Martin;Debora Masini;Giada Spigolon;Roman A;Rivetti Cervo,_
10.1186/s13287-017-0658-3,Homo sapiens,Fibroblasts,Induced Cortical Neurons,30,"CHIR99021,9956119;SB431542,4521392;LDN193189,25195294","iCtx medium: Neurobasal, 2% B27 without vitamin A, 0.5 mM glutamine and 100 U/ml penicillin/streptomycin",BDNF;GDNF;NT3;Noggin,"Human fetal lung fibroblasts (henceforth referred to as HEFL) were isolated from dead aborted human fetuses aged 7–9 week postconception. After removal of the central nervous system and spinal ganglia, the trachea was exposed and resected at the bifurcation. Lungs were then transferred to a clean petri dish, washed several times with cold hibernation medium, and sub-dissected with another set of sterile tools. Great care was taken to remove the residual bronchi. The tissue was transferred several times to a clean petri dish containing sterile cold hibernation medium to remove contaminating cells. The sub-dissected pulmonary tissue was digested with 0.25% trypsin (Sigma-Aldrich) at 37 °C for 10 min and manually triturated to reach a single cell suspension. Cells were plated onto 0.1% gelatin (Sigma) in Dulbecco’s modified Eagle’s medium (DMEM) 4.5 g/L glucose supplemented with 2 mM glutamax and 10% fetal bovine serum (FBS) (all from Life technologies) (herein indicated as human fibroblast expansion medium; hFEM) and were passaged after reaching confluence with 0.25% trypsin. The HEFL cell line was used for neuronal differentiation protocols after passage 3 to avoid contamination from neural tissue and other cell types",Inhibitor of GSK3β;Inhibitor of the Activin/BMP/TGF-β pathway;Inhibitor of TGF-beta/Smad signaling,BRN2;MYT1L;FEZF2,Direct conversion of human fibroblasts to functional excitatory cortical neurons integrating into human neural networks,_,16,"The iCtx (induced cortical) cells exhibited electrophysiological properties of functional neurons, had pyramidal-like cell morphology, and expressed key cortical projection neuronal markers.",2,_,Zaal Kokaia;Olle Lindvall;Henrik Ahlenius;Johan Bengzon;Niels Bjarne;Daniel Tornero;Emanuela Monni;Marita Gronning;Karthikeyan Devaraju;Giedre Miskinyte,_
10.1038/srep40285,Homo sapiens,Fibroblasts,Induced Cardiomyocytes,14,"JAK inhibitor I,5494425;Sodium butyrate,5222465","Transdifferentiation medium was purchased from Lonza (AGMTM, CC-3186) and was reconstituted according to the technical specifications without the addition of EGF",_,"HDF (Lonza, CC-2509) were plated and expanded in standard growth medium: DMEM – High Glucose, 10% Fetal Bovine Serum (FBS), L-Glutamine, Non-essential amino acids, Sodium Pyruvate, Gentamicin.",JAK inhibitor;Inhibitor of histone deacetylase,GATA4;TBX5;MEF2C;MYOCD;NKX2–5;miR-;miR-133a,"Core Transcription Factors, MicroRNAs, and Small Molecules Drive Transdifferentiation of Human Fibroblasts Towards The Cardiac Cell Lineage",GSE81723,25,Percent of ACTN2 and TNNT2 positive cells,2,_,Kam Leong;Russell Addis;Andrew Adler;Robert Kirkton;Syandan Chakraborty;Nicolas Christoforou,_
10.1007/s11064-016-2086-7,Homo sapiens,Neural Progenitor Cells,Induced Neurons,21,"CHIR99021,9956119;I-BET151,52912189;RepSox,449054;Bucladesine,9687;Forskolin,47936;Y-27632,448042","Neurobasal medium, low glucose DMEM, DMEM/F-12, FBS, L-glutamine, Glutamax, antibiotics, trypsin/EDTA, human growth factors, N2, B27 all were obtained from Gibco™, Thermo Fisher Scientific Inc. (MA, USA).
Neural stem cell culture media: DMEM/F-12 supplemented with 1 × N2 and 1 × B27 without vitamin A (N2/B27) or human NeuroCult™ NS-A Proliferation Medium (hNCult) (StemCell™ Technologies, BC, CA) supplemented with 20 ng/mL each human epidermal growth factor (EGF) and human fibroblast growth factor 2 (FGF2) plus 5 µg/ml heparin. 
Neuronal induction medium: 50 % Neurobasal medium, 50 % DMEM/F12 with 1 × N2 and 1 × B27 with vitamin A, 1 × Glutamax, 1 × nonessential aminoacids, and 20 ng/mL FGF2 plus 5 µg/mL heparin plus defined chemical cocktails for 8 days at 37 °C and 5 % CO2.",EGF;FGF2,"Human MSCs were isolated from three healthy donors (males, 15–30 years-old) according to the ethical guidelines of the Villacoapa Hospital, Mexican Institute for Social Security (IMSS), and characterized as previously described [27] (online resource 1). The cells were cultured in low glucose DMEM that was supplemented with 10 % fetal bovine serum (FBS), 4 mM L-glutamine, 50 U/mL of penicillin, 50 µg/mL of streptomycin and 50 µg/mL of gentamicin. The medium was changed every 2 days and cells were subcultured using trypsin/EDTA (0.05 % trypsin, 0.48 mM EDTA) when they reached 90 % confluence.",Inhibitor of GSK3β;Inhibitor of the BET family;Inhibitor of the ALK5 (TGF-β type 1 receptor);CAMP pathway activator;CAMP agonist;Inhibitor of ROCK1 and ROCK2,_,Improved Proliferative Capacity of NP-Like Cells Derived from Human Mesenchymal Stromal Cells and Neuronal Transdifferentiation by Small Molecules,_,12,Percent of β-III tubulin+ and MAP2+ cells,1,_,Gerardo Ramos-Mandujano;Htctor Mayani;Marta Castro-Manrreza;Lorena Cortts-Medina;Juan Montesinos;Herminia Pasantes-Morales;Alejandro Aguilera-Castrejon,_
10.1371/journal.pone.0183358,Mus musculus,Embryonic Stem Cells,Induced Neurons,14,"Nicotinamide,936","N2B27 serum-free medium: of a 1:1 ratio of DMEM/F12 (Invitrogen) and Neurobasal media (Invitrogen) containing 0.5% N2 (Fisher Scientific, Loughborough, UK), 1% B27 (Fisher Scientific), 200mM L-glutamine and 0.1M β-mercaptoethanol was added to each well. The medium was refreshed every alternate day.",_,"mESCs were cultured in Glasgow Modified Eagles Medium (Invitrogen, UK) with the addition of 10% FCS, 0.1 M β-mercaptoethanol, 1 mM L-glutamine, 10 mM non-essential amino acids, 100 mM sodium pyruvate and 100 U/ml leukaemia inhibitory factor. Undifferentiated cells were routinely passaged every two days re-plating at a density of 1 x 106 cells/cm2. mESCs were maintained on 0.1% gelatin-coated tissue culture plastic at 37°C in a 5% CO2 incubator.",_,_,Nicotinamide alone accelerates the conversion of mouse embryonic stem cells into mature neuronal populations,_,6.8,Percent of βIII-tubulin-positive neurons,1,_,Rosemary Fricker;Adrian Williams;Clive Hawkins;Rowan Orme;Mark Pickard;Sile Griffin,_
10.1016/j.ymthe.2016.11.014,Homo sapiens,Amniocytes,Induced Pluripotent Stem Cells,28,"Valproic Acid,312;CHIR99021,9956119",NutriStem medium,_,"After obtaining informed consent, human amniocytes, i.e., AFS cells, were isolated from the amniotic fluid at 12 weeks of gestation (normal pregnancy). The AFS cells from three individuals with normal karyotype (samples 1, 2, and 3) were selected for c-KIT expression and expanded (104 cells per square centimeter) on plastic culture dishes without feeders in DMEM (DMEM-HG) (Invitrogen) supplemented with 10% FBS (Biosera), 2 mmol/L L-glutamine, 50 IU/mL penicillin, and 50 mg/mL streptomycin (GIBCO-BRL) at 37°C in a 5% CO2 incubator.",Inhibitor of histone deacetylase;Inhibitor of GSK3β,_,Human Amniocytes Are Receptive to Chemically Induced Reprogramming to Pluripotency,GSE26940,_,"Expression of the pluripotency markers TRA-1-60, TRA-1-81, SSEA3, NANOG, Oct4",1,_,Pascale Guillot;James Adjaye;Adrian Thrasher;Michelangelo Campanella;David Monk;Paolo Coppi;Simon Eaton;Fabio Tommasini;Veronica Sanchez;Anna Ranzoni;Kwan-Leong Hau;Alex Martin-Trujillo;Wasco Wruck;Danilo Faccenda;Dafni Moschidou;Kate Hawkins,_
10.1021/acs.accounts.7b00020,Homo sapiens,Keratinocytes,Induced Pluripotent Stem Cells,56,"PS48,44141940;Sodium butyrate,5222465;A83-01,16218924;Parnate,19493;CHIR99021,9956119;PD0325901,9826528",_,_,_,"Activator of the PDK1;Inhibitor of histone deacetylase;Inhibitor of ALK4, ALK5, ALK7 (activin receptor-like kinases);Inhibitor of lysine-specific demethylase 1 (LSD1);Inhibitor of GSK3β;Inhibitor of MEK/ERK pathway",Oct4,Pharmacological Reprogramming of Somatic Cells for Regenerative Medicine,_,_,_,2,_,Sheng Ding;Ke Li;Shibing Tang;Min Xie,_
10.1021/acs.accounts.7b00020,Mus musculus,Fibroblasts,Induced Cardiac Progenitor Cells,17,"JAK inhibitor I,5494425;CHIR99021,9956119;SU5402,5289418",_,BMP4;Activin A,_,"JAK inhibitor;Inhibitor of GSK3β;Inhibitor of the VEGFR2, FGFR1 and PDGFRB",Oct4;Sox2;Klf4;c-Myc,Pharmacological Reprogramming of Somatic Cells for Regenerative Medicine,_,_,_,2,_,Sheng Ding;Ke Li;Shibing Tang;Min Xie,_
10.1021/acs.accounts.7b00020,Mus musculus,Fibroblasts,Induced Pancreatic Beta Cells,16,"BIX01294,25150857;Retinoic acid,444795;A83-01,16218924;LDE225,24775005;Vitamin C,10990876",_,Activin A,_,"Inhibitor of the G9a histone methyltransferase;Agonist of a retinoic acid receptor;Inhibitor of ALK4, ALK5, ALK7 (activin receptor-like kinases);_;_",Oct4;Sox2;Klf4;c-Myc,Pharmacological Reprogramming of Somatic Cells for Regenerative Medicine,_,_,_,2,_,Sheng Ding;Ke Li;Shibing Tang;Min Xie,_
10.1021/acs.accounts.7b00020,Mus musculus,Fibroblasts,Induced Cardiomyocytes,49,"Parnate,19493;Forskolin,47936;SB431542,4521392;CHIR99021,9956119",_,BMP4,_,Inhibitor of lysine-specific demethylase 1 (LSD1);CAMP agonist;Inhibitor of the Activin/BMP/TGF-β pathway;Inhibitor of GSK3β,Oct4,Pharmacological Reprogramming of Somatic Cells for Regenerative Medicine,_,_,_,2,_,Sheng Ding;Ke Li;Shibing Tang;Min Xie,_
10.1021/acs.accounts.7b00020,Mus musculus,Fibroblasts,Induced Neural Stem Cell,10,"LDN193189,25195294;A83-01,16218924;CHIR99021,9956119;Hh-Ag1.5,44195701;Retinoic acid,444795;RG108,702558;Parnate,19493;SMER28,1560402",_,bFGF,_,"Inhibitor of TGF-beta/Smad signaling;Inhibitor of ALK4, ALK5, ALK7 (activin receptor-like kinases);Inhibitor of GSK3β;Agonist of the Smoothened (Smo) receptor; activator of the sonic hedgehog (Shh) signaling;Agonist of a retinoic acid receptor;Inhibitor of the DNA methyltransferase;Inhibitor of lysine-specific demethylase 1 (LSD1);Enhancer of the mammalian autophagy",_,Pharmacological Reprogramming of Somatic Cells for Regenerative Medicine,_,30,_,1,_,Sheng Ding;Ke Li;Shibing Tang;Min Xie,_
10.1021/acs.accounts.7b00020,Mus musculus,Fibroblasts,Induced Cardiomyocytes,11,"A83-01,16218924;AS8351,135400486;BIX01294,25150857;CHIR99021,9956119;JNJ10198409,9797370;OAC2,2814138;SU16F,5329150;Y-27632,448042",_,Activin A;BMP4;VEGF,_,"Inhibitor of ALK4, ALK5, ALK7 (activin receptor-like kinases);Inhibit of the histone demethylase KDM5B;Inhibitor of the G9a histone methyltransferase;Inhibitor of GSK3β;_;_;Platelet-derived growth factor receptor (PDGFR)-β inhibition;Inhibitor of ROCK1 and ROCK2",_,Pharmacological Reprogramming of Somatic Cells for Regenerative Medicine,_,_,_,1,_,Sheng Ding;Ke Li;Shibing Tang;Min Xie,_
10.1038/cr.2017.17,Mus musculus,Fibroblasts,Induced Cardiomyocytes,22,"RepSox,449054;Tranylcypromine,19493;CHIR99021,9956119;Forskolin,47936;Sodium pyruvate,23662274;Vitamin C,54670067;Ciprofloxacin,2764;Dorsomorphin,11524144;IWR1,3137736",iMT medium,bFGF,"MEFs were isolated from E14.5 B6/C57, Oct4-GFP, ANF-GFP or GFAP-GFP mouse embryos. Head, vertebral column, dorsal root ganglia and all internal organs were removed and discarded and the remaining embryonic tissue was manually cut into pieces and incubated in 0.25% trypsin for 5 min. Cells from embryos were plated onto a 15cm tissue culture dish in MEF medium containing DMEM (Life Technologies) and 10% fetal bovine serum (FBS, Gemini). Mouse adult fibroblasts were isolated from tail tip samples. Tail tips were minced into pieces, placed on culture dishes, and incubated in MEF medium for 7days. MEFs and TTF cells were seeded at a density of 20 000 cells per 35 mm dish. The next day, MEF medium was replaced with the iMT media containing DMEM (Life Technologies) supplemented with 15% FBS (Gbico), 2 mM GlutaMax supplement (Life Technologies), 1% nonessential amino acids (Life Technologies), 0.1 mM β-mercaptoethanol (Sigma) and 40 ng/ml basic fibroblast growth factor (bFGF, Stemgent), as well as chemical combinations (Supplementary information, Table S2). ","Inhibitor of the ALK5 (TGF-β type 1 receptor);Inhibitor of lysine-specific demethylase 1 (LSD1);Inhibitor of GSK3β;CAMP agonist;_;_;_;Inhibitor of ALK2, ALK3	 ALK6, and AMPK;Inhibitor of WNT pathway",_,A molecular roadmap for induced multi-lineage trans-differentiation of fibroblasts by chemical combinations,GSE91374,_,_,1,_,Yuko Fujiwara;Yanhong Cen;Fen Zhang;Xueying Tian;Mengmeng Jiang;Shujing Lai;Luca Pinello;Jie Yu;Lengmei Wang;Xia Li;Assieh Saadatpour;Yang Xu;Daosheng Huang;Hao Yu;Xiaoping Han,_
10.1038/cr.2017.17,Mus musculus,Fibroblasts,Induced Astrocytes,22,"RepSox,449054;Tranylcypromine,19493;CHIR99021,9956119;Forskolin,47936;A83-01,16218924;CHIR99021,9956119;Forskolin,47936;Valproic Acid,3121",iMT medium,bFGF,"MEFs were isolated from E14.5 B6/C57, Oct4-GFP, ANF-GFP or GFAP-GFP mouse embryos. Head, vertebral column, dorsal root ganglia and all internal organs were removed and discarded and the remaining embryonic tissue was manually cut into pieces and incubated in 0.25% trypsin for 5 min. Cells from embryos were plated onto a 15cm tissue culture dish in MEF medium containing DMEM (Life Technologies) and 10% fetal bovine serum (FBS, Gemini). Mouse adult fibroblasts were isolated from tail tip samples. Tail tips were minced into pieces, placed on culture dishes, and incubated in MEF medium for 7days. MEFs and TTF cells were seeded at a density of 20 000 cells per 35 mm dish. The next day, MEF medium was replaced with the iMT media containing DMEM (Life Technologies) supplemented with 15% FBS (Gbico), 2 mM GlutaMax supplement (Life Technologies), 1% nonessential amino acids (Life Technologies), 0.1 mM β-mercaptoethanol (Sigma) and 40 ng/ml basic fibroblast growth factor (bFGF, Stemgent), as well as chemical combinations (Supplementary information, Table S2). ","Inhibitor of the ALK5 (TGF-β type 1 receptor);Inhibitor of lysine-specific demethylase 1 (LSD1);Inhibitor of GSK3β;CAMP agonist;Inhibitor of ALK4, ALK5, ALK7 (activin receptor-like kinases);Inhibitor of GSK3β;CAMP agonist;Inhibitor of histone deacetylase",_,A molecular roadmap for induced multi-lineage trans-differentiation of fibroblasts by chemical combinations,GSE91374,_,_,1,_,Yuko Fujiwara;Yanhong Cen;Fen Zhang;Xueying Tian;Mengmeng Jiang;Shujing Lai;Luca Pinello;Jie Yu;Lengmei Wang;Xia Li;Assieh Saadatpour;Yang Xu;Daosheng Huang;Hao Yu;Xiaoping Han,_
10.1038/cr.2017.17,Mus musculus,Fibroblasts,Induced Adipocytes,18,"RepSox,449054;Tranylcypromine,19493;CHIR99021,9956119;Forskolin,47936;RepSox,449054;Tranylcypromine,19493;Forskolin,47936",iMT medium,bFGF,"MEFs were isolated from E14.5 B6/C57, Oct4-GFP, ANF-GFP or GFAP-GFP mouse embryos. Head, vertebral column, dorsal root ganglia and all internal organs were removed and discarded and the remaining embryonic tissue was manually cut into pieces and incubated in 0.25% trypsin for 5 min. Cells from embryos were plated onto a 15cm tissue culture dish in MEF medium containing DMEM (Life Technologies) and 10% fetal bovine serum (FBS, Gemini). Mouse adult fibroblasts were isolated from tail tip samples. Tail tips were minced into pieces, placed on culture dishes, and incubated in MEF medium for 7days. MEFs and TTF cells were seeded at a density of 20 000 cells per 35 mm dish. The next day, MEF medium was replaced with the iMT media containing DMEM (Life Technologies) supplemented with 15% FBS (Gbico), 2 mM GlutaMax supplement (Life Technologies), 1% nonessential amino acids (Life Technologies), 0.1 mM β-mercaptoethanol (Sigma) and 40 ng/ml basic fibroblast growth factor (bFGF, Stemgent), as well as chemical combinations (Supplementary information, Table S2). ",Inhibitor of the ALK5 (TGF-β type 1 receptor);Inhibitor of lysine-specific demethylase 1 (LSD1);Inhibitor of GSK3β;CAMP agonist;Inhibitor of the ALK5 (TGF-β type 1 receptor);Inhibitor of lysine-specific demethylase 1 (LSD1);CAMP agonist,_,A molecular roadmap for induced multi-lineage trans-differentiation of fibroblasts by chemical combinations,GSE91374,_,_,1,_,Yuko Fujiwara;Yanhong Cen;Fen Zhang;Xueying Tian;Mengmeng Jiang;Shujing Lai;Luca Pinello;Jie Yu;Lengmei Wang;Xia Li;Assieh Saadatpour;Yang Xu;Daosheng Huang;Hao Yu;Xiaoping Han,_
10.3892/mmr.2017.7652,Rattus _,Müller Glial Cells,Induced Photoreceptors,15,"Purmorphamine,5284329",_,,"Briefly, the eyes from postnatal day 7 Sprague-Dawley rats (5 rats each time, male, weighing ~20 g, supplied by Department of Laboratory Animal Science of Fudan University) were enucleated under sterile conditions. The retinal tissues were then digested in 0.25% trypsin and 0.1% type I collagenase at 37˚C for 5 min. Dissociated retinal cells were plated onto tissue culture dishes in monolayer-culture medium, which was composed of Dulbecco's modified Eagle's medium/F12 supplemented with N-2 Supplement, 2 mM glutamine, 0.1% penicillin-streptomycin and 10% fetal bovine serum (all purchased from Invitrogen; Thermo Fisher Scientific, Inc., Waltham, MA, USA), and the plates were incubated at 37˚C in humidified atmosphere containing 5% CO2. ",Agonist of hedgehog,_,Directed Transdifferentiation of Müller Glial Cells to Photoreceptors Using the Sonic Hedgehog Signaling Pathway Agonist Purmorphamine,_,42,Percent of Pax6+ cells,1,_,Guomin Zhou;Peng Zhang;Shuai Zhang;Songtao Wang;Dandan Gu,_
10.1016/j.ejmech.2017.03.082,Homo sapiens,Mesenchymal Stem Cells (Umbilical cord-derived),Induced Neurons,_,"Geldanamycin,5288382",DMEM complete medium supplemented with 10% FBS.,,_,Inhibitor of the Heat Shock Protein 90,_,Geldanamycin-inspired Compounds Induce Direct Trans-Differentiation of Human Mesenchymal Stem Cells to Neurons,_,_,"Expression of the nestin, agrin and RTN4",1,,Prabhat Arya;Subhadra Dravida;Murali Ramgopa;Ranjith Indarapub;Girdhar Deorac;Srinivas Chamakuria;Jagan Gaddama;Anand Soorneedib;Srinivas Jogulaa,_
10.1007/978-1-4939-6688-2_5,Homo sapiens,Embryonic Stem Cells,Induced Motor Neurons,25,"Y-27632,448042;SB431542,4521392;Dorsomorphin,11524144;Vitamin C,54670067;Retinoic acid,444795;SAG,5284330","DMEM/F12: 50 % Dulbecco’s Modifi ed Eagle Medium (DMEM), 50 % Nutrient Mixture F-12. 
Neural Induction Media (NIM): 1 % (v/v) Glutamax(e.g., Life Technologies #35050079), 1 % (v/v) MEM nonessential amino acids (NEAA) (e.g., Life Technologies 10370088), 8.88 mM D-(+)- glucose( see Note 5) in DMEM/F12 (e.g.,
Life Technologies #11320033). After sterile fi ltering add 1 % (v/v) of N2supplement (e.g., Life Technologies #17502048) and 2 μg/mL heparin sulfate. 
Knockout Serum Replacement Medium (KOSR): 15 % (v/v) KnockOut™Serum Replacement (e.g., Life Technologies #10828028) (KSR), 1 % (v/v) Glutamax , 1 % (v/v) NEAA in DMEM/F12. 
Neurobasal Medium (NBM): 1 % (v/v) Glutamax, 1 % (v/v) NEAA, 1 % (v/v) N2supplement, 2 % (v/v) B27 supplement in Neurobasal medium (e.g. Life Technologies #21103049). Add N2 and B27supplements after sterile filtering. 
Complete Neurobasal Medium(cNBM): 10 ng/mL BDNF, 10 ng/mL GDNF, 10 ng/mL CNTF , 0.2 μg/mL Ascorbic acid (AA)in NBM. Prepare fresh from stock solutions of BDNF , GDNF , CNTF , and AA.
GliaMedium: 33.3 mM D-(+)- glucosein H 2O, 10 % (v/v) HorseSerum (heat inactivated) in Minimum Essential Media ",BDNF;GDNF;CNTF,_,"Inhibitor of ROCK1 and ROCK2;Inhibitor of the Activin/BMP/TGF-β pathway;Inhibitor of ALK2, ALK3         ALK6, and AMPK;_;Agonist of a retinoic acid receptor;Agonist of the Smoothened",_,Generation of Spinal Motor Neurons from Human Pluripotent Stem Cells,_,_,_,1,_,"Evangelos Kiskinis, David Santos",_
10.1155/2017/8452830,Rattus _,Mesenchymal Stem Cells (Bone marrow derived),Induced Neurons,2,"N-hydroxy-2-oxo-3-(3-phenylprophyl)-1'2-dihydroquinoxaline-6-carboxamide,_","Dulbecco’s modified Eagle’s medium (DMEM; Invitrogen, Grand Island, NY, USA), containing 10% of fetal bovine serum (FBS; Invitrogen, Grand Island, NY, USA), along with 100 U/ml penicillin, 100 μg/ml streptomycin, and 0.25 μg/ml amphotericin B (Gibco, Grand Island, NY, USA).",_,"MSCs were isolated from the femur bone marrow of male Fisher rats. The cells were then maintained in Dulbecco’s modified Eagle’s medium (DMEM; Invitrogen, Grand Island, NY, USA), containing 10% of fetal bovine serum (FBS; Invitrogen, Grand Island, NY, USA), along with 100 U/ml penicillin, 100 μg/ml streptomycin, and 0.25 μg/ml amphotericin B (Gibco, Grand Island, NY, USA). The nonadherent cells were removed after 48 h, and the adherent cells were washed with phosphate-buffered saline (PBS) and then cultured in fresh medium. The cultured cells were maintained for 12 to 20 passages during the experiment. ",_,_,Neuron-Specific Fluorescence Reporter-Based Live Cell Tracing for Transdifferentiation of Mesenchymal Stem Cells into Neurons by Chemical Compound,_,95,"Two days after NHPDQC treatment, MSCs showed neuron-like phenotype with neurite outgrowth and high expression of neuron-specific markers in more than 95% cells.",1,_,Dong Lee;Kwang Kim;Hee Jung;Jaeho Jang;Hyun Kwon;Do Hwang,_
10.1016/j.stem.2016.02.001,Mus musculus,Fibroblasts,Induced Cardiac Progenitor Cells,35,"CHIR99021,9956119;SU5402,5289418;JAK inhibitor I,5494425","SFD medium.
EGM-2 medium.",Activin/Nodal;BMP;FGF;VEGF;PDGF,_,"Inhibitor of GSK3β;Inhibitor of the VEGFR2, FGFR1 and PDGFRB;JAK inhibitor",_,Expandable Cardiovascular Progenitor Cells Reprogrammed from Fibroblasts,GSE77375,35,Percent of cTnT positive cells,1,_,Sheng Ding;Deepak Srivastava;Benoit Bruneau;Shaohua Xu;Ke Li;Tao Xu;Baoming Nie;Kai Liu;Chen Yu;Ji-dong Fu;Ian Spencer;Yu Huang;Nan Cao;Yu Zhang,_
10.1038/srep38290,Homo sapiens,Fibroblasts,Induced Neurons,12,"Kenpaullone,3820;Prostaglandin E2,5280360;Forskolin,47936;BML210,53789347;PP2,4878","MEF medium: DMEM (Gibco) supplemented with 100 mg/mL Penincilin/Streptomycin (Sigma), 2 nM L-Glutamine (Sigma), and 10% FBS (Biosera).
Neuronal induction medium.",_,Human Fetal Lung Fibroblasts (hFL1) (ATCC- CCL- 153) were purchased from the American Type Culture Collection (ATCC). hFL1 cells were expanded in MEF medium,Inhibitor of the GSK3β;Modulator of the cAMP/PKA;CAMP agonist;Inhibitor of the HDAC;Activator of the SIRT1 and Inhibitor of the aminoresveratolsulfat and Src kinase,Ascl1;Brn2;Myt1L,Small molecules increase direct neural conversion of human fibroblasts,GSE83896,6.88,Percent of the MAP2+ cells,2,_,Malin Parmar;Roger Olsson;Shamit Soneji;Stefan Lang;Fredrik Ek;Ulrich Pfisterer,_
10.1007/7651_2014_69,Homo sapiens,Embryonic Stem Cells,Induced Neurons,14,"Retinoic acid,444795","HESC media: DMEM/F12 or KO-DMEM (80 %), KO serum replacement (20 %), L-alanyl-L-gln or L-gln (2 mM), MNAA (1), and β-ME (100 μM), filtered and stored at 4 C, supplemented with 20 ng/ml bFGF immediately before use. Or replacing “KO serum replacement” with defined components: DMEM/F12 or KO-DMEM (100 %), L-alanyl-L-gln or L-gln (2 mM), MNAA (1), MEAA (1), and β-ME (100 μM), filtered and stored at 4 C, supplemented with bFGF (20 ng/ml), human insulin (20 μg/ml), ascorbic acid (50 μg/ml), human activin A (50 ng/ml), human albumin/Albumax (10 mg/ml), and human transferrin (8 μg/ml) immediately before use.
HNSC media: DMEM/F12 (100 %), N-2 supplement (1), heparin.",bFGF;VEGF;NT-3;BDNF,"Allow undifferentiated hESC colonies to grow to 5–7 days old, and take hESC culture plate to dissecting microscope (pre-warm dissecting stage to 37 C) underneath dissecting sterilized hood",Agonist of a retinoic acid receptor,_,Direct Conversion of Pluripotent Human Embryonic Stem Cells Under Defined Culture Conditions into Human Neuronal or Cardiomyocyte Cell Therapy Derivatives,_,_,_,1,_,Xuejun Parsons,_
10.1007/7651_2014_69,Homo sapiens,Embryonic Stem Cells,Induced Cardiomyocytes,14,"Nicotinamide,936","HESC media: DMEM/F12 or KO-DMEM (80 %), KO serum replacement (20 %), L-alanyl-L-gln or L-gln (2 mM), MNAA (1), and β-ME (100 μM), filtered and stored at 4 C, supplemented with 20 ng/ml bFGF immediately before use. Or replacing “KO serum replacement” with defined components: DMEM/F12 or KO-DMEM (100 %), L-alanyl-L-gln or L-gln (2 mM), MNAA (1), MEAA (1), and β-ME (100 μM), filtered and stored at 4 C, supplemented with bFGF (20 ng/ml), human insulin (20 μg/ml), ascorbic acid (50 μg/ml), human activin A (50 ng/ml), human albumin/Albumax (10 mg/ml), and human transferrin (8 μg/ml) immediately before use.
HNSC media: DMEM/F12 (100 %), N-2 supplement (1), heparin.
HESC cardiac differentiation media: DMEM/F12 (90 %), defined FBS (10 %), and L-alanyl-L-gln or L-gln (2 mM)",bFGF,"Allow undifferentiated hESC colonies to grow to 5–7 days old, and take hESC culture plate to dissecting microscope (pre-warm dissecting stage to 37 C) underneath dissecting sterilized hood",_,_,Direct Conversion of Pluripotent Human Embryonic Stem Cells Under Defined Culture Conditions into Human Neuronal or Cardiomyocyte Cell Therapy Derivatives,_,_,_,1,_,Xuejun Parsons,_
10.1126/sciadv.1600691,Homo sapiens,Embryonic Stem Cells,Induced Osteoblasts,21,"Adenosine,60961;PSB603,44185871;Dexamethasone,5743","Dulbecco’s modified Eagle’s medium (DMEM).
Growth medium: high-glucose DMEM, 10% (v/v) fetal bovine serum (HyClone), 4 mM L-glutamine, and penicillin/streptomycin (50 U/ml), growth medium supplemented with adenosine (30 μg/ml) (Sigma-Aldrich, catalog no. A4036), growth medium supplemented with adenosine (30 μg/ml) and 100 nM PSB 603 (Tocris Bioscience, catalog no. 3198), or osteogenic-inducing medium [growth medium containing 10 mM β-glycerophosphate (Calbiochem, catalog no. 35675), 50 μM ascorbic acid-2-phosphate (Sigma-Aldrich, catalog no. A8960), and 100 nM dexamethasone (Sigma-Aldrich, catalog no. D2915)",bFGF,"Briefly, hPSCs were cultured on feeder layers of mitotically inactivated mouse embryonic fibroblasts using a medium consisting of KnockOut DMEM (Life Technologies, catalog no. 10829-018), 10% (v/v) KnockOut Serum Replacement (Life Technologies, catalog no. 10828028), 10% (v/v) human plasmanate (Talecris Biotherapeutics), 1% (v/v) nonessential amino acids, 1% (v/v) GlutaMAX, 1% (v/v) penicillin/streptomycin, and 55 μM 2-mercaptoethanol. hPSCs were passaged using Accutase (Millipore) at approximately 80% confluence. The fresh medium was supplemented with bFGF (30 ng/ml) (Life Technologies) and replenished daily.",Osteogenic inducer;Antagonist of the A2B;Activator of glucocorticoid pathway,_,Small molecule–driven direct conversion of human pluripotent stem cells into functional osteoblasts,_,_,"Osteogenic differentiation of hiPSCs was further evaluated through time-resolved quantitative analyses for various osteogenic genes (RUNX2, OCN, and SPP1). ",1,_,Shyni Varghese;Harsha Kabra;Manando Nakasaki;Yu-Ru Shih;Heemin Kang,_
10.1016/j.jmb.2015.10.028,Mus musculus,Radial Glia Type Neural Stem Cells,Induced Neuroepithelial Progenitors,11,"CHIR99021,9956119;Tranylcypromine,19493;SB431542,4521392;Valproic Acid,3121","NSC cell culture medium: 98.8% EuroMed, 1% N-2 Supplement, 0.1% EGF, 0.1% FGF",BMP4;GDNF;BMP4;B27;EGF;FGF,"RG-NSC were isolated from Oct4-GiP mouse embryos E14 21 as described previously 9 . For the cultivation of RG-NSCs plates were coated with poly-ornithine and laminin (PO/Ln) for at least two hours at 37°C. To facilitate attachment to the
plates, 1ng/mL laminin was added to the culture medium after seeding of the NSCs. Cells were cultured in NSC cell culture medium 14 (98.8% EuroMed, 1% N-2 Supplement, 0.1% EGF, 0.1% FGF), which was changed every other day.",Inhibitor of GSK3β;Inhibitor of lysine-specific demethylase 1 (LSD1);Inhibitor of the Activin/BMP/TGF-β pathway;Inhibitor of histone deacetylase,Brn2;c-Myc,Partial Dedifferentiation of Murine Radial Glia-Type Neural Stem Cells by Brn2 and c-Myc Yields Early Neuroepithelial Progenitors,_,_,Expression of neuroepithelial markers: Dach1 and Sox1,2,_,Frank Edenhofe;Martina Gebhardt;Kathrin Lemke;Marc Thier;Philipp Worsdorfer;Raffaela Bung,_
10.1016/j.lfs.2016.08.032,Mus musculus,Fibroblasts,Induced Pancreatic Beta Cells,4,"Dexamethasone,5743",Modified Eagle’s Medium / F12,,"Mouse embryonic fibroblast cell line, NIH3T3 was purchased from American Type Culture Collection (ATCC) by the Bio-bank facility of the Dr. Panjwani Center for Molecular
Medicine and Drug Research (PCMD). The cells were seeded in high glucose Dulbecco’s Modified Eagle’s Medium / F12 (DMEM/F12) supplemented with 20% fetal bovine serum
(FBS); 100 units/mL penicillin and 100 μg/mL streptomycin.",Activator of glucocorticoid pathway,_,Conditioned Media Trans-Differentiate Mature Fibroblasts Into Pancreatic Beta-Like Cells,_,_,"Expression of the pancreatic genes (insulin, MafA, and Ngn3)",1,_,Asmat Salim;Sehrish Usman;Anwar Ali;Hana Iqbal;Nadia Naeem;Irfan Khan;Shumaila Usman,_
10.1016/j.celrep.2016.04.066,Homo sapiens,Embryonic Stem Cells,Induced Cytotrophoblast Stem Cells,12,"PD407824,4369491;CHIR124,135399748","Standard medium: DMEM supplemented with 10% fetal bovine serum.
hESC medium: 80% DMEM/F12, 20% knockout serum replacement, 10 ng/ml human recombinant basic fibroblast growth factor, 2 mM GlutaMax, 0.1 mM nonessential amino acids, and 0.1 mM β-mercaptoethanol.
Differentiation medium: 80% knockout DMEM, 20% FBS (Hyclone), 2 mM GlutaMax, 0.1 mM nonessential amino acids, and 0.1 mM β-mercaptoethanol with DMSO or PD407824 combined with 3 or 10 ng/ml BMP4",BMP,Human ESC H1 and H9 cells were purchased from WiCell Research Institute.,Inhibitor of the checkpoint kinase 1 (CHK1);Inhibitor of the checkpoint kinase 1 (CHK1),_,Discovery of a Small-Molecule BMP Sensitizer for Human Embryonic Stem Cell Differentiation,_,_,Expression of the ALK,1,_,Shuibing Che;Todd Evans;Brooke LaFlamme;Ting Zhou;Su-Yi Tsai;Brandoch Cook;Lingling Feng,_
10.1016/j.celrep.2016.04.066,Homo sapiens,Embryonic Stem Cells,Induced Mesodermal Cells,12,"PD407824,4369491;CHIR124,135399748","Standard medium: DMEM supplemented with 10% fetal bovine serum.
hESC medium: 80% DMEM/F12, 20% knockout serum replacement, 10 ng/ml human recombinant basic fibroblast growth factor, 2 mM GlutaMax, 0.1 mM nonessential amino acids, and 0.1 mM β-mercaptoethanol.
Differentiation medium: 80% knockout DMEM, 20% FBS (Hyclone), 2 mM GlutaMax, 0.1 mM nonessential amino acids, and 0.1 mM β-mercaptoethanol with DMSO or PD407824 combined with 3 or 10 ng/ml BMP4",BMP,Human ESC H1 and H9 cells were purchased from WiCell Research Institute.,Inhibitor of the checkpoint kinase 1 (CHK1);Inhibitor of the checkpoint kinase 1 (CHK1),_,Discovery of a Small-Molecule BMP Sensitizer for Human Embryonic Stem Cell Differentiation,_,42.6,Percent of the TNNT2 + cells,1,_,Shuibing Che;Todd Evans;Brooke LaFlamme;Ting Zhou;Su-Yi Tsai;Brandoch Cook;Lingling Feng,_
10.1016/j.celrep.2016.03.073,Mus musculus,Epiblast Stem Cells,Induced Embryonic Stem Cells,8,"Epiblastin A,118987042;PD0325901,9826528","EpiSCmedium: DMEM/F12 (Gibco BRL) con-taining 20% knockout (KO) serum replacement (Gibco BRL), 2 mM glutamine,nonessential amino acids, and 5 ng/ml bFGF.",bFGF,EpiSCs were cultured on feeder-free dishes that had been precoated with fetalcalf serum (FCS) for 15 min in MEF (CF1 mice)-conditioned medium.,Inhibitor of the casein kinase 1 alpha;Inhibitor of MEK/ERK pathway,_,Distinct Signaling Requirements for the Establishment of ESC Pluripotency in Late-Stage EpiSCs,_,97.3,Percent of the Oct4-GFP-positive cells,1,_,Hans Scholer;Herbert Waldmann;Shaorong Gao;Ian Chambers;Slava Ziegler;Wiebke Herzog;Susanne Hoing;Boris Greber;Jiayu Chen;Kathrin Grassme;Douglas Colby;Davood Sabour;Daniel Esch;Guangming Wu;Marcos Arauzo-Bravo;Juyong Yoon;Kee-Pyo Kim;Rodrigo Osorno;Andrei Ursu;Miao Zhang;Damir Jacob,_
10.1074/jbc.M115.709808,Mus musculus,Fibroblasts,Induced Parvalbumin Neurons,7,"Forskolin,47936","Neural medium: 1 g/Lglucose DMEM/F12/Neural Basal  2:2:1, 1×B-27, 10 or 20 ng/ml BDNF.",BDNF,"We used E13.5 C57BL/6 or PV-GFP transgenic mouse embryos to isolate primary mouse embryonic fibroblasts. The dissociated cells were cultured in high glucose DMEM (Invitrogen), supplemented with 10% fetal bovine serum (FBS) (Biochrom), 0.1 mM non-essential amino acids (NEAA), and 2 mM Glutamax in a 37°C and 5% CO2 incubator. ",CAMP agonist,Ascl1,"Conversion of Fibroblasts to Parvalbumin Neurons by one Transcription Factor, Ascl1, and the Chemical Compound Forskolin",GSE79146,77.2,"At 7 dpi, PV-positive cells accounted for 77.2% of the total cells and were almost all Tuj1-positive neuronal cells",2,_,Qi Zhou;Baoyang Hu;Qianwen Zhu;Huimin Qiao;Xuepei Lei;Yanxin Li;Shuangquan Chen;Juan Zhang;Zixiao Shi,_
10.1186/s13619-015-0027-6,Mus musculus,Fibroblasts,Induced Neurons,16,"Vitamin C,54670067;β-mercaptoethanol,1567","M1 medium: DMEM/F12 supplemented with N2, B27, bFGF, EGF, LIF, Vc, βMe, GlutaMax (Glu), and non-essential amino acids (NEAA).",bFGF;LIF,MEFs were derived from 13.5-day ICR mouse embryos. All MEFs and astrocytes were cultured in FBS medium for additional two passages in non-coating plate after recovering from freezing in liquid nitrogen,_;_,_,Reprogramming somatic cells to cells with neuronal characteristics by defined medium both in vitro and in vivo,GSE68902,40,Percent of the TuJ+ cells,1,_,Hui Zheng;Duanqing Pei;Jiekai Chen;Huanxing Su;Lingyu Li;Lining Liang;Hao Sun;Fuhui Wang;Qiang Liu;Chuanming Luo;Yi Zheng;Chunhua Liu;Haitao Wang;Lin Guo;Lilong Lin;Xiang Li;Chengqian Feng;Yuan Li;Yixin Zhang;Yiping Guo;Songwei He,_
10.1073/pnas.1422818112,Homo sapiens,Induced Pluripotent Stem Cells,Induced Retinal Pigment Epithelium,15,"Chetomin,2693;Nicotinamide,936","Differentiation Medium: DMEM/F12 425 mL, KO SR 75 mL, Glutamine 100,NEAA 100,Anti-Anti 100,β-Mercaptoethanol.
RPE medium: DMEM, F12, B27,Anti-Anti.",_,"hiPSC lines H1, H7, and H9 (WiCell) were maintained on growth factor-reduced Matrigel (BD Biosciences), in mTeSR1 medium (Stem Cell Technologies), in a 10% CO2/5% O2 incubator. hPSCs were seeded at 20,000 cells per cm2 on Matrigel and grown in mTeSR1 in a 10% CO2/5% O2 incubator for 5 d. Afterward, they were transferred to a 5% CO2/20% O2 incubator and cultured for 5 additional days.",Inhibitor of the hypoxia inducible factors;_,_,"Small-molecule–directed, efficient generation of retinal pigment epithelium from human pluripotent stem cells",_,50,Percent of the PMEL17+ cells,1,High-throughput quantitative PCR screening,Donald Zack;Gerard Lutty;Imran Bhutto;Bogdan Olenyuk;Ramin Dubey;Sally Temple;Barbara Corneo;Jiang Qian;Jun Wan;Lijun Zhao;Catherine Kim;Janine Davis;Cynthia A;Valentin M;Vinod Ranganathan;Karl J;John Fuller;Kapil Bharti;Srinivas R;Julien Maruotti,_
10.22074/cellj.2015.522,Homo sapiens,Fibroblasts,Induced Neural Progenitor Cells,14,"5-Aza-2'-deoxycytidine,451668",_,_,_,Inhibitor of DNA methylation,_,Brief azacytidine step allows the conversion of suspension human fibroblasts into neural progenitor-like cells,_,_,Expression of the neural progenitor gene markers SOX2 and PAX6,1,_,Hossein Baharvand;Sahar Kiani;Bahman Zeynali;Fahimeh Mirakhori,_
10.1038/cr.2013.156,Homo sapiens,Fibroblasts,Induced Neural Stem Cells,28,"A83-01,16218924;CHIR99021,9956119;Lysophosphatidic acid,5497152;Rolipram,5092;SP600125,8515","N2 medium.
Reprogramming initiation medium (RepM-hIni):Advanced DMEM/F12 supplemented with 10% KSR, 5% ES-FBS, 2 mM Glutamax, 0.11 mM βmercaptoethanol, 3 μM CHIR99021 and 0.5 μM A83-01",BDNF;GDNF;FGF2;EGF,"Human foreskin fibroblasts (CRL-2097, ATCC) or adult human dermal fibroblasts were cultured in MEF medium (Dulbecco’s modified Eagle’s medium supplemented with 10% fetal bovine serum (FBS), 0.1 mM non-essential amino acids, and 2 mM Glutamax.","Inhibitor of ALK4, ALK5, ALK7 (activin receptor-like kinases);Inhibitor of GSK3β;Phospolipid derivative;Inhibitor of the type 4 cyclic nucleotide phosphodiesterases (PDE4);Inhibitor of JNK",Oct4,Small molecules enable Oct4-mediated direct reprogramming into expandable human neural stem cells,GSE38045,_,Expression of the hNSC marker -- PAX6,2,_,Sheng Ding;Janghwan Kim;Stuart A;Yee Sook;Scott R;Eliezer Masliah;Sara Sanz;Sofiyan Saleem;Jeffrey D;Han-Seop Kim;James Parker;Timothy Laurent;Yu Zhang;Mingliang Zhang;Xiaojing Wang;Maria Talantova;Hyun Jung;Woong Sun;Rajesh Ambasudhan;Saiyong Zhu,_
10.1016/j.cmet.2014.03.019,Mus musculus,Fibroblasts,Induced Islet Cells,_,"Retinoic acid,444795;A83-01,16218924;Vitamin C,91899426;LDE225,24775005;BIX01294,25150857;SB203580,176155",_,_,_,"Agonist of a retinoic acid receptor;Inhibitor of ALK4, ALK5, ALK7 (activin receptor-like kinases);_;_;Inhibitor of the G9a histone methyltransferase;Inhibitor of the MAP kinase",Oct4;Sox2;Klf4;c-Myc,Small Molecules Convert Fibroblasts into Islet-like Cells Avoiding Pluripotent State,_,30,Percent of the Pdx-1+/Nkx6.1+ cells,2,_,Nadya Lumelsky,_
10.1016/j.yexcr.2014.01.006,Homo sapiens,Induced Pluripotent Stem Cells,Induced Definitive Endoderm,9,"IDE1,23749403","hES medium: DMEM/F12 supplemented with 15% KnockOut Serum Replacement and 10 ng/ml bFGF.
Osteogenic medium: DMEM/F12 supplemented with 10% FBS, 10 mM β-glycerophosphate, 50 m g/mL ascorbic acid, and 100nM dexamethasone.
Differentiation medium: DMEM/F12 supplemented with 2% FBS, 1  ITS, 50 m g/mL ascorbic acid, 100 nM dexamethasone, 40 m g/ml prolin, 10 ng/ml BMP-2 and 10 ng/ml TGF-β1).
Adipogenic medium: DMEM/F12 supplemented with, 10% FBS, 0.5 mM IBMX, 0.25 m M dexamethasone, 1 m g/ml insulin, 0.2 mM indomethacin and 1 m M pioglitazon",Wnt3a;Activin A,"The stromal fibroblast-like cells were isolated as we previously described (S. Nadri, M. Soleimani, J. Kiani, A. Atashi, R. Izadpanah, Multi- potent mesenchymal stem cells from adult human eye conjunc- tiva stromal cells, Differentiation 76 (2008) 223–231.)",Activator of the activin/BMP/TGF-β pathway,_,"Efficient programming of human eye conjunctiva-derived induced pluripotent stem (ECiPS) cells into definitive endoderm-like cells
",_,45,"Expression of the definitive endoderm specific markers: GSC, Sox17 and Foxa2",1,_,Mohammad Khorramizadeh;Mohammad Nabiuni;Masoud Soleimani;Athena Hajarizadeh;Farzaneh Pourasgari;Samad Nadri;Leili Ghazizadeh;Abdollah Hooti;Parvaneh Baktash;Elham Hoveizi;Mohammad Massumi,_
10.1371/journal.pone.0100369,Homo sapiens,Fibroblasts,Induced Pancreatic Beta Cells,30,"Nicotinamide,936","Transdifferentiation medium (TM): 40 ng/mL bFGF, 20% xeno-free serum replacement (Invitrogen), 2 mM glutamine, 0.1 mM nonessential amino acids, 0.1 mM β-mercaptoethanol, and 2% antibiotics in DMEM/F12 Knockout]",Exendin-4;bFGF;B27;insulin-transferrin-selenium-A;insulin;IGF1,Skin biopsies were obtained from two T1D patients (HF1 and HF2; Table 1) and one healthy volunteer (HF0). The skin biopsies were cultured and expanded in fibroblast medium (FM: DMEM-Knockout with 10% FBS and 1% antibiotics) at 37°C in 5% CO2 and frozen in FM containing 10% DMSO at passage 3. ,_,_,,,42.8,Expression of the essential pancreatic transcription factors and genes: PDX1,1,_,Pablo Argibay;Leon Litwak;Patricia Fainstein;nica Loresi;Marta Balzaretti;Sung-Ho Hyon;Carla Gimenez;Johana A;Marcelo Ielpi;Nelson Argumedo;a Gimeno;Federico Pereyra-Bonnet,_
10.1111/j.1755-5922.2012.00320.x,Rattus _,Mesenchymal Stem Cells (Bone marrow derived),Induced Cardiomyocytes,15,"Zebularine,100016;5-Aza-2'-deoxycytidine,451668","Dulbecco's modified Eagle's medium: DMEM; GIBCO‐Life Technologies, Carlsbad, CA, USA) supplemented with 10% fetal bovine serum (FBS), 100 U/mL penicillin, and 100 μg/mL streptomycin",,"Mesenchymal stem cells (MSCs) were isolated from tibia and femur of SD rats under aseptic conditions. Whole bone marrow was cultured in Dulbecco's modified Eagle's medium (DMEM; GIBCO‐Life Technologies, Carlsbad, CA, USA) supplemented with 10% fetal bovine serum (FBS), 100 U/mL penicillin, and 100 μg/mL streptomycin. ",Inhibitor of the DNA methyltransferase;Inhibitor of DNA methylation,_,"DNA Methylation Inhibitors, 5‐azacytidine and Zebularine Potentiate the Transdifferentiation of Rat Bone Marrow Mesenchymal Stem Cells into Cardiomyocytes",_,66,"Expressions of GATA 4, Nkx 2.5, and cardiac troponin T",1,_,Asmat Salim;Siddiqua Jamall;Hanaa Iqbal;Nurul Kabir;Kanwal Haneef;Nadia Naeem,_
10.1038/nprot.2012.156,Homo sapiens,Induced Pluripotent Stem Cells,Induced Neural Crest Stem Cells,15,"SB431542,4521392;BIO,448949","hESC maintenance medium (500 ml): Combine 432 ml of DMEM/F12, 50 ml of Probumin (20% (vol/vol) stock solution), 5 ml of penicillin-streptomycin, 5 ml of L-alanyl-L-glutamine, 5 ml of MEM non-essential amino acids, 0.5 ml of trace elements A, 0.5 ml of trace elements B, 0.5 ml of trace elements C, 0.9 ml of 2-mercaptoethanol, transferrin (10 μg ml−1), (+)-sodium L-ascorbate (50 μg ml−1), Heregulin β-1 (10 ng ml−1), activin A (10 ng ml−1), LONGR3 IGF-I (200 ng ml−1), and Fgf2 (8 ng ml−1) or Stempro (Invitrogen) supplemented with Fgf2 (8 ng ml−1). Filter-sterilize the medium before use. Store the medium for up to 1 week at 4 °C.
Neural crest differentiation medium (50 ml): Use the hESC maintenance medium without activin A and add GSK3 inhibitor IX (BIO) (2–4 μM) and SB431542 (20 μM). Store the medium for up to 1 week at 4 °C.
FBS medium for pMEFs and fibroblasts, 10% (vol/vol) (500 ml): Combine 440 ml of DMEM/F12, 50 ml of FBS, 5 ml of penicillin-streptomycin, 5 ml of L-alanyl-L-glutamine and 0.9 ml of 2-mercaptoethanol. Filter-sterilize the medium before use. Store the medium for up to 2 weeks at 4 °C.
KSR medium, 20% (vol/vol) (500 ml): Combine 390 ml of DMEM/F12, 100 ml of KSR, 5 ml of penicillin-streptomycin, 5 ml of L-alanyl-L-glutamine, 0.9 ml of 2-mercaptoethanol and Fgf2 (4 ng ml−1). Filter-sterilize the medium before use. Store the medium for up to 2 weeks at 4 °C.
Peripheral neuron medium (50 ml): Combine DMEM/F12, 0.5 ml of N2 supplement, 0.5 ml of penicillin-streptomycin, BDNF (10 ng ml−1), NGF (10 ng ml−1), GDNF (10 ng ml−1), NT3 (10 ng ml−1), ascorbic acid (200 ìm) and cAMP (0.5 mM). Store the medium for up to 1 week at 4 °C.
Cryoprotective medium (20 ml): For TCS fibroblasts, combine 18 ml of FBS and 2 ml of DMSO. For hiPSCs and hESCs, combine 18 ml of hESC maintenance medium and 2 ml of DMSO. Store the medium for up to 1 month at 4 °C.",NGF;Nanog;BDNF;GDNF;NT3,"TCS patient cells (containing a mutation in exon 21 of the TCOF1 gene, consistent with a diagnosis of TCS 1), hESCs or hiPSCs",Inhibitor of the Activin/BMP/TGF-β pathway;Inhibitor of GSK3,_,Directed differentiation of human pluripotent cells to neural crest stem cells,_,90,Percent of p75+ Hnk1+ cells,1,_,Michael Cunningham;James Lauderdale;Sarah Park;Austin Page;Michael Kulik;Laura Menendez,_
10.2174/1566524011313050015,Homo sapiens,Induced Pluripotent Stem Cells,Induced Hepatocytes,17,"SB431542,4521392;Ly294002,3973","RPMI with 0.5 mg/ml BSA, 5% Knock-out serum replacement (Invitrogen) and 100 ng/ml Activin A",BSA;Activin A;FGF4;HGF,"For iPSC generation 30,000 human fetal fibroblasts were seeded in a 6-well dish (TPP Techno Plastic Products; Switzerland) in MEF Media with 10g/ml protamine sulphate and 2mM Valproic Acid. Cells were transduced with a MOI of 5 with a polycistronic VSVG pseudotyped SIN lentivirus encoding the reprogramming factors Oct4, KLF4 and SOX2 with an IRES mediated dTomato expression. MEF media was
changed daily containing 2 mM Valproic Acid after three days media was changed to 50% MEF media and 50% hES media containing 2mM Valproic Acid with daily media change. After one week cells were replated on CF1 MEFs and kept one week in hES media with 40ng/ml bFGF with daily media change. Single colonies were mechanically picked and expanded on CF1 MEFs in hES media with 20ng/ml bFGF. ",Inhibitor of the Activin/BMP/TGF-β pathway;Inhibitor of the PI3 kinase,_,"Improved Hepatic Differentiation Strategies for Human Induced
Pluripotent Stem Cells",_,35,FACS analyses for albumin promoter-dependent dTomato expression (The Percent of differentiated cells was quantified by FACS analysis),1,_,T. Cantz;M. Ott;B. Greber;A. Schambach;D. Sharma;J. Hoepfner;S. Mobus;M. Sgodda,_
10.1186/s13287-019-1407-6,Mus musculus,Gallbladder Stem Cells,Induced Pancreatic Beta Cells,7,"Nicotinamide,936;LDE225,24775005;Ly294002,3973;FR180204,11493598;Retinoic acid,444795",Kubota’s medium,Noggin;HGF,"Male, 8–10-week-old C57BL/6J mice (Shanghai Model Organisms Center, Shanghai, China) and CK19CreERT;Rosa26R-GFP mice (Tongji University, Shanghai, China) were housed in specific pathogen-free (SPF) rooms under controlled temperature, exposed to alternating 12-h light/dark cycles. After sacrificing the animals, the gallbladders of C57BL/6J and CK19CreERT/Rosa26R-GFP mice were dissected from the liver, cut into pieces, and washed with ice-cold Hanks’ Balanced Salt Solution. For immunofluorescence staining, the tissues were embedded in optimal cutting temperature compound (OCT, Sakura, Japan) and maintained at − 80 °C. For digestion, the tissues were cut into small pieces and incubated with 0.25% trypsin/0.1% EDTA (Thermo Fisher, Waltham, MA, USA) for 30 min at 37 °C to obtain a cell suspension.",_;_;Inhibitor of the PI3 kinase;Inhibitor of the ERK;Agonist of a retinoic acid receptor,_,,_,15.9,The efficiency of cells differentiated into insulin+ cells was 15.9% ± 1.2%.,1,_,Min-Jun Wang;Yi-Ping Hu;Yongquan Shi;Haiying Zhu;Jiajia Chen;Tao Yang;Qinggui Liu;Yu Sun;Tuo Li;Fei Chen,_
10.1155/2012/140427,Homo sapiens,Induced Pluripotent Stem Cells,Induced Neurons,60,"Dorsomorphin,11524144;SB431542,4521392;Purmorphamine,5284329","Neural induction media (NIM): DMEM/F12, 1x NEAA, 0.5x L-Glu, and freshly made and sterile filtered N2, which contained 1.55 g/L glucose, 2 g/L sodium bicarbonate, 100 μM putrescine, 30 nM sodium selenite, 20 nM progesterone, 0.1 mg/mL transferrin, 0.025 mg/mL insulin and FGF2.
Neural progenitor cell media (NPC media): neurobasal media (Invitrogen, Cat. No. 21103049), 1x NEAA, 1x L-Glu, 1x P/S, 1x B27 supplement (Invitrogen, Cat. No. 17504044), and FGF2 (20 ng/mL)",Transferrin;FGF2,"iPSCs were cultured and maintained on mitomycin C inactivated mouse embryonic fibroblasts (iMEF) (EMD Millipore Cat. No. PMEF-CF) in hESC media containing DMEM/F12, 20% knockout serum replacement (Invitrogen, Cat. No. 10828028), 1x NEAA, 1x P/S, 0.1%  β-Mercaptoethanol (Invitrogen, Cat. No. 21985023), 0.5x L-Glu and 6 ng/mL of basic fibroblast growth factor (FGF2) ","Inhibitor of ALK2, ALK3, ALK6 and AMPK;Inhibitor of the Activin/BMP/TGF-β pathway;Agonist of hedgehog",_,Small Molecules Greatly Improve Conversion of Human-Induced Pluripotent Stem Cells to the Neuronal Lineage,_,90,We detected >90% Nestin and Sox1 immunoreactive NPCs in all iPSC cell lines taken through this protocol,1,_,Birgitt Sch;William Langston;Loan Nguyen;Ramya Sundararajan;Malini Vangipuram;Shifteh Iranmanesh;Anne Huang;Sally Mak,_
10.1089/cell.2010.0067,Mus musculus,Fibroblasts,Embryonic Stem Cells,21,"BIO,448949;4-(Methylnitrosamino)-1-(3-pyridyl)-1-butanone,47289;Forskolin,47936;Nicotine,89594;Phorbol 12-myristate 13-acetate,27924;Retinoic acid,444795;Troglitazone,5591;Cytochalasin D,5458428;Etoposide,36462;Butyric acid,264;Trichostatin A,444732;BIX01294,25150857;Chaetocin,161591;5-Aza-2'-deoxycytidine,451668;N-Acetyl-L-cysteine,12035;Lovastatin,53232","Mouse ESC medium: DMEM medium supplemented with 15% FBS, 100U/mL penicillin and 100 mg/ mL streptomycin, 1000U/mL Leukemia Inhibitory Factor, 1% (v/v) nonessential amino acid, and 1% (v/v) 2- mercaptoethanol, chemical cocktail",Leukemia Inhibitory Factor,B6/129 mouse embryonic fibroblasts (MEFs) at passage 3,Inhibitor of GSK3;_;CAMP agonist;_;_;Agonist of a retinoic acid receptor;_;_;_;_;Inhibitor of the histone deacetylases I and II;Inhibitor of the G9a histone methyltransferase;_;Inhibitor of DNA methylation;_;_,_,Reprogramming of Mouse Fibroblasts to an Intermediate State of Differentiation by Chemical Induction,_,0.02,colony formation; positive for both alkaline phosphatase and surface specific embryonic antigen-1 (SSEA-1) at a comparable level to those of mouse embryonic stem cells,1,_,X. Cindy Tian; Chih-Jen Lin; Tomokazu Amano; Yong Tang; Chul Kim;Joonghoon Park,_
10.1097/MPA.0b013e318221933d,Homo sapiens,HepG2 Cells,Induced Pancreatic-like Cells,24,"Carbon tetrachloride,5943;D-Galactosamine,24154;Zinc chloride,5727","Dulbecco’s modified Eagle medium with 10% fetal bovine serum, 100 mM CCl4, 2 mM D-galactosamine, 200 KM ZnCl2",,Cell line HepG2,_;_;_,_,"In Vitro Transdifferentiation of HepG2 Cells to Pancreatic-Like Cells by CCl4, D-Galactosamine, and ZnCl2",_,66.2,"Fluorescence-activated cell sorting analysis, expression of albumin-GFP along with elastase-DsRed",1,_,Katsunori Sasaki; Fengming Yue; Ken Matsumoto; Masahiro Mizuguchi; Jun Ito; Shin-Ichi Mae; Tadayuki Yokoyama; Hinako Ichikawa; Susumu Yoshie; Sakiko Shirasawa; Daihachiro Tomotsune;Yoshiya Kanoh,_
10.1186/1477-5956-9-3,Mus musculus,Hair bulge progenitor cells (HBPCs),Induced cardiomyocyte-like Cells,21,"Cardiogenol C,11345983","GMEM plus 5 μM Cardiogenol C, 7.5% ESQ-FBS",,anagen staged vibrissal hair follicles,Inducer of cardiac differentiation,_,Cardiogenol C can induce Mouse Hair Bulge Progenitor Cells to Transdifferentiate into Cardiomyocyte-like Cells,_,_,_,1,_,Kenneth KH Lee; Henry SS Lee; Ivan WC Wong; YaoYao; Elve Chen; Mei Kuen Tang;Winifred WY Yau,_
10.1371/journal.pone.0026592,Homo sapiens,Human somatic cells,Induced Pluripotent Stem Cells,24,"Sodium butyrate,5222465;SB431542,4521392;PD0325901,9826528","human reprogramming medium (DMEM/F12, 20% knockout serum replacement, 1× non-essential amino acid, 2 mM L-glutamine, 0.1 mM 2-mercaptoethanol, 20 ng/ml FGF-2 and 1% penicillin-streptomycin), and treated with 0.5 mM sodium butyrate, 2 µM SB431542, and 0.5 µM PD0325901 or other combinations of the compounds",FGF- 2,HFF-1 and human hepatocytes,Inhibitor of histone deacetylase;Inhibitor of the Activin/BMP/TGF-β pathway;Inhibitor of MEK/ERK pathway,OCT3 / 4;KLF4;SOX2;c-MYC,Efficient Generation of Fully Reprogrammed Human iPS Cells via Polycistronic Retroviral Vector and a New Cocktail of Chemical Compounds,_,100,Immunostaining with anti-Tra-1-60 antibodies,2,_,Wen-Shu Wu; Zhijian Qian; Zack Z. Wang; Albert Gordon; Yongxing Gao;Zhonghui Zhang,_
10.1007/s11010-010-0664-6,Mus musculus,Myoblasts,Osteoblasts,5,"SVAK-12,_",DMEM containing 2% FBS and various concentrations of selected compound,BMP-2,Mouse C2C12 cells,_,_,A synthetic compound that potentiates bone morphogenetic protein-2-induced transdifferentiation of myoblasts into the osteoblastic phenotype,_,_,_,1,_,Scott D. Boden; Louisa Titus; Katsuro Tomita; Sreedhara Sangadala;Satoshi Kato,_
10.1371/journal.pone.0012297,Homo sapiens,Fibroblasts,Induced Pluripotent Stem Cells,28,"5-Aza-2'-deoxycytidine,451668;Trichostatin A,444732;Retinoic acid,444795","Serum replacement (SR) medium: KO-DMEM-high glucose, 20% SR, 2 mM L-glutamax, 0.1 mM non-essential amino acid, 0.1 mM 2-mercaptoethanol, 1× insulin transferring selenium, 25 U/ml penicillin, 25 µg/ml streptomycin and 4 ng/ml basic fibroblast growth factor (bFGF).",bFGF,"HFFs were derived from primary fetal skin tissue after therapeutic termination of pregnancies and cultured in DMEM-high glucose medium containing 10% fetal bovine serum (FBS), 25 U/ml Penicillin and 25 µg/ml Streptomycin.",Inhibitor of DNA methylation;Inhibitor of the histone deacetylases I and II;Agonist of a retinoic acid receptor,_,A Combined Epigenetic and Non-Genetic Approach for Reprogramming Human Somatic Cells,_,15,Percent of the NANOG+ cells,1,_,Kuldip Sidhu;Perminder Sachdev;Jinnuo Han,_
10.1038/ncb2894,Homo sapiens,Embryonic Stem Cells,Induced Metanephric Mesenchyme Cells,18,"CHIR99021,9956119",Serum-free media APEL,FGF9;BMP7;Activin A,"HES3 (MIXL1GFP/wt) cells were routinely cultured on irradiated mouse embryonic fibroblast feeder cells in F12/DMEM (Life Technologies) supplemented with 20% KnockOut serum replacement (Life Technologies), 100 μM MEM NEAA (Life Technologies), 110 μM 2-mercaptoethanol (Life Technologies), 1× penicillin/streptomycin (Life Technologies), 1× Glutamax (Life Technologies) and 10 ng ml−1 bFGF",Inhibitor of GSK3β,_,Directing human embryonic stem cell differentiation towards a renal lineage generates a self-organizing kidney,_,60,Percent of the SIX2+ cells,1,_,M. H. Little;A. G. Elefanty;E. G. Stanley;E. G. Stanley;E. G. Stanley;J. M. Vanslambrouck;M. Becroft;P. X. Er;M. Takasato,_
10.1371/journal.pone.0084881,Homo sapiens,Induced Pluripotent Stem Cells,Induced Intermediate Mesoderm Cells,8,"AM580,2126;TTNPB,5289501;CHIR99021,9956119;Y-27632,448042","MEF-conditioned Primate ES medium. Stage 1 medium: DMEM/F12+Glutamax (Invitrogen) supplemented with 500 U/ml penicillin/streptomycin, 2% FBS (HyClone) and 10 µM Y-27632 for two days. ",BMP;bFGF,"Five hiPSC lines, were routinely cultured on feeder layers of mitomycin C-treated mouse SNL feeder cells in Primate ES medium supplemented with 500 U/ml penicillin/streptomycin and 4 ng/ml recombinant human basic fibroblast growth factor (bFGF, Wako).",Agonist of the retinoic acid receptor;Agonist of a retinoic acid receptor;Inhibitor of GSK3β;Inhibitor of ROCK1 and ROCK2,_,Efficient and Rapid Induction of Human iPSCs/ESCs into Nephrogenic Intermediate Mesoderm Using Small Molecule-Based Differentiation Methods,_,90,Percent of the OSR1+ cells,1,_,Kenji Osafune;Shinya Yamanaka;Akira Ohta;Motonari Uesugi;Yuko Kurose;Shin-ichi Mae;Toshikazu Araoka,_
10.1038/ncomms4071,Homo sapiens,Induced Pluripotent Stem Cells,Induced Folliculogenic Epithelial Stem Cells,40,"Retinoic acid,444795;Y-27632,448042","hESC culture medium: 80% DMEM/F12 (1:1) medium, 20% knockout Serum Replacement, 100 μM non-essential amino acids, 2 mM L-glutamine, 0.1 mM β-mercaptoethanol, 100 unit per ml penicillin, 100 μg per ml streptomycin and 10–15 ngper ml bFGF.",BMP4;EGF,,Agonist of a retinoic acid receptor;Inhibitor of ROCK1 and ROCK2,_,Generation of folliculogenic human epithelial stem cells from induced pluripotent stem cells,GSE51028,26.8,Percent of the CD200+/ITGA6+ cells,1,_,Xiaowei Xu;George Cotsarelis;Suresh Kumar;Wei Guo;Arben Nace;Zhi Wei;Shujing Liu;Michelle Burrows;Ying Zheng;Ruifeng Yang,_
10.1073/pnas.1113746108,Homo sapiens,Induced Pluripotent Stem Cells,Induced Neural Crest-like cells,14,"SB431542,4521392;BIO,448949","Cells were plated on Geltrex-coated plates in defined media without Activin A, supplemented with 20 μM SB 431542 (Tocris) and 500 ng/mL Noggin (R&D Systems) for 11 d with or
without 2 μM of BIO (GSK3 Inhibitor IX; Calbiochem) or 15 ng/mL Dkk. For direct neural crest differentiation, cells were plated at a density of 1 × 105 cells/cm2 in defined media lacking Activin A and supplemented with 2 μM BIO and 20 μM SB 431542 (SB media). Media was replaced every day.
Additional experiments were performed by adding 25 ng/mL Wnt3a, 500 ng/mL Noggin or 5–50 ng/mL of BMP4 (R&D Systems) to SB media. For peripheral neuron differentiation, neural crest cells were plated in poly-L-ornithine/aminin or Geltrex-coated four-well chamber slides. The following day, SB media was switched to DMEM/F12 N2 supplemented media with BDNF (10 ng/mL), GDNF (10 ng/mL), NGF (10 ng/mL), neurotrophin-3 (10 ng/mL), 2-phospho-L-ascorbic acid (200 μM), and dbcAMP (0.5 mM).",IGF1;bFGF,"HiPSCs were cultured on Geltrex-coated plates (Invitrogen) in chemically defined media containing Heregulin β (10 ng/mL), Activin A (10 ng/mL), LR-Igf (200 ng/mL), and Fgf2 (8 ng/mL) as described
previously.",Inhibitor of the Activin/BMP/TGF-β pathway;Inhibitor of GSK3,_,Wnt signaling and a Smad pathway blockade direct the differentiation of human pluripotent stem cells to multipotent neural crest cells,_,90,"Percent of cells expressig neural crest markers (p75, Ap2 and Hnk1)",1,_,Stephen Daltona;Parker Antin;Tatiana Yatskievych;Laura Menendeza,_
10.1161/CIRCRESAHA.111.249540,Homo sapiens,Embryonic Stem Cells,Induced Cardiomyocytes,12,"IWR1,3137736","StemPro-34 medium: bFGF (5 ng/mL), Activin A (3 ng/mL), and BMP4 (10 ng/mL).
",BMP4;bFGF;Activin A,"Human embryonic stem cell (hESC) H9 lines carrying MYH6-mCherry reporters were grown on a mouse embryonic fibroblast coated matrigel plate in Knock Out DMEM (Gibco) media supplemented with 20%
Knock Out Serum Replacement (GIBCO) and 8ng/ml bFGF (Sigma)",Inhibitor of WNT pathway,_,Small-molecule Inhibitors of the Wnt Pathway Potently Promote Cardiomyocytes From Human Embryonic Stem Cell-Derived Mesoderm,_,30,Flow cytometry analysis demonstrated that IWR yielded up to 30% cardiomyocytes,1,_,Mark Mercola;John Cashman;Marcia Dawson;Zebin Xia;Marion Lanier;Herman Davidovics;Sean Spiering;Erik Willems,_
10.1074/jbc.RA118.006000,Homo sapiens,Fibroblasts,Induced Cardiomyocytes,14,"MM-589,129010138;A83-01,16218924;PTC-209,1117196;BX471,512282","MEFs medium: DMEM medium containing 10%FBS, 1% penicillin/ streptomycin, 10 μl/ml GlutaMAX and 1 mM Sodium Pyruvate.
FB medium: IMDM media with 20%FBS and 1% penicillin/ streptomycin.
Induction medium: DMEM/199 (4:1) (Gibco, Thermo Fisher Scientific) containing 10% FBS, 1% penicillin/ streptomycin and 10 μl/ml GlutaMAX.",CCR1;CCL3;CCL6;CCL17;IGF-1,"Briefly, embryos were harvested from α-MHC-GFP transgenic mice at 13.5 days post coitum followed by decapitation and removal of internal organs. The tissue was minced and digested with 0.05% trypsin/EDTA (Gibco, Thermo Fisher Scientific). Cells were resuspended in MEFs medium (DMEM medium containing 10%FBS, 1% penicillin/ streptomycin, 10 μl/ml GlutaMAX and 1 mM Sodium Pyruvate) and plated onto one 10cm dish per embryo. Cells were passaged at the ratio of 1:3 (passage 1). Passage 3 MEFs were used for reprogramming.","Inhibitor Mll1;Inhibitor of ALK4, ALK5, ALK7 (activin receptor-like kinases);Inhibitor of Bmi1;Inhibitor of the CCR1",MEF2C;GATA4;TBX5,Chemical suppression of specific C-C chemokine signaling pathways enhances cardiac reprogramming,_,24.9,Percent of the iCMs with α-MHC-GFP+ cells,2,_,Zhong Wang;Liu Liu;Shaomeng Wang;Yangbing Li;Karatas Hacer;Wenbin Gao;Shuo Tian;Ienglam Lei;Yijing Guo,_
10.1038/nature13020,Mus musculus,Fibroblasts,Induced Hepatocytes,33,"CHIR99021,9956119;Dilauroyl phosphatidylcholine,512874;Sodium butyrate,5222465;Parnate,19493;RG108,702558;Compound E,11306390","Endoderm differentiation medium (EDM).
Reprogramming initiation medium (RIM): 3 μM CHIR, 100 μM dilauroyl phosphatidylcholine (DLPC; Tocris), 0.1 mM sodium butyrate (NaB), 2 μM Parnate (Par), 0.5 μM RG108 (RG), 10 ng ml−1 epidermal growth factor (EGF) and 10 ng ml−1 basic fibroblast growth factor (bFGF), followed by culture for 14–21 days in endoderm differentiation medium (EDM) supplemented with 3 μM CHIR, 100 μM DLPC, 0.1 mM NaB, 2 μM Par, 0.5 μM RG and 100 ng ml−1 activin A",EGF;bFGF;Activin A.,Human fibroblasts were grown in reprogramming initiation medium for 7 days.,Inhibitor of GSK3β;Agonist of the liver receptor homologue-1;Inhibitor of histone deacetylase;Inhibitor of lysine-specific demethylase 1 (LSD1);Inhibitor of the DNA methyltransferase;Inhibitor of the Notch signaling,_,Mouse liver repopulation with hepatocytes generated from human fibroblasts,GSE52309,57.5,Percent of the HNF4α+ cells,1,_,Sheng Ding;Holger Willenbring;Leslie Benet;Alan Wolfe;Aras Mattis;Jack Harbell;Milad Rezvani;Saiyong Zhu,_
10.3892/ijmm.2018.3375,Homo sapiens,Fibroblasts,Induced Neurons,7,"Valproic Acid,3121;CHIR99021,9956119;DMH1,50997747;RepSox,449054;Forskolin,47936;Y-27632,448042;SP600125,8515","Induction medium was composed of a 1:1 ratio of Dulbecco's modified Eagle's medium (DMEM)/F12 (cat. no. 11330032) and Neurobasal medium (cat. no. 21103049) with 0.5% N-2 supplement (cat. .no. 17502048), 1% B-27 supplement (cat. no. 17504044; all from Thermo Fisher Scientific, Inc., Waltham, MA, USA) and 100 μM cAMP. 
Maturation medium was composed of DMEM/F12:Neurobasal medium (1:1), 0.5% N-2 supplement, 1% B-27 supplement, 100 μM cAMP, 20 ng/ml BDNF, 20 ng/ml GDNF and 20 ng/ml NT3.",BDNF;GDNF;NT3,_,Inhibitor of histone deacetylase;Inhibitor of GSK3β;Inhibitor of the BMP;Inhibitor of the ALK5 (TGF-β type 1 receptor);CAMP agonist;Inhibitor of ROCK1 and ROCK2;Inhibitor of JNK,_,Chemical conversion of human lung fibroblasts into neuronal cells,_,90,Percent of the Tuj1‑positive cells,1,_,TAO XIAO;LAN ZHAO;DONG HUANG;QIU-LIANG JI;HONG SUN;BING LI;YUN XU;YU WAN,_
10.1038/srep00280,Homo sapiens,Human liver cancer cells,Hepatocytes,6,"Peretinoin,6437836; Zopolrestat,1613","Culture medium, the anticancer drugs (10 μM ACR alone, 10 μM zopolrestat alone or 10 μM ACR plus 10 μM zopolrestat)",,10 liver cancer samples were obtained from patients who underwent a liver transplantation at our institutions. The 10 patients with HCC before a liver transplantation had an age range of 34–60 years (median: 55.7). All of the males (n = 7) were diagnosed with stage II cancer and were HCV-positive with a Child-Pugh score of A; all of the females (n = 3) were diagnosed with stage III cancer and were HCV-positive with a Child-Pugh score of B.,Agonist of retinoid acid receptor (RAR);Inhibitor of carboxylic acid aldose reductase,_,A therapeutic method for the direct reprogramming of human liver cancer cells with only chemicals,_,_,_,1,_,Chifumi Sato; Makoto Mihara; Yue Zhang;Hisashi Moriguchi,_
10.1038/nmeth.1972,Homo sapiens,Fibroblasts,Induced Neuron-like Cells,23,"SB431542,4521392;LDN193189,25195294;CHIR99021,9956119","Neuronal medium containing DMEM/F12 (1% (vol/vol) N2 supplement) and Neurobasal (2% (vol/vol) B27 supplement) mixed at a 1:1 ratio, cAMP (100 ng ml−1), doxycycline (1 μg ml−1), SB-431542 (10 μM), noggin (500 ng ml−1) or a combination of low noggin (100 ng ml−1) and LDN-193189 (0.5 μM) and/or CHIR99021 (2 μM)","FGF2, EGF, BDNF, GDNF, NT3","Primary HPFs were established from dissociated foreskin tissue of a healthy newborn donor (HPF1, passage 9; provided by J. Itskovitz-Eldor; see Acknowledgments) and skin biopsies from a 1-year-old female donor with Miller-Dieker lissencephaly syndrome (HPF2, passage 7; Coriell Institute, catalog ID GM06097), a 4-year-old female donor with epilepsy (HPF3, passage 8; cells provided by W.S. Kunz; see Acknowledgments) and a 34-year-old healthy male donor (passage 5).",Inhibitor of the Activin/BMP/TGF-β pathway;Inhibitor of TGF-beta/Smad signaling;Inhibitor of GSK3β,Noggin,Small molecules enable highly efficient neuronal conversion of human fibroblasts,GSE36246,80,Tthe percentage of βIII-tub+ cells in relation to the initial number of plated cells,2,_,Oliver Brüstle; Philipp Koch; Franz-Josef Müller; Gesine Kögler; Peter Wernet; Stefan Herms; Finnja Glaue; Daniel Poppe; Jonas Doerr; Jaideep Kesavan; Jerome Mertens;Julia Ladewig,_
10.1007/s11064-012-0819-9,Rattus _,Muscle-derived Stem Cells,Induced Dopaminergic Neurons,14,"Vitamin C,54670067;Forskolin,47936","Neurobasal A, N2, 2 mM L-glutamine, 40 ng/ml bFGF, 100 ng/ml FGF8 and 200 ng/ml SHH, 200 lM ascorbic acid, 10 lM forskolin, 10 ng/ml GDNF","bFGF, EGF, SHH, FGF, GDNF",MDSCs were isolated from six-month old Sprague–Dawley rat gastrocnemius muscle,_;CAMP agonist,_,Dopaminergic neuronal conversion from adult rat skeletal muscle-derived stem cells in vitro,_,1.34,Expression of TH,1,_,Xiao-Min Wang; Jun Jia; Ding-Zhen Luo; Zi-Xuan Guo; Yue Wang; Xuan Wang;Jian Yang,_
10.1093/humrep/des204,Mus musculus,Testicular Cells,Germline-derived pluripotent stem cells (gPSCs),14,"CHIR99021,9956119","Ko-DMEM, L-glutamine 2 mM, non-essential amino acids 1%, penicillin 100 U/ml, streptomycin 100 mg/ml, β-mercaptoethanol 0.1 mM, 2% fetal calf serum, 1% FCS, glial-derived neurotrophic factor (GDNF, 20 ng/ml), mouse epidermal growth factor (EGF, 20 ng/ml), human basic fibroblast growth factor (bFGF, 10 ng/ml) and mouse LIF (1000 U/ml), SM","GDNF, EGF, bFGF, LIF","Testicular cells were isolated from neonatal male mice (3 day old, NMRI and C57BL/6 strains). Embryonic day (E) 12.5–13.5 fetuses (NMRI strain) were used to produce mouse embryonic fibroblasts (MEFs) as feeder cells.",Inhibitor of GSK3β,_,Inhibition of glycogen synthase kinase-3 promotes efficient derivation of pluripotent stem cells from neonatal mouse testis,_,0.065,"number of colonies; cells maintained ESC morphology, as indicated by light microscopy; showed strong positive staining for AP activity; expressed SSEA1 and the pluripotency markers Oct4 and Nanog",1,_,Hossein Baharvand; Nasser Aghdami; Hananeh Fonoudi; Seyedeh-Nafiseh Hassani; Ali Farrokhi; Houri Sepehri; Abdolhossein Shahverdi; Farnoosh Attari;Seyedeh-Faezeh Moraveji,_
10.5966/sctm.2011-0022,Homo sapiens,Induced Pluripotent Stem Cells,Mesenchymal stem/stromal cells (MSCs),10,"SB431542,4521392","KOSR medium (DMEM‐Ham's F‐12 basal medium supplemented with 20% knockout serum replacement) without bFGF, supplemented with 10 μM SB431542 (SB) in DMSO","bFGF, TGF-β",Human iPSCs (MR90CL2 and ES4CL1) and ESCs (Mel1 and HES3),Inhibitor of the Activin/BMP/TGF-β pathway,_,Small Molecule Mesengenic Induction of Human Induced Pluripotent Stem Cells to Generate Mesenchymal Stem/Stromal Cells,_,90,monolayers with an epithelial‐like morphology,1,_,Nicholas M. Fisk; Ernst J. Wolvetang; Rachel Horne; Rebecca L. Ellis; Rebecca A. Pelekanos;Yen Shun Chen,_
10.1126/science.1199082,Caenorhabditis elegans,Germ cells,Induced Neuron-like Cells,_,"Valproic Acid,3121;Trichostatin A,444732",_,_,Cells showing gcy-5 and ceh-36 induction located within the gonad,Inhibitor of histone deacetylase;Inhibitor of the histone deacetylases I and II,CHE-1,Direct Conversion of C. elegans Germ Cells into Specific Neuron Types,_,52,Phenotype is observed in the germ line of up to 52% of heat-shocked animals,2,_,Oliver Hobert; Paschalis Kratsios; Tulsi Patel;Baris Tursun,_